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SOMMARIO 
 
Introduzione: 
Lo sviluppo tecnologico degli ultimi 20 anni ha impegnato tutti gli sforzi al fine di 
implementare modalità innovative di imaging non invasive per accelerare la 
translazionalità dalla ricerca di base alla clinica, specialmente in ambito 
cardiologico.  
In questo lavoro è presentato e spiegato nel dettaglio, un innovativo approccio 
all’imaging cardiaco. Questo approccio è chiamato valutazione video cinematica 
(Vi.Ki.E. da Video Kinematic Evaluation) ed è in grado di monitorare, con modalità 
non invasiva, la cinetica e la deformazione cardiaca in-situ durante la chirurgia. La 
cinetica cardiaca è stata approfonditamente valutata spaziando dall’animale 
sperimentale alle patologie cardiache negli umani che colpiscono entrambi i 
ventricoli, destro e sinistro.  
 
Metodi: 
La tecnologia Vi.Ki.E. può essere definita “tanto semplice quanto innovativa”. 
Infatti, consiste semplicemente in una telecamera ad alta risoluzione temporale 
posizionata sopra un cuore battente in-situ, dopo esposizione tramite toracotomia e 
sospensione pericardica, che ne registra i cicli cardiaci. Successivamente un 
software di tracking è applicato al video precedentemente registrato per seguire i 
movimenti del tessuto epicardico. Questo tracker fornisce informazioni sulle 
traiettorie dell’epicardio e, grazie ad un algoritmo customizzato, la tecnologia 
recupera informazioni sulla meccanica cardiaca come forza di contrazione o fatica 
cardiaca, consumo energetico, velocità di contrazione, spostamento del marker e 
torsione epicardica. 
Questa tecnica è stata testata su 21 ratti (9 sottoposti a protocollo di 
ischemia/riperfusione e/o per le validazioni, 12 per lo studio sulla differenza di 
genere) e 37 pazienti sottoposti a differenti operazioni tra il 2015 e il 2019. Nel 
dettaglio 10 pazienti sono stati sottoposti a Bypass aortocoronarico, 12 hanno 
effettuato una sostituzione della valvola polmonare dopo riparazione chirurgica di 
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Tetralogia di Fallot, 6 sono stati sottoposti ad un impianto di assistenza ventricolare 
sinistra (LVAD) (1 di questi è stato spostato nel capitolo case study), 6 pazienti con 
cuore ipoplasico sono stati sottoposti ad interventi di GLENN o FONTAN, 2 
pazienti sono stati sottoposti a trapianto cardiaco ed infine 1 paziente ha ricevuto 
una doppia sostituzione valvolare (paziente spostato nel capitolo case study). 
 
Risultati: 
I risultati mostrano che in tutti i pazienti la tecnologia Vi.Ki.E. è stata in grado di 
discriminare in tempo reale, con potenza statistica, le differenze di cinetica cardiaca 
prima e dopo la chirurgia, suggerendo possibili implicazioni cliniche nel 
trattamento dei pazienti prima della chiusura del torace e/o in terapia intensiva. Per 
quanto riguarda gli animali sperimentali i risultati ottenuti sono alla base delle 
validazioni della tecnologia. Alcuni di essi sono stati usati come modello in 
comparazione coi risultati Vi.Ki.E. ottenuti da pazienti. 
 
Conclusioni: 
In conclusione, questo studio ha dimostrato che la tecnologia di valutazione video 
cinematica è sicura e non invasiva con una possibile e promettente applicazione 
clinica. La facilità della valutazione e l’approccio basato sull’algoritmo rendono il 
Vi.Ki.E. una tecnologia ad ampio spettro, in grado di acquisire dati dalle cellule 
battenti in vitro fino alla clinica, passando per la valutazione preclinica e 
possibilmente anche in quella ex-vivo come l’approccio nel cuore isolato di 
Langerdorff. 
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ABSTRACT 
 
Introduction: 
The technological development of the last 20 years pledges the intensity of efforts 
for implementing novel imaging contactless modalities that accelerate the 
translation from the research bench to the patient bedside, especially in the cardiac 
field. In this work, a novel intraoperative cardiac imaging approach, named Video 
Kinematic Evaluation (Vi.Ki.E.), is presented and explained in detail. This 
technology is able to monitor, contactless, the cardiac mechanics and deformation 
in-situ during heart surgery. Cardiac kinematics have been deeply evaluated ranging 
from the experimental animal approach to the human myocardial pathologies in 
both left and right ventricles.  
 
Methods: 
Vi.Ki.E. can be defined “as simple as innovative”. It only consists of a high-speed 
camera placed upon an exposed beating heart in-situ to record cardiac cycles. 
Afterwards a tracker software is used on the recorded video to follow the epicardial 
tissue movements. This tracker provides information about trajectories of the 
epicardium and, thanks to a custom-made algorithm, the technology supplies heart 
mechanical information such as: Force of contraction or cardiac fatigue, Energy 
expenditure, Contraction velocity, displacement of the marker and epicardial 
torsion. 
This approach has been tested on 21 rats (9 ischemia/reperfusion and/or for 
validation, 12 for the gender difference study) and on 37 patients who underwent 
different surgery between 2015 and 2019. In detail 10 patients underwent Coronary 
Artery Bypass Grafting, 12 underwent Valve Replacement after Tetralogy of Fallot 
correction surgery, 6 implanted a Left Ventricular Assist Device (1 is moved in the 
case study section), 6 patients with Hypoplastic Heart Syndrome underwent 
GLENN or FONTAN surgery, 2 patients underwent Heart Transplantation and 
finally 1 patient underwent double valve replacement (this patient is moved into 
case study section). 
6 
 
Results: 
The patients’ results demonstrated that the Vi.Ki.E. technology was able to 
discriminate, with statistic potency, the kinematic differences before and after the 
surgery in real-time, suggesting possible clinical implications in the treatment of 
the patients before the chest closure and/or in the intensive care unit. As it concerns 
the experimental animals, the results are the basics of the validation technology. 
Some of them were used as accepted model in comparison with the Vi.Ki.E. results 
on patients. 
 
Conclusions: 
In conclusion, this study has shown that Vi.Ki.E. is a safe and contactless 
technology with promising possible clinical application. The ease in the evaluation 
and the algorithm-based approach makes Video Kinematic Evaluation a widespread 
technique from cellular level to human cases covering the entire experimental field 
with in-vivo evaluation and possibly Langendorff/Working Heart approaches. 
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1. INTRODUCTION 
1.1. Cardiac Imaging 
Thanks to the technological development of the last 20 years, a lot of efforts have 
been spent to implement novel imaging technologies accelerating the translation 
from the research bench to patient bedside especially in the cardiac field. 
The main idea behind every technique must be the safety for the patients, ease in 
the analysis and the cost reduction. The concept of a single technology able to 
evaluate every cardiac pathological situation is still a utopia. However, the 
multitude of techniques around the cardiac field is the best way to provide the 
clinicians different points of view to extend the knowledge of the pathology and its 
course and minimizing the invasive surgical procedures when possible.  
 
The most important imaging branches in cardiology are: 
1. Echocardiography  
2. Nuclear Cardiology 
3. Cardiac Computer Tomography 
4. Magnetic Resonance [1] 
Brief but detailed information on those techniques will be presented in the 
following chapters. 
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1.1.1. Echocardiography (ECHO) 
The Echocardiography is based on the use of ultrasounds to create an image of the 
heart. Ultrasound results from a phenomena called the “piezoelectric effect”, a 
peculiar feature of some crystals to transform electrical oscillations into mechanical 
oscillations (sound) and vice versa [2]. The Echo machinery functioning is based 
on the piezoelectric crystal transducer. When a current is applied to it, the crystal 
vibrates emitting ultrasounds. Afterwards, the ultrasounds bounce on the object and 
return to the transducer, hitting and distorting the crystal. The distortion generates 
an electrical signal that is analyzed by the Echo machinery. In summary, the crystal 
emits ultrasounds and then “listens” for the reflections [3]. 
The Echocardiogram can be performed in many ways, but the most common are: 
- Transthoracic (TTE) 
- Transesophageal (TEE) 
The transthoracic is the most used for heart check-ups and for pathology diagnosis, 
while the transesophageal is commonly used during cardiac surgery to check the 
intervention phases and the correct heart functionality before the patient’s chest 
closure. In the TEE, the Echo probe is inserted in the anesthetized patient’s 
esophagus until it reaches the heart position. This is particularly useful to visualize 
the posterior side of the heart (Left Ventricle; LV).  
There are several different functions in every Echo machinery, and each gives a 
different heart point of view. 
- Two-dimensional (2D) imaging 
- M-Mode imaging 
- Doppler imaging 
- 3D echocardiography 
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2D imaging is the most 
used echo mode; it allows 
the detection of abnormal 
anatomy or abnormal 
movement of structures 
[4]. The most common 
cross-sectional views are 
the parasternal long axis, 
the parasternal short axis, 
and the apical view 
(Figure 1). These axes 
are only referred to the 
TTE. For the TEE, there 
are different views, the 
midesophageal four-chamber, the midesophageal short- and long-axis, and the 
transgastric views. 
 
M-mode (Figure 2) is a 1-dimension echocardiography derived from an M line 
superimposed on a cross-sectional image. It shows the time as the second 
dimension. Controlling the sweep speed gives access to accurate measurements of 
cardiac cycle intervals and thanks to the high-repetition frequency of the technique, 
precise measurements of mural thickness and cavitary size are obtained. In this way, 
the derived information is superior to the one obtained from cross-sections. M-
mode echocardiography is commonly used for the evaluation of left ventricular 
Figure 1. The most common two-dimensional imaging echo views. Upper 
panel illustrates the three planes (think of them as three plates of glass 
intersecting at 90°), the second line shows these three planes separated, and 
the third line shows the accompanying echo views. (a) Parasternal long axis; 
(b) parasternal short axis; (c) apical 4-chamber view (note, in the UK, the 4-
chamber view is shown upside down). AV: aortic valve; LA: left atrium; LV: 
left ventricle; RA: right atrium; RV: right ventricle. From [3] 
Figure 2. M-mode image of (a) the aorta/left atrium and (b) the mitral valve, both in a healthy heart. 
From [3] 
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function, using short- or long-axis cuts through the left ventricle, and the timing of 
cardiac events such as left ventricular ejection time, using a long-axis cut through 
the aortic valve [5]. 
 
Doppler Imaging merges the Doppler Effect with the imaging. The Doppler Effect 
is the change in the frequency of a wave emitted by a moving source in relation to 
the observer, caused by the different sound wavelengths (frequencies) travelling in 
the air. The same approach is used to measure the blood flow velocity by comparing 
the frequency change between the transmitted and reflected sound waves [4]. In 
cardiac ultrasound, Doppler is used in three ways: 
- Continuous-wave (CW) Doppler 
- Pulsed wave (PW) Doppler 
- Color-flow mapping (CFM) or Color Doppler 
 
CW Doppler (Figure 3) does not provide 
spatial information since one crystal 
transmitting continuously and another 
recording continuously to read reflected 
signals. It estimates the severity of valve 
stenosis or regurgitation.  
 
PW Doppler was created to overcome the spatial information limit on CW Doppler. 
It simply consists in a transducer emitting intermittently and reading returning 
signals in the time interval between two waves. This provides spatial information 
like conventional 2D mode while recording the blood flow velocities. The 
limitation of this modality lies in the pulse velocities that is limited by the returning 
signals time. If the transducer emits faster than the signal returns, the Aliasing effect 
will occur [5]. PW Doppler is used to assess ventricular in-flow patterns, intra-
cardiac shunts and to make precise measurements of blood flow at valve orifices 
[4]. 
 
Figure 3. Example of Continuous wave doppler 
signal. From [3] 
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Color-flow mapping (CFM) or Color Doppler 
displays the blood direction and flow velocities 
superimposed on the image. A color is assigned to 
the flow direction; blue if the flow is going away 
from the transducer and red if the flow is going 
towards the transducer (Figure 4). The velocity of 
flow is displayed in blue and red shades; the faster 
the flow, the brighter the color. CFM is a modality 
of PW Doppler, so it doesn’t avoid the limitation of the Aliasing effect [5]. 
 
Echocardiography has been used since 1953 thanks to the collaborations between 
Edler and Hertz [6]. Echocardiography is the gold standard for cardiac imaging and 
diagnostic evaluation. It is very hard to find limitations in such an old and upgraded 
technology. However, technological imaging evolution is running faster, especially 
concerning spatial and temporal resolution. From this point of view 
echocardiography suffers from significant limitations due to the very low framerate 
and limited image resolution [5]. Some Echo machineries have been developed to 
overcome those limitations, but the costs make them affordable only to prestigious 
health care centers. Therefore, the standard cheap echo machinery, with all its 
limitations, remains the most used. Another echo limitation is the skill-based 
parameters evaluation, considering the sensibility and difficulty to properly set the 
probe. This results in different values from the same heart based on the technician’s 
skill. Finally, during the surgical procedures the only available echo is the TEE that 
provides useful Left Ventricle information while only providing qualitative 
information of the Right Ventricle [7]. Moreover, TEE leads to misinterpretations 
on patient’s prognosis, especially in those with Right Ventricle based pathologies, 
i.e. most of the congenital heart diseases. In some limited case the TEE can cause 
ventricular fibrillation after the probe insertion in the esophagus, due to the 
mechanical stimulation of cardiac structures [8].   
Figure 4. Example of Color Flow 
Mapping. From [3] 
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3D echocardiography is used to overcome the 
above-mentioned limitations. It offers the 
possibility of having 3D heart images from any 
spatial point of view. This is possible thanks to the 
particular “array” 3D probe (Figure 5) that uses 
thousands of fully sampled elements for 360-
degree focusing and steering. 3D 
echocardiography provides information about 
volumes and functionality of heart chambers [9].  
The 3D echo is usable in both TTE and TEE, with two main advantages compared 
to the conventional 2D echo and M-mode evaluation (Figure 6): 
- Quantification of absolute cardiac chambers volumes (LV and RV), and left 
atrial (LA) volumes and their function [9]. 
- Visualization of 3D structures and dynamic motion images of the heart, 
especially of heart valve conformations [9]. 
  
M-mode 2D echo 3D echo 
Figure 6. Functionality comparison between the linear M-mode evaluation (Left panel), conventional 2D Echo (middle 
panel) and 3D echo (right panel). Modified from “Basics of Real Time 3D Echocardiography” Erasmus MC University 
Medical Center of Rotterdam. 
Figure 5. Example of 3D echo transducer 
array functioning. Modified from 
“Basics of Real Time 3D 
Echocardiography” Erasmus MC 
University Medical Center of Rotterdam. 
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These two fundamental advantages could open new prospective on heart structures 
and functionality. However, 3D echo entails some strong limitations derived from 
the ultrasound procedures. As for 2D echo, the 3D echo image quality is limited by 
the acoustic windows. The spatial and temporal resolution of current 3D echo 
technology are still inferior to the 2D echo. 
  
There are two different 3D data acquisition modes. 
- The multi-beat acquisitions 
- Real-time 3D mode 
 
Multi-beat acquisition allows faster acquisition of a thin section of a 3D pyramidal 
volume. However, it requires four cardiac cycles and gated capture to reconstruct 
the 3D image. Therefore, it is prone to stitch artifacts in patients with rhythm 
disturbance and respiratory motion [10].  
Real-time imaging captures the entire heart movement in a single beat overcoming 
the limitations of multi-beat mode, but suffering deteriorations in spatio-temporal 
resolution [10].  
 
Because of these limitations, the use of 3D echo remains an uncommon and little 
widespread practice. This leads to a limited number of 3D echo specialists further 
reducing its use.  
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1.1.2.  Nuclear Cardiology 
Nuclear cardiology is based on the injection of a radioactive dye in the patient’s 
body. An imaging machine (gamma camera, Figure 7), sensible to radioactive 
elements, creates pictures of the blood flow. The test is performed in resting and/or 
exercise state to evaluate possible areas with reduced blood flow or damage [11, 
12].  
According to the American Society of Nuclear Cardiology, there are several uses 
for this imaging branch. The most important are: 
- Myocardial perfusion scintigraphy (MPS) 
- Evaluation of Cardiac Function with Radionuclide Ventriculography 
(RNV) 
- Assessment of Myocardial Injury, Infarction and Infection 
- Imaging of the Nervous System of the Heart 
- Positron Emission Tomography (PET) 
 
Myocardial perfusion scintigraphy is the mainstay of the nuclear cardiology for 
the coronary artery health evaluation.  It is performed by the use of single-photon 
emission computer tomography (SPECT; Figure 7, right panel, MIBI) evaluated by 
a gamma camera [12]. This test is usually performed in resting conditions and then 
Figure 7. Example of a gamma camera and the results it provides. After the injection of a radioactive 
dye, a patient is evaluated by a gamma camera (left panel). The data provided from the machinery (right 
panel) give estimation of cardiac blood flow. Moreover, the right panel shows the differences between 
two radioactive dyes used in two different techniques the SPECT (top panel) and the PET (bottom 
panel): F-18 flurpiridaz PET (FLUR) versus Tc-99m MIBI SPECT (MIBI). “Reversible perfusion 
defect in the anterior and antero-septal wall is readily seen in a patient with left anterior descending 
coronary artery occlusion using F-18 flurpiridaz PET but the perfusion abnormality is not clearly 
appreciated using Tc-99m MIBI SPECT.”  Modified from [10]. 
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during exercise (stress test) to assess differences in cardiac function. In patients 
with respiratory disorders, the stress test is performed with pharmacological 
administration such as dipyridamole, adenosine, regadenoson or dobutamine [12, 
13]. If there is a blockage in the coronary artery, the blood flow supply will be 
inefficient to support the exercise. The gamma machinery detects (nowadays 
automatically) the decrease in the blood flow. 
 
The Evaluation of Cardiac Function 
with Radionuclide Ventriculography 
(RNV) is a non-invasive test to assess the 
pumping function of the heart (Figure 8). 
This technique can also provide 
information about the function of the 
valves, the integrity of the cardiac 
chambers and can be used to monitor the 
effect of different drugs on the heart 
muscle. RNV is still one of the gold 
standard methods for the measurement of LV ejection fraction (LVEF).  
 
Assessment of Myocardial Injury, Infarction and Infection. Limited blood 
supply or inflammation can heavily or irreversibly impair cardiac cellular function. 
Nuclear cardiology techniques can be used to determine which areas of the heart 
muscle have been damaged by infection or by a stroke (Figure 7, STRESS FLUR, 
SHORT AXIS, MID).  
  
Imaging of the Nervous System of the Heart. The cardiac nervous system is 
crucial for its proper functioning. When there is a damage in the heart muscle, the 
nervous system can be impaired with an abnormal function of the electrical system, 
possibly leading to Ventricular Tachycardia (VT). An abnormal heart rate and 
disarray of the normal cardiac rhythm can reveal this abnormality.  
Figure 8. Polar maps and histograms from a RNV 
evaluation. Top panel shows a normal subject; 
bottom panel shows mechanical cardiac disease 
(myocardial infarction). Modified from [11] 
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Positron Emission Tomography (PET) was developed to be more precise than 
SPECT and, nowadays, is used to provide information about either the blood supply 
to the heart muscle and the metabolic activity of the heart [14]. To date, there are 
different opinions concerning which technology gives the most reliable and precise 
data. Accordingly to Dr. Daniel J Bell, lead for radiology 2014-18 at the North 
Middlesex University Hospital (London), the main differences between SPECT and 
PET are the following: 
PET: 
- Very expensive. A PET CT-scanner is around $2 million 
- Uses positron-emitting radioisotope as tracer, in detail the fluorine-18 
(FDG) (Figure 7, FLUR) 
- Better contrast and spatial resolution (Figure 7) 
SPECT: 
- Lower cost. A SPECT scanner gamma camera costs from $400,000 to 
$600,000 
- Uses gamma-emitting radioisotope as tracers; in detail technetium-99m 
(Figure 7, MIBI), iodine-123, iodine-131 
- Less contrast and spatial resolution (Figure 7) 
 
For most of the clinicians, “PET is just a bit better than SPECT” but it costs too 
much which is the reason why PET still has not replaced SPECT as the Gold 
standard for the Nuclear Cardiology. 
 
Nuclear Cardiology has been the main nuclear base technique in medicine for 
several decades. The development of new imaging technologies like CT, as well as 
MR, has raised the question about the usefulness of Nuclear Cardiology. In the 
recent guidelines for Nuclear Cardiology [13], the effect of radioactive dyes on 
patients has been highlighted as well as the pharmacological impact, to mimic the 
stress test, in subjects with respiratory impairment. Another strong limitation for 
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both SPECT and PET is the poor contrast and spatial resolution. However, the 
Nuclear Cardiology has accomplished remarkable achievements and, also thanks to 
the development of novel radiopharmaceuticals, still holds promise as one of the 
major imaging techniques in medicine.  
 
1.1.3. Cardiac Computed Tomography  
Cardiac computed tomography (CT) scan uses x-rays to make detailed pictures of 
the heart [15]. The picture is created merging different 2D radiographic images 
(slices) rotating on the same axis to create a full 3D cross-sectional image [15]. 
There are several types of CT scanners and the basic difference is the number of 
slices the machinery can reproduce per second (64, 256 or 320). More slices, it 
means the highest image quality. The 320 slices cost around two and half times the 
64 slices ($2.5 million vs $1 million) and whether it is worth it or not, is still a 
matter of debate in the clinical community. 
The routinely use of cardiac CT concerns the evaluation of cardiac or coronary 
anatomy, to diagnose the coronary artery disease (CAD), to monitor coronary artery 
bypass surgery and/or implanted coronary stents and finally to calculate chambers 
volumes and cardiac function (including ejection fraction) [16]. 
The main analyses performed by the cardiac CT are: 
- Calcium scoring 
- Coronary CT angiography 
o Retrospectively ECG-gated cCTA protocols 
o Prospectively ECG-gated cCTA protocols 
- Ventricles Function 
 
Calcium scoring. Coronary artery calcium results from the sedimentation of 
substances over time which have hardened and become calcified. This is well 
documented in coronary atherosclerosis, where atherosclerotic plaques become 
calcified in the latest stages of the pathology leading to CAD [17]. 
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A calcium score is obtained using a 
validated algorithm. The algorithm is 
based on the Agatston score who 
introduced a useful application to CT 
scan back in 1990 [16]. 
The score is calculated using the area 
and a weighted value related to the 
density of calcification. 
A structure with an area of at least 1 
mm2 and a density greater than 130 
Hounsfield unit (HU) is considered a 
calcified locus. If the locus 
corresponds to an anatomical position 
of a coronary, it represents a calcified 
CAD plaque (Figure 9). A score of 1 is assigned for a value of 130–199 HU, a score 
of 2 for 200–299 HU, 3 for 300–399 HU, and a score of 4 for values of 400 HU and 
higher. The weighted score is multiplied by the area of the coronary to obtain the 
Agatston score [16]. Although this technique does not give any hemodynamic 
information about stenosis, the Agatston score is very useful to calculate the early 
risk stratification for patients. Patients with a score above 160 have an increased 
risk for a major adverse cardiac event. Moreover, results from a large Multi-Ethnic 
Study of Atherosclerosis (MESA) showed that a calcium score twofold higher than 
normal increased the probability of major coronary events by approximately 25% 
[18]. 
 
Coronary CT angiography can show coronaries without the risks associated with 
invasive treatments. It provides information on their anatomy highlighting the 
possible non- or obstructive CAD and plaque characteristics (Figure 10, left panel). 
CT angiography is possible due to the injection of a contrast fluid into the 
bloodstream. When the fluid reaches the anatomical site under examination, a 
picture is taken. Images are usually acquired based on patient’s electrocardiogram 
(ECG) phases (Figure 10, right panel). 
Figure 9. Coronary calcium within the left anterior 
descending artery. The calcium is seen as bright white and is 
highlighted by the red arrow. Modified from [15]. 
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Indeed, for most patients, the best moment to acquire images is when the heart is 
fully relaxed; in the ECG this phase is approximatively at 75% of the R-R interval 
(the distance between two R peaks) in mid-diastole (Figure 10, right panel, b, c) 
[16]. Methods of image acquisition can be Retrospective or Prospective. 
 
Retrospective studies use X-Ray beams during the R-R interval with a full dose of 
radiation (Figure 10, right panel, a). Due to the high level of radiation on the 
patients, nowadays it is common to use ECG-modulated dosage consisting in basal 
low dosage increased when the 75% along the R–R cycle is reached (Figure 10, 
right panel, b). This upgrade provides high-quality images while decreases the 
amount of radiation emitted [16]. 
Retrospective studies use a standard spiral CT acquisition. The heart rhythm is 
detected, and the machinery scans the whole heart during multiple cardiac cycles. 
Finally, information from different phases of the cardiac cycle is obtained and used 
as trigger for the radiation emission.  
 
Prospective studies use prediction of R wave timing to the image acquisition and 
the radiation emission. It allows to have a fixed table without spiral CT and most of 
all to limit the radiation on the patient only at the 75% of the R-R cycle (Figure 10, 
right panel, c). The main issue of the prospective study is that it requires a stable 
heart rate, otherwise image acquisition may not occur at every heartbeat. 
Consequently, there may be a longer acquisition time and radiation exposure than 
Figure 10. Left Panel: Coronary CTA showing a severe proximal left anterior descending artery lesion highlighted 
by the red arrow. Note the lack of calcium in this lesion. Right panel: Diagram showing ECG (black line) and 
radiation windows from different methods (gray zones). (a) Full dose radiation retrospective study (b) ECG-
modulated dose radiation retrospective study at 75% R-R cycle (c) Prospective imaging during which the radiation 
exposure occurs only during mid-diastole.  Modified from [15]. 
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in retrospective studies, making it more sensible to heart rate and breathing artefacts 
and so less useful [16].  
 
Ventricles Function 
With the advent of the new technological 
expansion in the last 20 years, a lot of 
improvements to CT have been made. 
Dual-source CT scanners allow to acquire 
in a modality called High-pitch. It permits 
to have an image just with a single high 
source of radiation triggered with ECG, in 
the same way of the prospective study, in 
less than a second. In combination with 
reconstruction technique (such MRI or 
SPECT) it is possible to measure chambers 
functional parameters such as left and right 
ventricular end-diastolic and end-systolic 
volumes, stroke volume, ejection fraction, 
and myocardial mass during the entire 
heartbeat [15] (Figure 11). 
 
 
Even if the CT scan is widely used in clinic, it shows several limitations. The first 
one is the radiation emission that, even in the prospective studies, where the 
emission is limited to a short period of time, is correlated with lifetime attributable 
risk (LAR) of cancer development in both simulation study and patients [19, 20]. 
As it concerns the machinery accuracy the 64-slices imply 5 to 10 seconds to 
acquire images leading to possible artefacts and diagnostic positive- negative-false 
due to the patients’ motion, arrhythmias and breath-hold failure. The introduction 
of new but extremely expensive 256- 320-slices with faster rotation and short 
scanning time has improved but not eliminated the tendency for artefacts. 
Figure 11. Evaluation of left ventricular function 
and volume via dual-source CT scanner. By tracing 
endocardial contours (red line in both top left and 
right images) of end-systolic and end-diastolic short- 
and long-axis views, left ventricular volumes and 
left ventricular ejection fraction can be derived from 
multidetector row computed tomography 
reconstruction. Modified from [14]. 
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Other limitations with cardiac CT are the use of pharmaceutical drugs for every 
scanning method like beta-blockers and sublingual nitrate, potential allergic 
reactions to the injected contrast fluid as well as its renal toxicity and finally poor 
contrast filling of distal vessels that could lead to diagnostic uncertainty [15]. 
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1.1.4.  Magnetic Resonance 
Magnetic resonance imaging (MRI) is a scanning technique able to provide detailed 
images of the inner body structures. The technology is based on a strong magnetic 
field and radio waves to generate images. The human body is roughly composed 
for 70% of water which contains hydrogen nuclei (protons) that become aligned in 
a magnetic field. An MRI scanner applies a strong magnetic field (usually 1.5 
Tesla), which aligns the proton "spins". This alignment (or magnetization) is next 
perturbed by the application of an external Radio Frequency (RF) energy. The 
protons absorb the energy from the magnetic field and flip their spins. When the 
field is turned off, the protons gradually return to their normal spin (relaxation 
process) producing a radio signal that can be measured by receivers in the scanner 
and converted into an image [21].  
The MRI in the cardiac field (named CMR) is used for assessing infarcted regions 
and their relative late wall thinning, LV volumes, distortion of LV shape and 
compensatory hypertrophy of non-infarcted myocardium [22]. MRI is also used for 
ischemic/non-ischemic heart diseases, as well as heart failure and congenital heart 
disease [23, 24]. 
 
Tissues can be characterized by two different relaxation times, T1 and T2.  
- T1 (longitudinal relaxation time) is the time constant which determines the 
rate at which excited protons return to equilibrium. It is a measure of the 
time taken for spinning protons to realign with the external magnetic field. 
- T2 (transverse relaxation time) is the time constant which determines the 
rate at which excited protons reach equilibrium or go out of phase with each 
other [25]. 
 
The most used modality for CMR is the pulse mode or pulse sequence. 
A pulse sequence is a series of RF pulses to produce MRI signals. Different types 
of pulses generate different image contrasts due to different T1 or T2 values. The 
two major pulses sequences are:  
- Spin-Echo (SE) sequence 
- Gradient-Echo (GRE) sequence [21]  
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Spin-Echo sequence. In this modality, a 90° RF is firstly applied to rotate the 
magnetization. When the proton relaxation starts, another 180° RF or a series of 
180° RF impulses are applied to refocus the decaying transverse magnetization and 
produce a signal, called spin echo.  
The most important parameters in the SE are echo time (TE) and repetition time 
(TR); TE is the time from the application of the 90° RF pulse to the formation of 
the spin echo, and TR is the time from the 90° RF pulse to the next 90° RF pulse. 
Those parameters are useful because:  
- short TR and short TE produce T1-weighted contrast  
- long TR and long TE produce T2-weighted contrast  
- long TR and short TE produce proton-density-weighted contrast. 
 Spin echo-sequence requires time to acquire an image, resulting in a blur effect 
when fitting one beat in one image, thus requiring to merge different images to 
obtain an entire beat. It is used primarily for the Dark Blood imaging (Figure 12, 
left panel) to evaluate LV chamber [21, 26].  
 
Gradient-Echo (GRE) sequence uses a weaker RF pulse, compared to that of SE, 
to move the magnetization by a small angle and refocus the decaying transverse 
magnetization through a bipolar magnetic gradient. The echo signal produced by 
the GRE sequence is called the gradient echo or field echo. These modifications 
allow TR in the GRE sequence to be as short as tens of milliseconds or less in the 
upgraded machinery.  
It is used primarily for Bright Blood imaging (Figure 12, right panel) to evaluate 
global and segmental LV function. It has been used for measurements of LV mass, 
myocardial perfusion, blood flow and coronary anatomy [21, 26]. 
 
 
 
 
 
 
  
Figure 12. Black blood imaging (spin 
echo, left panel) and bright blood 
imaging (gradient echo, right panel) 
obtainer by MRI. Modified from [25]. 
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Cine MRI modality is made to capture a sequence of images in motion of the 
cardiac cycle, displaying the cardiac motion in a cine loop way. Differences 
between the myocardium and blood allow visualizing changes in the cardiac 
chambers and ventricular walls. Thus, it allows an easy quantification of the 
ventricular function and local wall motion and provides important information 
about the cardiac function. Accurate quantification of the RV is important for 
congenital heart disease, such as Tetralogy of Fallot, transposition of great arteries 
and arrhythmogenic RV dysplasia. [21] 
 
Perfusion MRI (Late gadolinium enhancement MRI; LGE-MRI). As stated 
before, the human body is roughly composed for 70% of water and this is the focal 
basis of the MRI functioning. For this reason, the best choice for a contrast agent is 
a water-soluble one. Gadolinium (Gd) is a water-soluble chelated agent that lies in 
the intravascular space and permeates the interstitial space of tissues except for the 
brain (due to the blood brain barrier). Therefore, with Gd injection it is possible to 
assess the myocardium state. A healthy tissue will display different Gd 
concentration curves compared to a pathological one due to the different kinetics. 
Moreover, pathological myocardium has larger interstitial space, compared to the 
healthy one, due to the loss of intact myocardium in infracted/scarred hearts. 
Since the Gd is a contrast agent that predominantly shortens the longitudinal 
relaxation time (T1) of the proton spins, abnormal myocardium with increased Gd 
concentration will show signal enhancement on MRI images (hyperenhancement) 
(Figure 13) [21, 26]. 
  
Ischemic scar Acute Myocarditis 
Figure 13. Different hyperenhancement patterns in different 
pathologies. Left panel: ischemic cardiomyopathy. Right panel Acute 
Myocarditis. Red arrows: hyper enhanced regions. Modified from [20]. 
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Myocardial T1 mapping. LGE-MRI alone is not efficient to evaluate fibrosis 
because the signal intensity of the affected myocardium is not enhanced. Therefore, 
the quantification of T1 relaxation time is used to provide information about 
fibrosis. The modified Look-Locker inversion recovery (MOLLI) sequence is a 
novel pulse sequence that allows T1 quantification of the myocardium [26].  
Using the Gd injection as contrast agent, T1 of healthy and pathological 
myocardium shows different behaviors, with normal myocardium displaying high 
T1 compared to the pathological one or LV cavity [27]. T1 values similar or lower 
than the LV cavity blood are used as index of abnormal Gd accumulation in the 
myocardium due to a higher level of fibrosis. 
The main limitation of T1 mapping lies in the results highly dose dependent. 
Therefore, clinicians need to standardize the optimal dose, especially in patients 
with impaired kidney or chronic renal diseases [26]. Another important limitation 
consist in the lack of standard physiological values approved by the scientific 
community.  
 
Myocardial T2 mapping. T2 relaxation time evaluation is used to reconstruct a 
parametric image. As stated before, the accumulation of water in the myocardium 
is associated with pathology. Studying the T2 relaxation time could be useful to 
identify myocardial regions with water accumulation or edema, specific 
characteristics of Acute Myocardial Infractions (AMI). This is important to identify 
salvageable myocardial tissue that is highly associated with short- and long-term 
survival after AMI [21, 26].  
 
MRI has introduced a very important upgrade in the cardiac imaging field 
especially for its safety avoiding radiations and contrast agents with adverse 
reactions. However, MRI machineries are very expensive and it takes long time to 
perform a proper investigation. Furthermore, the lack of standard examination 
protocols limits the possible comparisons in different studies to set proper clinical 
guidelines [21]. 
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1.2. Video Kinematic Evaluation (Vi.Ki.E.) 
 
1.2.1. Introduction 
The cardiac imaging field has grown faster in the last three decades reaching a very 
accurate diagnostic and prognostic capability. However, even if there is a fully 
comprehension in both diagnosis and prognosis, there is still a big gap in the 
intraoperative evaluation of cardiac parameters. As well as the patients lie down 
unconscious on the surgical table, the cardiac evaluation during surgery is 
suspended. None can evaluate intraoperative cardiac parameter in surgery that 
requires aortic clamping with the consequent cessation of the heart beats. However, 
all the normothermic surgeries performed at beating heart, as well as heart 
transplantation or LVAD implantations, impacts immediately and strongly on heart. 
 
Will these heavy and invasive procedures have an impact directly on the heart 
functionality? Will the cardiac modifications (patches, VAD, transplanted heart) 
lead to the future development of pathological situations? 
Is it really necessary to preventively operate young patients or it would be better to 
postpone the surgery by waiting the pathology progression?  
 
To date there are no answers and many clinical trials are trying to figure out which 
parameters should be used as diagnostic/prognostic markers, like a sort of “Holy 
grail” rush. 
 
Video Kinematic Evaluation has been developed to provide a novel point of view 
trying to answer some of the above questions. 
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1.2.2. Vi.Ki.E. functioning 
Vi.Ki.E. technology is as simple as innovative. It only consists of a high-speed 
camera (from 200 fps in humans, up to 1700 fps in animals) positioned above the 
open chest (Figure 14, a) recording cardiac cycles after the pericardial suspension. 
A virtual tracking allows to follow the epicardial movement of the heart in the 
recorded video (Figure 14, b), providing its trajectories (Figure 14, c) and Video 
Cardiograms (ViCGs) (Figure 14, d). Furthermore, a custom-made algorithm 
evaluates trajectories and ViCGs, converting them into kinematic parameters, based 
on Hamiltonian mechanics (Table 1). All the parameters are shown in real-time to 
surgeons in the operating room, providing data about mechanical performance 
progression of the heart [28, 29]. 
 
 
Figure 14. Workflow with video camera positioning, video recording, evaluation of the systolic and diastolic phases and 
Vi.Ki.E. parameters. (a) Schematic representation of the camera positioned using an extensible tripod on top of the open 
chest. (b) Sequence of video frames captured at 200 fps from a human beating heart with the video marker (red circle) 
‘anchored’ to the cardiac tissue while moving in x-y directions. (c) Counterclockwise trajectories of contraction (left to 
right) and relaxation (right to left) for every cardiac cycle with related acceleration vectors (pink arrows). (d) Video 
cardiogram (ViCG) showing the velocity of a selected video marker with contraction/relaxation peaks and peak-to-peak 
intervals.  
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1.2.3. Camera speed selection 
The camera speed selection is crucial. In this work, two different cameras have been 
used. A 200 fps camera for the operating room, and a fast 500 to 1000 fps camera 
for the experimental animals [30]. The selection of a slower camera for patients’ 
evaluation and a faster one for the experimental animals is due to two main aspects: 
- In the operating room, the spaces are limited, thus the necessity to use a 
small camera, working with a USB 3.0 linked to a laptop. Furthermore, the 
human heart counts approximately 75 beats/minute, usually lowered by 
anesthesia (around 1 beat per second). Therefore, 200 frames in one second 
lead to a very high accuracy sampling (1 image every 5ms) that is extremely 
accurate to study human phenomena like mechanical ventricular systole 
(300-400ms) and diastole (400-500ms). 
- In the laboratory, there is almost no space limitation, thus, the possibility to 
use a 500 to 1000 fps camera which requires a very complex and bulky 
series of equipment connections to properly work. Furthermore, the rat 
heart, under anesthesia, has in average 240 beats/minute, approximately 1 
beat every 250ms. Therefore, the sampling is 1 image each ms (1000 fps) 
or 1 every 2ms (500 fps), that are both accurate to record mechanical 
ventricular systole (80-90ms) and diastole (140-150ms). 
Parameter name Formula Physiological meaning 
Displacement [pixel] U=dx 
Marker displacement between 2 consecutive video 
frames: it estimates the instantaneous movement of the 
cardiac tissue and builds the marker trajectory. 
Velocity [pixel/s] v=dx/dt 
Marker velocity between 2 consecutive video frames: it 
estimates the instantaneous motility or contractility of the 
cardiac tissue and builds the marker trajectory. 
Kinetic energy [pixel2/s2] E=½v2 
Marker kinetic energy between 2 consecutive video 
frames: it estimates the consumption of ATP to generate 
the cardiac movement. 
Frequency [Hz] f=beat number/video duration 
Contraction frequency calculated from the cardiac beats 
identified. 
Acceleration [pixel/s2] a=dv/dt 
Marker acceleration between 2 consecutive video frames: 
it estimates the instantaneous variation of the motility of 
the cardiac tissue and builds the marker trajectory. 
Force [N] F=ma Cardiac force moving the mass m. 
Table 1. Table displaying kinematic and dynamic parameters calculated with their physiological meaning. According to 
classical and Hamiltonian mechanics, x(t) is the position vector (pixel) in the coordinate system (x, y) of an orthonormal 
Euclidean space, where t is the time (s). 
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In the first Vi.Ki.E. publication [28], it was highlighted, in a rat model, the effect 
of different frame rates on trajectories, and consequently on data, as shown in 
Figure 15. 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 15. Marker’s trajectories and the related velocity vectors obtained at different 
acquisition rates. The rate of 500 fps (a) gave the best trajectory details, the rates of 
250 (b), 125 (c), 100 (d), and 50 (e) could be considered acceptable, whereas the 
other lower rates (≤25 fps in f) were significantly affected by the aliasing 
phenomenon with loss of trajectory details. 
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1.2.4. Trajectories and Video cardiograms: a qualitative point of 
view 
The cardiac tracking software provides a .csv file that, after its conversion in .txt 
format, is ready to be open by the custom-made algorithm in MATLAB (The 
MathWorks, Inc., Natick, MA, USA). 
Trajectories and ViCGs are, respectively, the main information on cardiac cycle 
and marker movement and all the Vi.Ki.E. parameters are calculated from them.  
The visualization of both Trajectories and ViCGs, however, is mainly qualitative. 
Indeed, Trajectories provides information about cardiac cycles as shown in Figure 
16. The cardiac cycles overlapping denotes a conserved mechanic of the beats 
(Figure 16, B, top panel). On the contrary, a spread trajectory denotes an impaired 
cardiac mechanics (Figure 16, A, top panel). Furthermore, trajectories provide 
information on systolic and diastolic phase, but they differ according to the position 
of the camera upon the heart (Human: left to right systole, Figure 14, c; Animals: 
left to right diastole, [30])  
Video cardiograms provide information about Marker velocities and/or 
acceleration, and their visualization can be used for qualitative speculation. As 
shown in Figure 16, A, middle and bottom panel, it is challenging for a beginner, 
and some time even for experts, to distinguish beats from spikes or noise signals, 
denoting an impaired cardiac mechanics. The opposite occurs in B, middle and 
bottom panels of the same figure, where the peaks are clear, with a constant distance 
between them, denoting a good mechanical behavior. 
Even if these parameters can help the operators to have a global idea on mechanical 
heart behavior, they cannot assess the cardiac function. In several cases, as LVAD 
implantation, trajectories are strongly impaired by the implantation, limiting the 
cardiac movement, and resulting in useless data.  
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Figure 16. Visualization of epicardial marker trajectories in a patient before surgery (column A) and after surgery 
(column B) and their related video cardiograms. Top panels: trajectories. Middle panels: video cardiograms on X axis. 
Bottom panels: video cardiograms on Y axis. To note trajectories in B are more conserved, even if shifted, compared to 
A where they are randomized. The same observation can be made for the repetitive patterns of video cardiograms in B 
column compared to A column.  
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1.2.5. Mechanical parameters explanation and physiological 
meaning 
The quantitative measures of the video kinematic evaluation are based on the 
Hamiltonian mechanics, thus based on the Kinetic Energy. Briefly, the Newtonian 
equation of motion (F=m*a) can be easily obtained not from the acceleration (which 
is easy to understand, but challenging to apply), but from the gradient of the total 
energy of the mechanical system. The total energy, also called “Hamiltonian 
function” is the sum of the kinetic and potential energies. In the Vi.Ki.E. specific 
case the potential energy of the heart system is supposed to be uniform in space 
since the concentration of ATP inside the tissue is uniform [31]. Therefore the 
mechanical force F is just the gradient (first derivate) of the kinetic energy.   
 
The Vi.Ki.E. algorithm, uses those formulas to obtain precise values starting from 
trajectories and Video Cardiograms, in other words, from the marker position and 
its velocity and acceleration in each frame. 
As stated in Table 1 the main parameters are: 
- Displacement (pixel); the instantaneous movement of the cardiac tissue in x 
and y directions; it builds the temporal-spatial trajectory. 
- Velocity (pixel/s); the instantaneous motility or contractility of the cardiac 
tissue; it builds the temporal-spatial trajectory.  
- Kinetic Energy (pixel2/s2); an estimation of the consumption of ATP for the 
generation of cardiac movement. 
- Frequency (Hz); contraction frequency calculated from the identified 
cardiac beats. 
- Acceleration (pixel/s2); the instantaneous variation of the cardiac tissue 
motility; it builds the temporal-spatial trajectory. 
- Force (N); cardiac force moving a mass [28]. 
 
The most relevant parameters for both clinical and experimental fields are the 
Energy and the Force. 
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The Energy, as stated in before, is an estimation of the ATP consumption [31]. This 
is very important because it can be used as a prognostic marker. 
Force is expressed in Newton, and it implicates a “mass” and an “acceleration” 
(F=m*a). In the next chapter, it will be explained in detail how the force was 
validated, but briefly, a note mass was attached on the epicardium and followed 
with the video Marker. 
In human surgery, it is not impossible to attach some mass onto the epicardium, 
especially for a whole ventricle evaluation. For this reason, the light is used as the 
“mass” to follow with video Marker, assuming that the weight of the light is unitary. 
Therefore, the Force is equal to the acceleration.  
In the clinical bench, the Force is not the real heart force of contraction because, as 
stated, we do not consider the real mass of the heart. However, Force parameter 
provides an evaluation of Cardiac Fatigue that can be very useful as a clinical 
marker. 
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1.3. Particle Image Velocimetry (PIV) 
In this work, a modified version of the well-known Particle Image Velocimetry 
(PIV) tool was adopted, in some cases, to further investigate the epicardial 
deformation of the heart. This software is used in literature to evaluate the motion 
of liquids “particle by particle” [32]. Adapting the software to the cardiac surface, 
as it would be a fluid, is useful to obtain interesting data about the epicardial 
velocity and the rotation frequency of its vectors that estimates the epicardial 
torsion as shown in Figure 17. 
  
Figure 17. PIV visualization of epicardial torsion. Six different frames from a video evaluation made by PIV (From A 
to F). Red arrows: velocity vectors. Blu Graph: visualization of the mean velocity for each frame visualized by the red 
dashed line. 
To note the rotational behavior of the Velocity vectors through the frames. This provide an estimation of epicardial 
torsion. 
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1.4. The Vi.Ki.E. competitive advantage 
 
In this chapter a summary of all the pros and cons of the technologies explained 
above will be presented, and it will be displayed which competitive advantage the 
Vi.Ki.E. approach can contribute to the cardiac imaging theater. 
 
Echography 
- Transthoracic Echocardiography: 
o Pros: Non-invasive 
                     Gold standard for the diagnostic evaluation 
                     Detects four-chambers anatomy and function in addition to  
                        wall thickness and cavitary sizes  
                     Provides information about blood flow 
o Cons: Not possible to use during cardiac surgery 
          Highly skill dependent 
          Requires time to obtain diagnostic data 
          Low image spatial and temporal resolution 
 
- Transesophageal Echocardiography: 
o Pros: Gold standard for the cardiac evaluation during surgery 
         Optimal LV evaluation (anatomy, function, wall thickness,    
 cavitary sizes) 
         Provides information about blood flow 
o Cons: Invasive 
          Risk of adverse events (ventricular fibrillation) 
          Does not evaluate the RV (provides only qualitative     
            information) 
          Highly skill dependent 
          Requires time to obtain diagnostic data 
          Low image spatial and temporal resolution 
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Nuclear Cardiology 
- Pros: Gold standard for the artery health evaluation (SPECT-MPS) and   
           provides information about both the blood supply to the heart muscle   
            and the metabolic activity of the heart (PET) 
         Detects chambers anatomy, valve function, and ventricles pumping  
           function with RNV   
         Assessment of Myocardial Injury, Infarction and Infection  
         Imaging of the Nervous System of the Heart  
- Cons: Side effects due to the radioactive dye injected  
          Limited use since the advent of CT and MRI 
          Low image spatial and temporal resolution  
 
Cardiac Computer Tomography 
- Pros: Calcium sedimentation in the coronaries (Calcium scoring) 
         Coronaries blood flow evaluation (Coronary CT angiography) 
         Provides chambers functional parameters (High-pitch CT scan) 
- Cons: Radiation emission correlated with LAR of cancer development 
          Side effects correlated to the drugs introduced to perform a proper CT   
 evaluation (i.e. sublingual nitrate, beta blockers) 
          Takes time to grab images resulting in artifacts especially in patients  
 with arrhythmias and/or respiratory impairments (even in the new    
 360-slices models) 
          Very expensive machineries 
 
Magnetic Resonance 
- Pros: Optimal chambers evaluation (anatomy, function, wall thickness,   
          cavitary sizes) 
                      Provides information about blood flow and coronary anatomy 
         Assesses the pathological state of the heart with a contrast agent     
         (hyperenhancement) 
Evaluates the fibrosis (T1 mapping MOLLI) and the AMI (T2     
mapping) 
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- Cons: Takes long time to perform a proper evaluation 
          No T1 mapping standard examination protocols (T1 mapping results   
 are dose dependent) and Lack of standard physiological values  
          Very expensive machineries 
 
Video Kinematic Evaluation 
- Pros: Non-invasive 
Innovative approach based on epicardial motion, and consequent   
novel set of useful clinical data, highlighting unexplored aspects of 
the cardiac function  
         Fast evaluation 
         Algorithm-based evaluation (no technical skill required, high data  
       reproducibility) 
         Quantitative RV evaluation  
         Translational technology, with low costs in each field (cellular, basic  
        research, clinic) 
         High spatial and temporal resolution (up to 1000fps) 
- Cons: Only applicable during open chest surgeries 
           Lack of standard physiological values 
           Limited number of cases evaluated 
           Only RV evaluation in human 
 
The medical technological evolution always carries innovative, less invasive, and 
cheaper approaches, leading to a constant amelioration of patients’ outcome and 
recovery. However, most of the times, the innovative approaches are barely 
comparable with the old technologies, and, when possible, only some aspects of the 
novel techniques can be comparable. Video Kinematic Evaluation suffers this 
complication. In fact, as stated before, the main limitation in all the current 
technologies in the heart imaging field is the spatial and temporal resolution. 
Vi.Ki.E has been developed to overcome this gap. The high speed cameras adopted 
allow to precisely evaluate every physiological aspect of the cardiac beat (i.e. the 
systolic/diastolic phase only, the atrial kick, the ventricular distension) without 
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artifacts and/or technician’s interpretations. Moreover the epicardial kinematic 
approach is unique in the cardiac field and cannot be compared with any of the other 
current techniques, except in some cases where a simple data linear regression can 
be performed. 
In the Vi.Ki.E. contest the most comparable technique is the TEE, since they are 
both intra-surgical approaches. The coupling of Vi.Ki.E. with TEE can provide a 
“360 degrees” heart evaluation, optimal in the surgeries implying both ventricles as 
LVAD implantation. 
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2. METHODS 
2.1. Instrumentation 
The setup adopted in this work is approximately the same for both clinical and basic 
research approaches, with some small differences, as cited above, due to the 
different heart size and rate between patients and experimental animals. 
 
Vi.Ki.E. Clinical instrumentation. 
- Extensible tripod holding the camera on top of the patient’s chest. 
- Low-speed camera: full HD (1920×1080 total pixel area) camera Samsung 
S10 (with an internal SD memory of 256 MB and internal rechargeable 
battery) 
- High-speed camera Basler acA1300-200um USB 3.0 with the ON 
Semiconductor PYTHON 1300 CMOS sensor, (1280x1024, Ahrensburg, 
Germany)  
- Edmund Optics 6mm compact fixed focal length lens (Barrington, NJ, 
USA) 
- High-performance PC Intel core i7-6700HQ 2.6GHz, 16GB DDR4 
2133MHz SDRAM, 1TB HDD 7200 RPM With 128GB SSD PCIE ×4 
- Acquisition software: Pylon 5 Camera Software Suite 5.0.5 for Microsoft 
Windows (Ahrensburg, Germany).  
 
Vi.Ki.E. Experimental instrumentation. 
- Low-speed camera: full HD (1920×1080 total pixel area) camera Samsung 
S10 (with an internal SD memory of 256 MB and internal rechargeable 
battery) 
- High-speed camera Baumer HXC13 (Baumer Italia, S.r.l. , Milano, IT) 
camera with full CameraLink® interface (1280×1024 total pixel area for 
500 fps or 1020×600 for 1000 fps)  
- Macro objective Kowa Industrial Lenses LM35XC, F = 1:2.0, f = 35 mm, 
picture size 13.8-18.4 mm (RMA Electronics, Hingham, MA, USA).  
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- The acquisition software was custom made in LabVIEW Visual 
Programming Language (National Instruments, Assago, Milano, Italy) 
- Frame grabber acquisition board PCIe 1433 (National Instruments, Italy) 
adapted into a Workstation HP Z220 (Crisel Instruments, Italy) with 24 GB 
RAM. 
 
2.2. Settings and placement of the marker 
To obtain reliable results, it is fundamental to place and set up the marker correctly.    
The tracking program implied is Video Spot Tracker (VST), an open-source 
software from CISMM (Computer Integrated Systems for Microscopy and 
Manipulation) University of Chapel Hill, North Carolina 
(http://cismm.web.unc.edu/software/). 
To start the tracking, it is necessary to open the video recorded or the sequence of 
images in the software. Figure 18 shows the workspace and the first video frame.  
The first setting step is to select the kernel (Figure 18, red ellipse). A kernel is the 
algorithm implied in the tracking. In this work, the “cone” was the optimal selection 
in all the evaluation (both patients and experimental animals) due to its capability 
Figure 18. VST workspace and first frame of the video. Colored ellipsis show the most useful sections of the “kernel” 
workspace. RV: Right Ventricle. Ao:Aorta. RA: Right Atrium 
Ao 
RA
RV
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to follow the brightest spots on the images. Other kernels track different aspects 
like shadows, edges, fluorescent dyes, and many others.  
The second step is the selection of the marker radius (Figure 18, blue ellipse), 
different radius provides different trajectories due to the number of points tracked 
(Figure 19). The radius selection is based on the required evaluation. As shown in 
Figure 19 (in the left column), the marker appears too small for an entire RV 
evaluation. The opposite is shown in Figure 19 (right column) where the marker 
includes both Aorta (Ao) and Right Atrium (RA) light spots, thus mediated in the 
trajectory. The Middle column, on the contrary, shows an optimal marker position 
where the most mobile region of the RV is tracked [33]. The third step is the marker 
optimization (Figure 18, Black ellipse), allowing the software to automatically fit 
the best marker starting area based on the selected kernel. 
 
 
  
Figure 19. Different marker radius and trajectories. Left column: Marker radius 50 pixels with marker optimization (top 
panel) and marker trajectory (bottom panel). Middle and Right column same as Left but for marker radius of 100 pixels 
and 200 pixels, respectively. 
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As stated before, the “cone” kernel is based on the light changes on the epicardium, 
thus the importance of the light placing step. This should be extremely accurate to 
allow the best reproducibility of the data, especially in the “Before-After surgery” 
data comparison where both the light and the marker radius should be as similar as 
possible.  
Figure 20 shows different frames of the same cardiac cycle to focus the attention 
on how the light is moving upon the epicardium. The changes in light are a 
consequence of the blood flow inside the chambers. When the “main spot” of light 
moves near the Aorta (Figure 20, A-B) it means that the epicardium in the heart 
base is in the nearest position to the light source. This is due to the augmented blood 
filling in the base of the heart compared to the apex; typical phenomena occurring 
during systole. On the contrary, when the “main spot” of light is moving further 
from the Aorta (Figure 20, C-D), the diastolic phase is underway. In the panel E of 
the Figure 20, the cardiac cycle reaches the same position of panel A and the cardiac 
cycle is closed. 
 
The light positioning can be very challenging in some cases. Figure 21 shows a 
wrong light positioning in which the “main spot” of light is placed on the chest 
divaricator leading to a jump in the marker. During a marker jump, the acceleration 
is tending to infinite thus corrupting the kinetic values. Marker jumps can occur any 
Figure 20. Different frames from a 
single cardiac cycle. Red Circle: 
Marker. Red line: Marker 
trajectory. Panel A: Marker 
starting point at first frame. Panel 
B, C: Systolic phase. Panel D: 
Diastolic phase. Panel E: Last 
frame of the first cardiac cycle. 
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time when two or more “main spot” of light appears during the cycle. Therefore, 
the importance to check the light positioning before the recording. 
  Figure 21. 
Example of a 
bad light 
positioning 
leading to a 
marker jump. 
Red circle: 
Marker, Red 
line: marker 
trajectory. The 
recording has 
been stopped 
and discarded. 
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2.3. Vi.Ki.E. Validation 
The Vi.Ki.E. technology is new and custom made, so it was necessary to perform a 
proper validation for each parameter especially for the clinical practice use. 
 
2.3.1. Kinetic Energy validation 
The kinetic energy evaluation was performed by acquiring videos of the periodic 
motion of a pendulum (mass of 200 g) oscillating (Figure 22). The pendulum was 
connected to an arm by a 21.5 cm non-stretchable string and the motion was 
acquired at 200 fps for five seconds. The video marker was anchored onto the white 
area of the pendulum and displayed the trajectories (Figure 22, A), the coordinate 
x vs. time (Figure 22, C) and the kinetic energy at the highest, intermediate and 
lowest positions (Figure 22, D). As expected, the marker movement was an arc. 
When the coordinate x was displayed vs. time, it drew a periodic wave. The kinetic 
energy measured for five consecutive frames in the three positions was ca. zero at 
the highest position (all the energy is potential; h = 17 cm) and maximal at the 
lowest position (all the energy is kinetic; h = 11.5 cm). In the intermediate position, 
the kinetic energy was in between the other two measurements [28]. 
 
 
 
 
 
 
 
 
 
Figure 21. 
Evaluation of kinetic 
energy during the 
harmonic motion of a 
pendulum. A. First 
acquired image of the 
pendulum at the 
highest point. Scale 
bar=1 cm. B. 
Trajectories and 
acceleration of the 
pendulum C.  
Movement of the 
marker vs. time. (d). 
Kinetic energy at the 
highest point, 
intermediated point 
and lowest point. 
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2.3.2. Force validation 
The Force evaluation was made by anchoring a known spherical mass (0.035 g, 
diameter = 3 mm) onto the epicardial surface in three different rat hearts (Figure 23, 
A). The use of a mass connected to the cardiac tissue allowed a switch from a 
description in terms of acceleration (pixel/s2) to the International System of Units 
and, consequently, we calculated the contraction force (N) accelerating the mass 
and the related ViCG in terms of displacement and velocity. In all three rats, the 
Force was about the same, suggesting that every cardiac cycle, even if in different 
animals, exerts a well-conserved force of contraction. We also observed, for every 
beat, a well-conserved contraction-relaxation trajectory (Figure 23, B), which was 
a kind of hysteresis loop due to the intrinsic viscoelastic properties of the 
myocardium [28, 34]. 
 
 
 
 
  
Figure 23. A. Position of the spherical mass at the 
beginning of systole (left) and at the beginning of 
diastole (right) with the related displacement vector 
(white arrow) between the two preceding moments. B. 
Trajectory and acceleration of the mass in three different 
rat hearts with the mean contraction force (N) during the 
observation period (10 s). Data are expressed as 
mean ± SEM. Top panel: 71 cardiac cycles. Middle 
panel: 31 cardiac cycles. Bottom panel: 40 cardiac 
cycles.  
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2.3.3. Validation of data during the time 
The Vi.Ki.E. validation during the time was evaluated by acquiring 1-second video 
recording of sinus rhythm at 1000 fps in three healthy rat hearts, every 10 min for 
1 h (Figure 24). The video marker was anchored in the same position and monitored 
changes in Velocity, Kinetic Energy, Force, and Displacement over time. We 
observed minimal percentage variations (likewise physiological) for the four 
parameters, suggesting a good reproducibility of our data over time. 
 
  
Figure 24. Reproducibility of the acquired data. A. Velocity (pixel/sec) monitored every ten minutes for one hour at 1 
kHz temporal resolution. B. Same as A for kinetic energy (pixel2/s2). C. Same as A for acceleration (pixel/s2). D. Same 
as A for displacement (pixel). Marker radius: 60 pixels. n=3. 
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2.3.4. Validation in a computer model 
The Vi.Ki.E. algorithm effectiveness, of the obtained data, was evaluated through 
a numerical simulation based on the cardiac electro-mechanical coupling (EMC) 
model. This model described the interplay between the spread of electrical 
excitation in the cardiac tissue and the consequent contraction/relaxation process. 
The EMC model consisted of four sub-components, two for the bioelectrical 
activity and two for the mechanical response of the cardiac tissue. The two 
bioelectrical components were the Bidomain model for the electric current flow 
[35] and the ten Tusscher human ventricular model [36] for the cellular membrane 
dynamics.  
Briefly, the Bidomain model takes into account the electrical properties of cardiac 
muscle, of both the intracellular and extracellular spaces, through an anisotropy 
perspective. The ten Tusscher model, takes into account the action potential of 
human ventricular cells, including a high level of electrophysiological detail (i.e. 
the fast sodium, L-type calcium, transient outward, rapid and slow delayed rectifier, 
inward rectifier currents, basic calcium dynamics, calcium transients, calcium 
current inactivation, and the contraction staircase)  
As it concerns the mechanical sub-components, stretch-activated channels were 
incorporated in the membrane model according to [37]. The macroscopic 
description of the mechanical activity was based on the equations of finite elasticity, 
where the passive mechanical properties of the myocardium were assumed to be 
transversely isotropic, hyper-elastic, and nearly incompressible, defined by an 
exponential strain energy function derived from [38]. The EMC model was finally 
closed by the active tension generation model developed describing the process of 
calcium binding to troponin C and cross-bridge cycling triggered by calcium release 
from the intracellular calcium stores during the electrical activation of a myocyte. 
The active tension generated by this model entered as input in the non-linear 
elasticity equations yielding the active component of the stress tensor.  
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The intracavitary blood pressure p in the left ventricular (LV) cavity was described 
by a pressure-volume loop model [39], based on the following four phases: 
 
- Isovolumetric LV contraction phase, where p increased from the end-
diastolic pressure (EDP) value of about 2 kPa to 10 kPa; 
- Ejection phase, where the pressure-volume relationship was described by a 
two-element Windkessel model, until the volume reduction stopped; 
- Isovolumetric LV relaxation phase, where p decreased to 1 kPa; 
- Filling phase, where p increased linearly to EDP. 
 
The model was modified incorporating a transmural ischemic region of 1 cm × 1 
cm with the sequent parameters: 
 
- The intra (i)- and extra (e)- cellular conductivity coefficients of the 
Bidomain model, along (l) and across (t) the fiber direction, were σil = 3, 
σel = 2, σit = 0.31525, σet = 1.3514, all in mΩ-1cm-1. The parameters of 
the strain energy function were the same of the original paper [39] apart 
from the bulk modulus, which amounted to 200 kPa 
- From the bioelectrical point of view, ischemic conditions were modeled 
modifying the following parameters of the ten Tusscher model [40]. The 
extracellular potassium concentration was increased from 5.4 mM to 8 mM; 
the maximal conductance of the INa and ICaL currents was decreased by 
25%; the parameters of the IKATP current were modified as in [41] for 
ischemia stage 2.  
- From the mechanical point of view, ischemic conditions were modeled by 
reducing the active tension and passive tissue stiffness by 10% and 25% 
compared to their normal values, respectively. 
 
The excitation process was initiated by stimulating three endocardial anterior apical 
sites and one endocardial posterior apical site, mimicking an idealized Purkinje 
network. Two simulations were performed, one for a healthy tissue (HEALTH) and 
one for a tissue with a transmural ischemic region (ISCH). In both cases, three beats 
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were simulated, at a basic cycle length of 500ms. Figure 25 (left panels) display the 
epicardial distributions of transmembrane and extracellular potentials computed in 
the HEALTH and ISCH simulations, during the plateau phase of the heartbeat (ST 
segment, t = 120ms). The ISCH transmembrane potential distribution showed a 
minimum in the ischemic region, whereas the ISCH extracellular potential 
distribution showed a maximum (ST elevation) in correspondence of the ischemic 
region. The kinematic evaluation applied to the experimental data was validated on 
the simulated data related to the healthy and ischemic tissue. Right panels of Figure 
25 report that ischemia decreased of about 20% in: i) the maximum displacement 
module (Figure 25, right panel, a), ii) the mechanical behavior of the cardiac tissue, 
with a reduction of the maximum velocity module (Figure 25, right panel, b) and 
iii) the mean kinetic energy (Figure 25, right panel, c). These theoretical findings 
validated the use of kinematic parameters markers as indices of cardiac mechanical 
performance. 
 
  
Figure 25. Numerical simulation results of epicardial transmembrane (V) and extracellular (UE) potential 
distributions. Left panel. (A). V distribution at t = 120ms after the onset of stimulation in the healthy tissue 
(HEALTH). (B). V distribution at t = 120ms after the onset of stimulation in the tissue with transmural ischemia 
(ISCH). (C) UE distribution at t = 120ms after the onset of stimulation in the healthy tissue. (D). UE distribution at t 
= 120ms after the onset of stimulation in the tissue with transmural ischemia. Right panel. (a) Left. Maximum 
displacement module, as defined in Table 1, in marker trajectories (frame distance = 0.25ms), which was averaged 
across 48 (HEALTH) and 48 ischemic (ISCH) sites. Data are expressed as mean ± SEM. Right. Time evolution of 
the displacement of a single sample marker; comparison between healthy (black) and ischemic (red) site. (b) Same 
as (a) for the maximum velocity module. (c) Same as (a) for the mean kinetic energy. *p<0.05, calculated from one-
way ANOVA, LSD post-hoc. No overlapping bars have statistical significance. 
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2.4. Conversion curve from pixels to millimeters   
The necessity to have comprehensible parameters usable by clinicians directly in 
the operating room forced the conversion of the Vi.Ki.E. pixel values in the SI 
millimeters unit.  
To do that, pictures of a millimeter paper was taken at different heights from 5cm 
to 60cm with a step of 5cm, counting how many millimeters fitted each image. 
Three different spots were counted, for both columns and rows, and an average 
measure for x and y axes was calculated. Since the resolution of the camera was 
known, it was possible to reconstruct a calibration curve (pixel to mm) as shown in 
Figure 26. 
In order to obtain precise values, the camera is usually placed, at the same distance 
from the heart before and after the surgery. However, it can occur to place the 
camera at different heights during the surgery due to some clinical necessities 
leading to a bias of the parameters evaluated. This is the reason why it was created 
the function to calculate the pixel/mm conversion (Figure 26) at every height in the 
range between 5 to 60cm. Knowing the camera distances from the heart makes all 
the parameters comparable.  
Figure 26. Conversion to SI unit (pixel to mm) in a 1280×1024 Camera. Left table: heights, x and y values and pixel 
in each mm for both x and y. Right Table: means and errors for every measurement. Graph shows the curve obtained 
plotting the heights on x axis and the millimeters on y axis. R2 shows the extremely good correlation between points. 
The function is used to calculate the pixel/mm at each distance. 
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2.5. Protocols 
Human Surgical Protocols. 
The human surgical protocols for CABG, GLENN, FONTAN, valve replacements, 
LVAD implantation, and Heart Transplantation followed the ESC guidelines. 
 
Vi.Ki.E. clinical protocols 
All methods and experiments were carried out in accordance with relevant 
guidelines and regulations set by the Institutional Review Board (IRB) of the 
Azienda Ospedaliera Universitaria Integrata of Verona, where all the experiments 
were done (approved protocol from ethics committee on 16th March 2016, # 
847CESC Protocol # 13371). All patients signed up an informed consent. 
In this work, several different pathological conditions have been monitored starting 
from Coronary Artery Bypass Grafting (CABG, N=10), Tetralogy of Fallot (TOF, 
N=12), Congenital Valvulopathy (N=1), Hypoplastic Heart Syndromes (HHS, 
N=6), Ventricular Assist Devices implantation (VAD, N=6) and finally Heart 
Transplantation (N=2). The Vi.Ki.E. protocol adopted was approximatively the 
same to obtain comparable data. 
 
Initially, two time-points were established to record cardiac cycles.  
The first time-point was recorded right after the chest opening and the pericardial 
suspension, where the heart is settled in the pericardial cradle without any 
compression or mechanical stimuli that can lead to a bias in the evaluation. The 
second time-point was recorded at the end of the surgery, before the chest closure. 
A third time-point, was recorded in-between the surgery at the ECC (Extra-
Corporeal Circulation) exit, and it was added after the CABG study just to 
understand the mechanical behavior of the heart in a different pathophysiological 
state. 
For each time-point the extensible tripod, holding the camera connected to the PC, 
was placed with the camera perpendicular to the heart at approximately 40 cm 
(Figure 27). Four consequent recordings of 5 seconds at 200 fps were performed.  
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In order to optimize the procedure, due to the long buffer time to download the 
images in the PC memory, leading in more than two minutes of surgeon inactivity 
and possible loss of focus, a single recording of 20 seconds at 200 fps was 
performed. The buffer time to download the images in this way is slower but it is 
performed in post-processing, avoiding surgeon inactivity and loss of focus. Later 
the videos were split in 4 recordings of 5 seconds each. 
 
Figure 27. Schematic intra-operatory setup. The operating room is divided in a “non-sterile” side, where perfusionists, 
anesthetists and students can assist the surgery and in a “sterile” side, where only surgeons and assistants can access 
and perform the surgery. The extensible tripod is in the “non-sterile” side of the operating room and it is just extended 
for some centimeters in the “sterile” side. This process is very accurate to avoid any touch with the surgical bed or 
other sterile objects interaction. 
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Animal surgical protocols 
The study was conformed to Italian (D.L.4/3/2014) and European guidelines 
(2010/63/UE). 
The animals were kept in single-sex groups of four individuals from weaning (4 
weeks after birth) until the onset of the experiments, in a temperature-controlled 
room at 20-24°C, with the light on between 7:00 AM and 7:00 PM. The bedding of 
the cages consisted of wood shavings; food and water were freely available. 
Animals were anesthetized either with a mixture of ketamine chloride 40 mg/kg (ip) 
(Imalgene, Merial, Milano, Italy), or with 0.20 mg/kg (ip) of a mixture of tiletamine 
hydrochloride and zolazepam hydrochloride (Zoletil; Virbac S.r.l., Carros, France) 
and medetomidine hydrochloride 0.15 mg/kg ip (Domitor, Pfizer Italia S.r.l., 
Latina, Italy) for the in vivo experiments. The heart was exposed through a median 
thoracotomy and suspended in a pericardial cradle under artificial ventilation 
(RoVent® Small Animal Ventilator, Kent Scientific, CT, USA), performed through 
tracheotomy. Body temperature was maintained constantly at 37 °C thanks to a heat 
lamp radiation, and further doses of anesthetic were administered as needed during 
the experiment. 
 
Vi.Ki.E. experimental protocols 
The approved protocols, by the Veterinary Animal Care and Use Committee of the 
University of Parma and conformed to the National Ethical Guidelines of the Italian 
Ministry of Health, were the following: 41/2009, 59/2012, 281/2017, 989/2017. For 
each of the underlying protocols, the camera was placed at approximately 17 cm 
from the heart. 
 
- Measurement of contraction Force. The ventricular force was measured by 
anchoring a known spherical mass (0.035 g, diameter = 3 mm) onto the 
epicardial surface in three different rat hearts (Figure 23, A). We then 
recorded, for each heart, 10 seconds video recording with a low-speed 
camera at 30 fps. 
- Reproducibility of the data acquired. The mechanical parameters were 
evaluated during time by acquiring 1-second video recording of sinus 
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rhythm at 1000 fps onto three healthy rat hearts, every 10 min for 1 h. We 
anchored the video marker in the same position and monitored changes in 
displacement, velocity, acceleration, and energy over time. 
- Ischemia/Reperfusion. Videos of in-situ rat hearts, undergoing an acute 
cardiac ischemia/reperfusion injury model, were recorded at 500 fps for 
1 second. The beating heart was recorded in normal conditions followed by 
anterior descending coronary ligation. The surgical needle was left within 
the performed knot as this allowed the removal of the ligation without 
damaging the tissue. Then, after waiting for 6 min and 12 min, other two 
videos of the beating heart (now ischemic) were recorded. The same 
procedure was followed after the removal of the ligation (i.e., two video 
files were recorded after 6 min and 12 min). 
- Induced AV block. A flexible cannula (0.8 mm diameter), firmly fixed to a 
three-axes manipulator, was adopted and positioned ca. 5 mm above the 
pulmonary cone. A gentle air-pressure flow (20 kPa) was delivered for 
1 second using an electro-valve (Asco Numatics, Bussero, Milano, Italy) 
remotely controlled by a stimulator (Crescent Electronics, Sandy, UT, 
USA). During the air delivery, a video of 2 seconds at 30 fps was recoded 
and the changing in the mechanical parameters after an AV block was 
evaluated. 
- Atrial Stimulation. The heart was stimulated with a cathodal suprathreshold 
train of stimuli (10 Vpp) at different basic cycle length (BCL: 390 ms, 
330 ms, 290 ms, 260 ms, 230 ms, 210 ms, 190 ms, 170 ms, 160 ms) by 
driving the right atrium with a silver electrode (0.05 mm) with one end 
connected to a stimulus generator (SIU-102, Warner Instruments CT, USA) 
and the other hooked to the atrial auricle appendage. The current return 
silver electrode has been placed in the right forearm. The stimulus generator 
was triggered by a function generator (Aim-TTi TG310, RS Components, 
Milano, IT). A video of 2 seconds at 500 fps was recorded for each BCL 
(Figure 28). 
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The complete analysis of the mechanical parameters was performed, for both clinics 
and basic research, as cited above. Once acquired, the video has been opened with 
VST, and the light was tracked through the epicardial surface. Finally, the .csv file 
was evaluated with a custom-made algorithm in MATLAB (Mathworks, USA). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28. Schematic representation of 
the experimental setup. A. The heart (red 
cartoon) is exposed after median 
thoracotomy. One end of the stimulating 
electrode (blue line) is hooked on the 
Right Atrial (RA) auricle appendage to 
perform atrial stimulation, while the 
other end is connected to a stimulus 
generator (black rectangular box). The 
current return electrode (green line) is 
placed on the right forearm. The high-
speed camera is placed perpendicular to 
the heart to record anterior epicardial 
kinematic. The grey shaded region 
represents the video camera field of 
view. The LED is placed beside the 
camera. The yellow shaded region 
represents the light beam. RV, Right 
Ventricle; LV, Left Ventricle; dashed 
red line, interventricular septum. 
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3. RESULTS 
The results shown in this work will be presented in a chronological order to offer 
to the reader the feeling of a growing project able to gradually evaluate more 
complex situations. Chapters 3.1, 3.2 and 3.3 will report the entire publications as 
they are, including images and references.  
 
3.1. Cardiac Kinematic parameters computed from video 
of in situ beating heart [28]. 
 
 
3.1.1. Abstract 
 
Mechanical function of the heart during open-chest cardiac surgery is exclusively 
monitored by echocardiographic techniques. However, little is known about local 
kinematics, particularly for the reperfused regions after ischemic events. We report 
a novel imaging modality, which extracts local and global kinematic parameters 
from videos of in situ beating hearts, displaying live video cardiograms of the 
contraction events. A custom algorithm tracked the movement of a video marker 
positioned ad hoc onto a selected area and analyzed, during the entire recording, the 
contraction trajectory, displacement, velocity, acceleration, kinetic energy and 
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force. Moreover, global epicardial velocity and vorticity were analyzed by means 
of Particle Image Velocimetry tool. We validated our new technique by i) 
computational modeling of cardiac ischemia, ii) video recordings of 
ischemic/reperfused rat hearts, iii) videos of beating human hearts before and after 
coronary artery bypass graft, and iv) local Frank-Starling effect. In rats, we 
observed a decrement of kinematic parameters during acute ischemia and a 
significant increment in the same region after reperfusion. We detected similar 
behavior in operated patients. This modality adds important functional values on 
cardiac outcomes and supports the intervention in a contact-free and non-invasive 
mode. Moreover, it does not require particular operator-dependent skills. 
 
3.1.2. Introduction 
 
Myocardial ischemic injury, resulting from severe impairment of the coronary 
blood flow, is usually related to thrombosis or other acute alterations of coronary 
atherosclerotic plaques [42]. Cardiovascular surgery re-establishes the blood flow 
in the downstream ischemic tissue by percutaneous coronary intervention (PCI) [43, 
44] or coronary artery bypass graft (CABG) [45, 46]. While several imaging 
techniques are present for post-operative evaluation of cardiac function (e.g., CT-
scan [46], MRI [47], SPECT [48]), only trans-esophageal echocardiography (TEE) 
can directly assist surgeons during open-chest surgery assuring, before closing the 
chest, an assessment of good-prognosis [49]. TEE can be combined with other 
imaging techniques also in the context of structural heart disease [50]. However, 
TEE handling requires essential skills for the operator [51] and primarily returns 
information only about global left ventricle function.  
Almost 3% of CABG patients undergo to a second open-chest operation, mainly 
due to vein graft failure alone or combined with other causes such as restenosis 
[52], perioperative ischemia/myocardial infarction [53] and ventricular aneurisms 
[54, 55]. Information about the kinematic parameters specifically from the re-
vascularized cardiac regions (i.e., once the blood flow is restored after reperfusion) 
is missing. To date, several efforts have been devoted to measuring the kinematics 
of local cardiac regions following the movement of a radio-opaque marker 
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glued/sewed on the cardiac tissue by a biplane cineradiography [55, 56]. The only 
reported video-tracking acquisition on the motion of a beating heart is related to 
mechanical compensation of a robotic arm movement during endoscopic CABG 
[57]. During open-chest procedures, all cardiac surgeons should confirm that a 
direct real-time rapid and contactless measurement of kinematic parameters, strictly 
related to a localized portion of the heart (i.e., ischemic or suffering regions), would 
be a benefit. 
 
We show, using a commercial low-speed full HD video camera (in ~60-bpm human 
hearts during CABG) as well as a high-speed video camera (in ~180-bpm rat hearts 
that underwent ischemia/reperfusion protocol), the tangible possibility to acquire a 
video (from few seconds to a minute) and display a video cardiogram (ViCG) and 
its related kinematic parameters in a contactless modality. An algorithm runs in 
post-processing mode by directly displaying the trajectories of selected tissue video 
markers and by computing their related kinematic parameters (such as frequency, 
displacement, velocity, acceleration, kinetic energy and force) during cardiac 
cycles. From the same video the algorithm, via an adapted Particle Image 
Velocimetry (PIV) tool, calculates the velocity and the vorticity (i.e., the rotation 
frequency of the velocity vectors) [32, 58] during systolic and diastolic phases. 
Recently, we have validated and acquired in vitro similar kinematic parameters in 
beating 2D syncytia of cultured cardiac cells [31] or in IPSCs-derived 
cardiomyocytes [59]. An application of in situ beating heart has never been 
proposed. Thus, the aim of this study is to introduce a contactless and user-friendly 
technology that can return, together with conventional gold standard techniques, 
important local and global functional parameters useful from experimental to 
clinical benches. 
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3.1.3. Results 
 
Both low-speed and high-speed cameras have been positioned above the heart in 
open-chest (Fig. 3.1.1a, left panel) Wistar rats [60] or patients, which underwent 
CABG [61]. The camera and the related optical macro-objective maximized the 
visualization of the heart, which was covered by the entire field of view.  
 
Figure 3.1.1: Workflow with video camera positioning, video recording and evaluation of the systolic and diastolic 
phases. (a) Left. Schematic representation of the camera positioned using an articulating arm on top of the open chest. The 
authors drew the scheme. Right. Sequence of video frames captured at 500 fps from a beating heart with the video marker 
(yellow circle) ‘anchored’ to the cardiac tissue while moving in x-y directions. (b) Video cardiogram (ViCG) showing the 
displacement of a selected video marker with contraction/relaxation peaks and peak-to-peak intervals. (c) Counterclockwise 
trajectories of contraction (left to right) and relaxation (right to left) for every cardiac cycle with related velocity vectors (pink 
arrows). The graph shows a typical overlapping in the x-y movements of the selected video marker. (d) Particle Image 
Velocimetry (PIV) showing the velocity vectors (yellow arrows) of the beating cardiac tissue.  
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- Validation of the measured parameters in rat hearts 
Using Video Spot Tracker (VST, CISMM, Computer Integrated Systems for 
Microscopy and Manipulation, UNC Chapel Hill, NC, USA), we tracked the 
spatial-temporal coordinates x, y and t of the chosen video marker, in each frame 
(Fig. 3.1.1a, right panel) [31]. Coordinates were analyzed by a custom algorithm 
implemented with Matlab Programming Language (The MathWorks, Inc., Natick, 
MA, USA). The algorithm computed tissue displacements both in the x and y 
directions (Fig. 3.1.1b) and, consequently, obtained the following parameters: the 
contraction peaks, the relaxation peaks, the beat-to-beat intervals, the systolic and 
diastolic phases, and the tissue trajectory (Fig. 3.1.1c). In particular, we took in 
consideration the following physical quantities (Table 3.1.1): 
 
Table 3.1.1: Kinematic and dynamic parameters calculated from video marker tracking with their physiological 
meaning. According to classical and Hamiltonian mechanics, x(t) is the position vector (pixel) in the coordinate system (x,y) 
of an orthonormal Euclidean space, where t is the time (s). 
 
(i) Displacement (pixel); the instantaneous movement of the cardiac tissue in x and 
y directions; it builds the temporal-spatial trajectory. 
(ii) Velocity (pixel/s); the instantaneous motility or contractility of the cardiac 
tissue; it builds the temporal-spatial trajectory. 
(iii) Kinetic energy (pixel2/s2); an estimation of the consumption of ATP for the 
generation of cardiac movement. 
(iv) Frequency (Hz); contraction frequency calculated from the identified cardiac 
beats. 
(v) Acceleration (pixel/s2); the instantaneous variation of the cardiac tissue motility; 
it builds the temporal-spatial trajectory. 
(vi) Force (N); cardiac force moving a mass. 
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The calculus of the preceding quantities was subjected to a de-noising procedure 
via wavelet compression (near symmetric wavelet: Symlets 4; decomposition level: 
3; compression method: global threshold leading to recover 99% of the signal 
energy). 
To study the cardiac cycle, we obtained fields of velocity vectors (Fig. 1d) in 
diastole and in systole by means of PIV. Consequently, it was possible to evaluate 
the mean rotation frequency of the velocity vectors (i.e., the mean vorticity in Hz) 
and the mean velocity module (calculated with respect to space and time). 
 
- Temporal and spatial resolution 
During the initial setting, we studied the effect of both video marker radius and rate 
effect (‘frame number per second’ or fps) of the video acquisition on the returned 
data quality. In Supplementary Fig. 3.1.1, we reported the temporal graphs of the 
velocity marker in the x direction (the y direction produced similar results and 
therefore it is not shown) in normal (HEALTH) heart. The radius equal to 15 pixels 
was the minimum required to correctly follow ventricular epicardial surface 
movements and, then, to correctly identify cardiac beats. 
In Supplementary Fig. 3.1.2a–f, we displayed trajectory and velocity vectors, which 
were obtained at different acquisition rates (500, 250, 125, 100, 50, and 25 fps). As 
expected, the rate of 500 fps gave the best trajectory and velocity results 
(Supplementary Fig. 3.1.2a). The rates between 250 and 30 fps could be considered 
acceptable (Supplementary Fig. 3.1.2b–e). However lower rates (≤25 fps, 
Supplementary Fig. 3.1.2f) were significantly affected by the aliasing phenomenon 
with loss of trajectory and velocity details and thereby not used in the present study. 
 
- Reproducibility of the acquired data 
We evaluated the aforementioned parameters during time by acquiring 1-s video 
recording of sinus rhythm at the highest possible temporal resolution (1 kHz) onto 
three healthy rat hearts, every 10 min for 1 h (Supplementary Fig. 3.1.3, 
Supplementary Video 1). We anchored the video marker in the same position and 
monitored changes in displacement, velocity, acceleration and energy over time. 
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We observed minimal percentage variations (likewise physiological) for the four 
parameters, suggesting a good reproducibility of our data. 
 
- Kinetic energy acquisition in a controlled and simple system 
We then evaluated the kinetic energy parameter by acquiring videos of the periodic 
motion of a pendulum (mass of 200 g) oscillating for small displacements 
(Supplementary Fig. 3.1.4a). The pendulum was connected to an arm by a 21.5 cm 
not-stretchable string and the motion was acquired at 200 fps for five seconds. We 
selected the video marker onto the white area of the pendulum and displayed the 
trajectories (Supplementary Fig. 3.1.4b), the coordinate x vs. time (Supplementary 
Fig. 3.1.4c) and the kinetic energy at the highest, intermediate and lowest positions 
(Supplementary Fig. 3.1.4d). As expected, marker movement is an arc. When the 
coordinate x was displayed vs. time, it drew a periodic wave. The kinetic energy 
we measured for five consecutive frames in the three aforementioned positions was 
ca. zero at the highest position (all the energy is potential; h = 17 cm) and maximal 
at the lowest position (all the energy is kinetic; 6.49 × 106 ± 6.01 × 105 pixel2/s2, 
h = 11.5 cm). In the intermediate position, the kinetic energy was 
4.26 × 106 ± 5.40 × 105 pixel2/s2. 
 
- Measurement of the contraction force 
We then measured the ventricular force by anchoring a known spherical mass 
(0.035 g, diameter = 3 mm) onto epicardial surface in three different rat hearts (Fig. 
3.1.2a, Supplementary Video 2). The use of a mass connected to the cardiac tissue 
allowed a switch from a description in terms of acceleration (pixel/s2) to the 
International System of Units and, consequently, we calculated the contraction 
force (N) accelerating the mass (Fig. 3.1.2b) and the related ViCG in terms of 
displacement and velocity (Fig. 3.1.2c). The ViCG was also useful to recognize the 
diastolic and systolic phases. 
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Figure 3.1.2: Validation of contraction force measured with a known spherical mass anchored onto the epicardial 
surface. (a) Position of the spherical mass at the start of systole (left) and at the start of diastole (right) with the related 
displacement vector (white arrow) between the two preceding moments. (b) Trajectory and acceleration of the mass in three 
different rat hearts with the mean contraction force (N) during the observation period (10 s). Data are expressed as 
mean ± SEM. (c) Video cardiograms of displacement vs. time (top) and of velocity vs. time (bottom). Systolic and diastolic 
phases are underlined in red. 
 
We found the following mean contraction forces (Fig. 3.1.2b): i) 
3.29 × 10−5 ± 5.62 × 10−6 N (n of beats = 72); ii) 3.30 × 10−5 ± 9.09 × 10−6 N (n of 
beats = 31); and iii) 3.86 × 10−5 ± 6.72 × 10−6 N (n of beats = 40), suggesting that 
every cardiac cycle exerts a well-conserved force of contraction. 
 
We also observed, for every beat, a well-conserved contraction-relaxation 
trajectory, which was a kind of hysteresis loop due to the intrinsic viscoelastic 
properties of the myocardium [34]. 
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- Simulation of kinematic parameter measurement in ischemic contractile 
hearts 
We evaluated the effectiveness of our algorithm on data obtained from numerical 
simulations based on the cardiac electro-mechanical coupling model. We 
incorporated a transmural ischemic region of 1 cm × 1 cm. The excitation process 
was initiated by stimulating three endocardial anterior apical sites and one 
endocardial posterior apical site, mimicking an idealized Purkinje network. Two 
simulations were performed, one for a healthy tissue (HEALTH) and one for a 
tissue with a transmural ischemic region (ISCH). In both cases three beats were 
simulated, at a basic cycle length of 500 ms. Supplementary Fig. 5 displays the 
epicardial distributions of transmembrane and extracellular potentials computed in 
the HEALTH and ISCH simulations, during the plateau phase of the heartbeat (ST 
segment, t = 120 ms). The ISCH transmembrane potential distribution showed a 
minimum in the ischemic region, whereas the ISCH extracellular potential 
distribution showed a maximum (ST elevation), in correspondence of the ischemic 
region. The kinematic evaluation applied to the experimental data was validated on 
the simulated data related to the healthy and ischemic tissue. The results reported 
in Fig. 3.1.3 show that ischemia reduced of about 20%: i) the maximum 
displacement module (Fig. 3.1.3a), ii) the mechanical behavior of the cardiac tissue, 
with a reduction of the maximum velocity module (Fig. 3.1.3b) and iii) the mean 
kinetic energy (Fig. 3.1.3c). These theoretical findings validated the use of 
kinematic parameters as indices of cardiac mechanical performance. 
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Figure 3.1.3: Simulation of kinematics in ischemic heart. (a) Left. Maximum displacement module, as defined in Table 
1, in marker trajectories (frame distance = 0.25 ms), which was averaged across 48 healthy (HEALTH) and 48 ischemic 
(ISCH) sites. The horizontal bars are the 95% confidence intervals for the differences between means according to one-way 
ANOVA and LSD (Least Significant Difference) post hoc test. There is a statistically significant difference between the 
means with non-overlapping bars (p < 0.05). Right. Time evolution of the displacement of a single sample site; comparison 
between healthy (black) and ischemic (red) site. (b) Same as (a) for the maximum velocity module. (c) Same as (a) for the 
mean kinetic energy. 
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- Video kinematic parameters in ischemic and reperfused rat hearts 
We then acquired videos of six in situ rat hearts before an acute cardiac 
ischemia/reperfusion injury model [62] with a high-speed camera (acquisition 
rate = 500 fps) for 1 s in control (HEALTH), ischemic (ISCH, 6 min) and reperfused 
(REP, 6 min) conditions. 
 
Figure 3.1.4 showed the data only at 6 min following reperfusion as the data at 
12 min were comparable. We selected always the same video marker on the well-
defined region beneath the ligation (Fig. 3.1.4b, left panel). We only extracted data 
where the ischemic tissue turned from deep red to trans-lucid white, as a sign of a 
nearly complete coronary occlusion. Alike the simulation results, the system 
captured that the brief ischemia patently corrupted the mechanical performance of 
the ischemic region in terms of trajectories, ViCGs (Fig. 3.1.4a) and kinematic 
parameters (Fig. 3.1.4b, right panel), while the reperfusion caused significant 
improvements of those parameters. 
 
Figure 3.1.4: Kinematic parameters and ViCGs 
obtained by using a high-speed video camera 
during ischemia/reperfusion protocol in rats. (a) 
Left column. Trajectories and velocities measured 
from a 1-s recording at 500 fps during 
ischemia/reperfusion protocol. Top: healthy tissue. 
Middle: ischemic tissue, 6 min after coronary ligation. 
Bottom: reperfused tissue, 6 min after reperfusion. 
Right column. Video cardiogram of velocity vs. time 
in the three conditions: healthy (top), ischemic 
(middle) and reperfused (bottom) tissue. (b) Left. 
Representative video marker position (blue circle) on 
a schematic rat heart. A video marker with a radius of 
20 pixel was selected onto the tissue underneath the 
coronary ligation. Right. Top. Maximum velocity 
module measured in healthy (HEALTH), ischemic 
(ISCH) and reperfused (REP) tissue. Middle. Same for 
mean kinetic energy. Bottom. Same for mean 
acceleration module. See the text for statistical 
significances. The horizontal bars are the 95% 
confidence intervals for the differences between 
means according to one-way ANOVA and LSD (Least 
Significant Difference) post hoc test. There is a 
statistically significant difference between the means 
with non-overlapping bars (p < 0.05). n = 6. 
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We found that the maximum velocity module was significantly reduced during 
ischemia from 9.71 ± 3.09 pixel/ms to 3.32 ± 1.05 pixel/ms (p < 0.05 vs. healthy 
tissue), while, after 6 min of reperfusion, this parameter showed significantly higher 
and more physiological values (5.88 ± 1.95 pixel/ms, p < 0.05 vs. ischemic tissue, 
p < 0.05 vs. healthy tissue). 
 
We observed an analogous behavior for the mean kinetic energy. Specifically, it 
significantly decreased during ischemia from 1.60 ± 0.68 pixel2/ms2 to 0.27 ± 0.11 
pixel2/ms2 (p < 0.05 vs. healthy tissue), whereas, after 6 min of reperfusion, this 
parameter showed significantly higher and more physiological values (0.68 ± 0.16 
pixel2/ms2, p < 0.05 vs. ischemic tissue, p < 0.05 vs. healthy tissue). 
 
The mean acceleration module significantly decreased during ischemia from 
1.51 ± 0.84 pixel/ms2 to 0.63 ± 0.16 pixel/ms2 (p < 0.05 vs. healthy tissue), whereas, 
after 6 min of reperfusion, this parameter showed physiological and significantly 
higher values (1.14 ± 0.22 pixel/ms2, p < 0.05 vs. ischemic tissue, not significant vs. 
healthy tissue). In addition, the mean frequency of contraction was also decreased 
in the ischemic heart in comparison with the healthy one (from 4.08 ± 1.81 Hz to 
3.64 ± 0.45 Hz, p > 0.05), whereas the reperfusion did not change the contraction 
frequency in comparison with ischemia (p = 0.21). The same experiment was 
performed for the non-ischemic regions (right ventricles) in the HEALTH, ISCH 
and REP conditions and we did not find significant differences for the 
aforementioned parameters (data not shown). 
 
During the same protocol, PIV was used to study some physical parameters of the 
cardiac cycle. In particular, as example of PIV imaging, we have reported the 
velocity vector field (pixel/s) in diastole (Fig. 3.1.5a, left panels) and in systole (Fig. 
3.1.5a, right panels).  
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Figure 3.1.5: Particle Image Velocimetry (PIV) analysis in ischemic/reperfused rat hearts. (a) PIV showing the 
velocity vectors for a rat heart as example in diastole (left column) and in systole (right column) for the HEALTH, ISCH 
and REP conditions. (b) Velocity module calculated by PIV analysis in the three aforementioned conditions. (c) Same as 
(b) for vorticity. The p-value was *p < 0.05, calculated from Student’s t test (paired). n = 6. 
 
The mean velocity module was decreased in ischemia in comparison with the 
healthy heart (from 43.10 ± 6.56 pixel/s to 36.24 ± 4.18 pixel/s, p > 0.05, Fig. 
3.1.5b); the reperfusion ameliorated, but not significantly, the mean velocity 
module (to 41.19 ± 5.23 pixel/s) in comparison to ischemia.  
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Compared with the initial value measured for the healthy heart, mean velocity 
module remained not significant (p > 0.05). 
 
The mean vorticity was significantly decreased in the ischemic heart in comparison 
with the healthy one (from 0.52 ± 0.18 Hz to 0.31 ± 0.05 Hz, p < 0.05, Fig. 3.1.5c); 
the reperfusion ameliorated the mean vorticity (to 0.33 ± 0.06 Hz) in comparison to 
ischemia (p > 0.05) but we did not obtain the initial value of the healthy heart 
(p < 0.05). 
 
- Video kinematic parameters in patients underwent CABG 
We then moved to experimental medicine by adapting our system to an operating 
room with the purpose of recording the beating hearts of ten patients that 
underwent CABG (Fig. 3.1.6). 
 
Figure 3.1.6: Kinematic parameters 
and video cardiograms in patients 
underwent coronary artery bypass 
graft (CABG). (a) Top. Maximum 
velocity module and acceleration 
module measured by using a low-
speed video camera. Bottom. Same 
for kinetic energy and maximum 
displacement module. (b) Video 
cardiogram (velocity vs. time) for the 
patient #1 before (top) and after 
(bottom) CABG. (c) Same as (b) for 
patient #3. 
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In average, the coronary occlusion for ten patients was 86.1 ± 2.5%. For all hearts, 
we selected a video marker (radius = 20 pixel) onto the epicardial surface beneath 
the region where CABG was performed. We performed three video recordings for 
each patient: i) at chest opening (at pericardium opening, time 0 min); ii) after 
CABG (but before protamine sulfate infusion with cannulated aorta, time 120–
180 min); iii) before chest closing (time 140–200 min). The TEE showed a 
significant improvement for the mean ejection fraction (EF%, from 31.75 ± 4.80 to 
46.70 ± 2.60, p = 0.004) and a not significant increment for the mean fractional 
shortening (FS%, from 38.40 ± 6.10 to 50.27 ± 2.50, p = 0.08) (Supplementary Fig. 
3.1.6a). With our method, we did observe significant changes for the acceleration 
module (p = 0.02, Fig. 3.1.6a, Supplementary Fig. 3.1.6b) and a substantial 
improvement for the other three parameters: maximum velocity module (p = 0.28), 
kinetic energy (p = 0.58), and maximum displacement module (p = 0.37) (Fig. 
3.1.6a, Supplementary Fig. 3.1.6b). However, when we looked at the individual 
patient’s outcome, patient #3, despite increased acceleration module, denoted a 
substantial reduction in the other three parameters. 
 
The corresponding ViCGs showed that cardiac cycles differed from each other for 
all patients before CABG. For the sake of comparison, we displayed the ViCG from 
patient #1 (which obtained an increment in all preceding parameters after surgery) 
(Fig. 3.1.6b, upper panel) and patient #3 (Fig. 3.1.6c, upper panel) before CABG. 
In both patients, we observed disturbed cardiac cycles and dissimilar 
contraction/relaxation trajectories (data not shown). After CABG, the cardiac 
cycles became more physiological for patient #1 (Fig. 3.1.6b, lower panel) but not 
for patient #3 (Fig. 3.1.6c, lower panel). 
 
Similarly, PIV analysis, before and after CABG in diastolic and systolic phases, for 
aforementioned patients, showed that the mean velocity module significantly 
increased by 32% (p < 0.05) in patient #1 (Fig. 3.1.7c) and only by 9% in patient #3 
(not significant, Fig. 3.1.7d). Accordingly, patient #3 received an inotropic agent 
and extra monitoring in the critical-care postoperative unit. 
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Figure 3.1.7: Particle Image Velocimetry (PIV) analysis in CABG patients. (a) PIV analysis for patient #1 before (top) 
and after (bottom) CABG for the diastolic (left) and systolic (right) phases. (b) Same as (a) for patient #3. (c) Velocity 
module calculated by PIV analysis for patient #1 before and after CABG (*p < 0.05). (d) Same as (c) for patient #3. 
Calculated from one-way ANOVA, LSD post hoc test. n = 1,732 video frames for patient #1 and n = 992 video frames for 
patient #3. 
 
- Improved kinetic energy following atrioventricular block in rat and human 
hearts: the Frank-Starling effect 
We ran a protocol whereby a gentle air-pressure mechanical stimulation (20 kPa for 
1 s), delivered onto the rat atrioventricular (AV) regions, exerted a limited stretch-
induced depolarization and caused AV blocks, resembling the condition of the 
commotio cordis [57, 63, 64]. This intervention delayed the preload and resulted in 
an increment of the end-diastolic volume. Following the Frank-Starling 
mechanisms, the stroke volume increased and therefore the required kinetic energy 
as well (Supplementary Video 3, Supplementary Fig. 3.1.7a–b) [65]. Our 
methodology detected, following the AV block, an increased kinetic energy from 
0.003 to 0.025 pixel2/ms2. 
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Similarly, we found a spontaneous increment of the end-diastolic volume in human 
heart (patient #2, Supplementary Fig. 3.1.7c–d) after CABG intervention but before 
protamine sulfate infusion. We observed an increment in kinetic energy after the 
pause from 0.084 to 0.149 pixel2/ms2 before returning to 0.093 pixel2/ms2. 
 
3.1.4. Discussion 
 
We report a video-based and contactless technique that can add, for the first time to 
our knowledge, precise cardiac kinematic information during open-chest 
procedures. Our technology can be adapted for both basic and clinical research and 
can work in conjunction with standard monitor procedures, without disturbing the 
intervention during open-chest cardiac surgery. We validated our kinematic 
parameters in the ‘physical’ case, i.e., tracking the movement of a pendulum during 
its periodic motion and in rats by connecting a known mass onto the epicardial 
surface and following its trajectories. The minimal differences we encountered in 
the force or acceleration measurements were only related to physiological changes 
in the kinematics of the cardiac tissue and were not an artifact of the measure (cf. 
Fig. 3.1.2). We also demonstrated the reproducibility of the data by monitoring over 
time our kinematic parameters from the same hearts (Supplementary Fig. 3.1.3). 
We were able to capture the contraction movement of the ischemic/reperfused 
tissue area and we computed the corresponding kinematic and dynamic parameters 
(such as displacement, velocity, kinetic energy, frequency, acceleration, force) 
which are undetectable via conventional TEE. We precisely interrogated the same 
epicardial areas before and after intervention i) in silico by modeling ischemic 
contractile hearts, ii) in an experimental rat model during ischemia/reperfusion 
protocol, and iii) in patients underwent CABG. 
 
Our image processing technology allowed monitoring the progression of the 
intervention by analyzing the cardiac kinematic parameters (by video markers with 
a radius of at least 15–20 pixel and a temporal resolution of ≥ 30 fps, Supplementary 
Figs 3.1.1–2). These data can be extracted and presented in the operating room 
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before closing the patient’s chest, permitting supplementary considerations about 
cardiac performance and prognosis. While the human heart beats at an intrinsic 
frequency of ca. 1.5 Hz, rat heart beats at ca. 4.5 Hz. Thus, we decided to use either 
a low-cost camera for human studies (full HD portable camcorder, built-in memory) 
with auto-zoom and low temporal resolution or a high-speed camera for animal 
studies (1000 fps with manual zoom, video acquisition connected to a fast PC via 
frame grabber). In all experiments, we never lost video marker tracking. We 
obtained data on patients before and after CABG (at the final check and after 
protamine sulfate infusion) showing that the acceleration of the reperfused tissue 
significantly increased (Fig. 3.1.6a). To note, also the other three parameters 
showed an increment in average. 
 
The differences observed in rats vs. humans (i.e., statistical significance was 
achieved in all ischemic rat parameters) were possibly related to the artificial 
almost-complete coronary occlusion in healthy rat hearts vs. pathophysiological 
coronary occlusion of 86.1% occurring in the failing human hearts (inclusion 
selection for CABG vs. stent placement). 
 
For human hearts, the local cardiac kinematics before and after CABG was 
extremely variable (cf. Fig. 3.1.6), possibly depending on the volume of ischemic 
region, age, gender, weight, lifestyle and medical records (i.e., when coronary 
occlusions have been detected). Moreover, we have to take into consideration that 
the field of view of open-chest human heart covers mainly the right ventricle 
compared to the rat heart where the left ventricular (LV) area, within the field of 
view, is larger. 
 
There is clinical evidence supporting the concept that all patients undergoing 
CABG have different degrees of myocardial stunning [66], which occasionally 
requires inotropic support after surgery (i.e., patient #3), but not signs of myocardial 
infarction. 
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In animals, stunned myocardium has been detected after 15–30 min of coronary 
occlusion [67], which was not our case. Certainly, prolonged ischemia would be 
important for understanding whether the method can detect abrupt evidence of 
myocardial pathophysiological alterations [68]. Indeed pioneering studies indicate 
that, following brief episodes of ischemia, creatine phosphate [69] increases rapidly 
after reperfusion, suggesting that local kinetic energy rapidly increases as well [70]. 
 
The power of our technique is that the ViCG, which was obtained during 
ischemia/reperfusion protocol or before and after CABG, may return an overall 
view of the quality of the intervention from a mechanical perspective, especially in 
the reperfused regions, where the video markers were positioned. In addition, the 
ViCG can be combined with the conventional ECG by returning information on in 
vivo data of excitation-contraction coupling machinery. 
 
The benefit of using high-fps acquisition in basic research (up to 1000 fps) is such 
that we can distinguish local contraction trajectories in a millimeter range during 
ventricular fibrillation (data not shown) in rat hearts or we can appreciate an 
increment of the kinetic energy after a mechanical stimulus inducing AV blocks (cf. 
Supplementary Fig. 3.1.7). The technique can be easily adapted to study other 
inherited or acquired cardiac complications at both laboratory and clinical levels by 
returning important physiological data on tissue contraction at open-chest stage. 
 
In summary, our technology can monitor and examine several cardiac regions in 
open-chest beating hearts. This not only provides mechanical insights, but it also 
offers new prognostic values. Moreover, kinetic energy, as indirect measurement 
of ATP consumption [31], can be embraced as a clinical marker. 
 
3.1.5. Limitations 
 
Video kinematic evaluation performed from a single camera is not able to study the 
movement in the z direction thus resulting in bi-dimensional analysis of three-
dimensional (3D) phenomena. Nevertheless, the designed and implemented 
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algorithm is already capable to acquire 3D motion and it was employed to study the 
3D data of mathematical modeling. A further development for a 
stereoscopic/double camera acquisition as well as concurrent monitoring of 
electrical activity could solve the limitations. Acceleration and kinetic energy are 
obtained from the linear parameters (displacement and velocity), so they are per se 
prone to the measure noise. We compared our data from the same sampling rate, 
i.e., HEALTH vs. ISCH in animal studies or before and after CABG in human 
studies. Doing so, we avoided the aliasing phenomena by maintaining the same 
signal-to-noise ratio. 
 
While we could measure kinematics on the left ventricle in animal studies, only the 
right ventricle is exposed in humans, thereby limiting our measurement at the 
closest regions near the CABG intervention. 
 
3.1.6. Methods 
 
- Experimental animals 
The study population consisted of nine male Wistar rats bred in the animal facility 
of the Department of Life Science, University of Parma. The rats were 12–14 weeks 
of age and weighed 300–350 g. The investigation was approved by the Veterinary 
Animal Care and Use Committee of the University of Parma (Italy) (Protocol # 
41/2009 and 59/2012) and it conformed to the National Ethical Guidelines of the 
Italian Ministry of Health and to the Guide for the Care and Use of Laboratory 
Animals (National Institute of Health, Bethesda, MD, USA, revised 1996). More 
information is detailed in the Supplementary methods section. 
 
- Human patients 
We performed video recording in patients during CABG surgery in the Azienda 
Ospedaliera Universitaria Integrata (Verona, Italy). Ten patients (9 males, 1 female) 
were enrolled from March to December 2016. Patients were selected for CABG as 
they presented coronary occlusion of 86.1% in average. No human tissue samples 
have been used. The video recording never interfered with the standard CABG 
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intervention, in accord with the guidelines for coronary artery bypass surgery [64]. 
All methods and experiments were carried out in accordance with relevant 
guidelines and regulations set by the Institutional Review Board (IRB) of the 
Azienda Ospedaliera Universitaria Integrata of Verona, where all experiments were 
done (approved protocol from ethics committee on 16th March 2016, # 847CESC 
Protocol # 13371). All patients signed an informed consent. 
 
- Functional imaging 
o Low-speed video camera 
A full HD (1920 × 1080 total pixel area) camera Samsung S10 (with an internal SD 
memory of 256 MB and internal rechargeable battery) has been used for the cardiac 
force measurement in rats and for the CABG recording in the operating room. The 
on-site monitor of the camera allowed the recording of the heart beating. Videos 
have been recorded for 60 s in full HD gray-scale mode at 30 fps. The hearts have 
been constantly illuminated with scialytic light by keeping it in the same position 
during video recording for both animals and patients. 
 
o High-speed video camera 
A Baumer HXC13 (Baumer Italia, S.r.l., Milano, Italy) camera with full 
CameraLink® interface (1280 × 1024 total pixel area for 500 fps or 1020 × 600 for 
1000 fps) was used for ischemia/reperfusion experiments in rats. The camera was 
equipped with a macro-objective Kowa Industrial Lenses LM35XC, F = 1:2.0, 
f = 35 mm, picture size 13.8–18.4 mm (RMA Electronics, Hingham, MA, USA). 
The acquisition software was custom made in LabVIEW Visual Programming 
Language (National Instruments, Assago, Milano, Italy). We ran 1-s acquisitions at 
either 1000 fps (reproducibility data) or 500 fps (ischemia/reperfusion data) 
allowing the recording of spontaneous beats in anesthetized rats. No pixel binning 
was used. The camera was connected with two CameraLink® cables to a frame 
grabber acquisition board PCIe 1433 (National Instruments, Italy) adapted into a 
Workstation HP Z220 (Crisel Instruments, Italy) with 24 GB RAM. The video file 
consisted of 1000 or 500 TIFF images (1.25 MB each) of the beating heart. For the 
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pendulum experiment, we ran an acquisition at 200 fps (1280 × 1024 total pixel 
area) for five seconds of recording. 
 
- Video acquisition 
o Video kinematic evaluation in rats 
In the anesthetized animals subjected to artificial ventilation (Rodent Ventilator, 
Ugo Basile, Italy), the heart was exposed through a longitudinal sternotomy and 
suspended in a pericardial cradle. Body temperature was maintained with infrared 
lamp radiation. In the present study, the camera was levelled at 17 cm above the 
spontaneously beating heart. A constant illumination was achieved using a scialytic 
lamp for laboratory (ElettroMedica, Italy). During recording, the ventilator was 
switched off to avoid motion artifacts and immediately re-switched on at the end of 
the recording. The distance between the camera and the heart, the focus and the 
heart’s orientation were never changed during the experiments. 
 
For the force measurement experiments, we employed known masses consisting of 
a pin-head with a 1 mm-long needle inserted on the epicardium surface. For the 
ischemia/reperfusion experiments, we recorded the beating heart in normal 
conditions followed by anterior descending coronary ligation, as recently 
described33. We left the surgical needle within the performed knot as this allowed 
the removal of the ligation without damaging the tissue. Then, we waited for 6 min 
and 12 min before recording another video of the beating heart (now ischemic). The 
same procedure was followed after the removal of the ligation (i.e., two video files 
were recorded after 6 min and 12 min). 
 
For the mechanically-induced AV blocks, we adopted a flexible cannula (0.8 mm 
diameter) firmly fixed to a three-axes manipulator and positioned ca. 5 mm above 
the pulmonary cone. A gentle air-pressure flow (20 kPa) was delivered for 1 s using 
an electro-valve (Asco Numatics, Bussero, Milano, Italy) remotely controlled by a 
stimulator (Crescent Electronics, Sandy, UT, USA), similar to what we had 
previously implemented for single cell mechanical stimulation [71]. 
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o Video kinematic evaluation during CABG in human patients 
In the operating room, the camera was positioned with an articulating arm at 40 cm 
above the open chests. We performed video recordings of beating hearts at chest 
opening (after pericardium opening, time 0 min), after CABG but before protamine 
sulfate infusion with cannulated aorta (data not shown, time 120–180 min), and 
before chest closing (time 140–200 min). All patients were in normal sinus rhythm 
during the intervention. Because, during CABG, the surgeons frequently move the 
operating table, we recorded the original position of the table and recalled it during 
video acquisitions. For the analysis (before and after CABG), we took into 
consideration additional anatomical markers, such as coronary vessels or skin edges 
for properly positioning the video marker. 
 
- Quantitative analysis 
Tracking of the cardiac contraction 
Using VST program (http://cismm.cs.unc.edu/downloads), which tracks the 
movement of biological objects starting from the video recording of their 
displacements, we anchored a single video marker to the cardiac tissue or to a mass 
(0.035 g) firmly connected to that tissue. The x and y coordinates are expressed in 
pixel, whereas the t coordinate in second (s). 
 
- Kinematics 
Using a custom algorithm based on the Matlab Programming Language (The 
MathWorks, Inc., Natick, MA) and the tracked spatial-temporal coordinates of the 
cardiac contraction, we identified the heartbeats and then calculated the 
corresponding kinematic parameters (see Table 1 for the mathematical definitions 
and their physiological meaning). 
 
- Particle Image Velocimetry 
We employed ‘Particle Image Velocimetry’ (PIV) tool, which is a fluid flow 
visualization and quantification technique, in particular its Matlab Central 
implementation in PIVlab 
(http://it.mathworks.com/matlabcentral/fileexchange/27659-pivlab-time-resolved-
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particle-image-velocimetry-piv-tool?s_tid=srchtitle). We applied the PIV to study 
the cardiac cycle and we reported the images of the velocity vectors (pixel/s) in 
diastole and in systole. During the whole observation period, it was possible to 
evaluate the mean rotation frequency of the velocity vectors, that is, the mean 
vorticity (Hz) and the mean velocity module (pixel/s). 
 
- Mathematical models 
o Numerical simulations 
The numerical simulations were based on the cardiac electro-mechanical coupling 
(EMC) model. This model described the interplay between the spread of electrical 
excitation in the cardiac tissue and the consequent contraction/relaxation process. 
The EMC model consisted of four sub-components, two for the bioelectrical 
activity and two for the mechanical response of the cardiac tissue. The bioelectrical 
components were the Bidomain model for the electric current flow [35] and the ten 
Tusscher human ventricular model [36] for the cellular membrane dynamics. We 
disregarded the presence of an ischemic damage in the surviving layers at the border 
of the ischemic region. From the bioelectrical point of view, ischemic conditions 
were modeled modifying the following parameters of the ten Tusscher model [40]: 
the extracellular potassium concentration was increased from 5.4 mM to 8 mM; the 
maximal conductances of the INa and ICaL currents were decreased by 25%; the 
parameters of the IKATP current were modified as in [41] for ischemia stage 2. In 
the normal ventricular tissue, the same set of Bidomain anisotropic conductivities 
was assigned, yielding the physiological conduction velocities of about 0.065 and 
0.03 cm/ms, when measured for wave front propagation along and across fiber, 
respectively, matching reported conduction velocities. Since we considered the 
early stage of myocardial ischemia, the conductivity coefficients inside the 
ischemic region were not modified, reflecting an unchanged distribution of 
connexin 43. From the mechanical point of view, ischemic conditions were 
modeled by reducing the active tension and passive tissue stiffness of 10% and 25% 
with respect to their normal values. Stretch-activated channels were incorporated in 
the membrane model according to [37]. The macroscopic description of the 
mechanical activity was based on the equations of finite elasticity, where the 
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passive mechanical properties of the myocardium were assumed to be transversely 
isotropic, hyper-elastic, and nearly incompressible, defined by an exponential strain 
energy function derived from [38]. Realistic fiber orientations were incorporated 
into both the conductivity tensors of the Bidomain model and the strain energy 
function. The EMC model was finally closed by the active tension generation model 
developed describing the process of calcium binding to troponin C and cross-bridge 
cycling triggered by calcium release from the intracellular calcium stores during the 
electrical activation of a myocyte. The active tension generated by this model 
entered as input in the non-linear elasticity equations yielding the active component 
of the stress tensor. The intracavitary blood pressure p in the left ventricular (LV) 
cavity was described by a pressure-volume loop model [39], based on the following 
four phases: 
 
Isovolumetric LV contraction phase, where p increased from the end-diastolic 
pressure (EDP) value of about 2 kPa to 10 kPa; 
 
Ejection phase, where the pressure-volume relationship was described by a two-
element Windkessel model, until the volume reduction stopped; 
 
Isovolumetric LV relaxation phase, where p decreased to 1 kPa; 
 
Filling phase, where p increased linearly to EDP. 
 
o Numerical methods 
The space discretization was based on Q1 finite elements. The computational 
domain was a truncated ellipsoid representing the left ventricle geometry. The size 
of the major axis of the ellipsoid was 5 cm, while that of the minor axis was 2.7 cm. 
Two different meshes were used, a fine one to solve the Bidomain equations and a 
coarser one for the finite elasticity equations. The nodes of the electrical mesh were 
3,631,488, while those of the mechanical mesh were 8,400. The time discretization 
was performed by a semi-implicit finite difference scheme. The time step size was 
0.05 ms for the electrical components of EMC model and 0.25 ms for the 
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mechanical components. Our parallel code was based on the PETSc library 
(https://www.mcs.anl.gov/petsc/). The simulations were run on 256 cores of the 
Bluegene cluster Fermi of the CINECA laboratory (http://www.cineca.it). For 
further details on the numerical methods, we remand to [35, 72, 73]. Parameters 
calibrations are detailed in the Supplementary methods section. 
 
- General statistics 
Normal distribution of variables was checked by the Kolmogorov-Smirnov test. 
Statistics of normally distributed variables included mean ± standard error of the 
mean (SEM), paired and unpaired Student’s t test. Statistical significance was set 
at p < 0.05. For the ischemia/reperfusion experiments, one-way Analysis of 
Variance (ANOVA) was applied with post hoc Least Significant Difference (LSD) 
test, electing a significance level of 5% (the results are expressed as mean ± 95% 
confidence intervals for the differences between means). Statistics was performed 
using GraphPad Prism v.6 (La Jolla, CA, USA). 
 
3.1.7. Supplementary Information 
 
- Supplementary Methods 
 
o Experimental animals 
The animals were kept in single-sex groups of four individuals from weaning (4 
weeks after birth) until the onset of the experiments, in a temperature-controlled 
room at 20-24°C, with the light on between 7:00 AM and 7:00 PM. The bedding of 
the cages consisted of wood shavings; food and water were freely available. 
Animals were anesthetized with a mixture of ketamine chloride 40 mg/kg ip 
(Imalgene, Merial, Milano, Italy) and medetomidine hydrochloride 0.15 mg/kg ip 
(Domitor, Pfizer Italia S.r.l., Latina, Italy) for the in vivo experiments; all efforts 
were made to minimize suffering. We used nine male rats in total. Six male rats 
were enrolled in i) the experiments related to the cardiac force measurement with a 
given mass (n = 6); ii) the same animals were used for the ischemia/reperfusion 
experiments (n = 6) and iii) three of them included in the “reproducibility” 
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experiments, monitoring parameters every ten minutes for 1 h before 
ischemia/reperfusion (n = 3). Three male rats were included in mechanically-
induced AV block experiments. This study was carried out in accordance with the 
recommendations in the “Guide for the Care and Use of Laboratory Animals” of 
the Italian National Institute of Health. The protocol was approved by the 
Veterinary Animal Care and Use Committee of the University of Parma and 
conformed to the National Ethical Guidelines of the Italian Ministry of Health 
(Protocol # 41/2009 and 59/2012). 
 
o Parameters calibration for the mathematical model of ischemia 
simulation 
The intra (i)- and extra (e)- cellular conductivity coefficients of the Bidomain 
model, along (l) and across (t) the fiber direction, were σil = 3, σel = 2, σit = 
0.31525, σet = 1.3514, all in mΩ-1cm-1. The parameters of the strain energy 
function were the same of the original paper [39] except for the bulk modulus, 
which amounted to 200 kPa. The size of the ischemic region was 1 cm × 1 cm, 
developing along the whole transmural thickness, from the endocardial to the 
epicardial surface. From the bioelectrical point of view, ischemic conditions were 
modeled modifying the following parameters of the ten Tusscher model: the 
extracellular potassium concentration was increased from 5.4 mM to 8 mM; the 
maximal conductance of the INa and ICaL currents was decreased of 25%; the 
parameters of the IKATP current were modified as in [41] for ischemia stage 2. 
From the mechanical point of view, ischemic conditions were modeled by reducing 
the active tension and passive tissue stiffness of 10% and 25% with respect to their 
normal values, respectively. The excitation process was initiated by stimulating 
three endocardial anterior apical sites and one endocardial posterior apical site, 
mimicking an idealized Purkinje network. Two simulations were performed, one 
for a healthy tissue (HEALTH) and one for a tissue with a transmural ischemic 
region (ISCH). In both cases, three beats were simulated, at basic cycle length of 
500 ms. 
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- Supplementary Figure legends. 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 3.1.1. Velocities in the x direction obtained at different marker radius. We used a video marker 
radius equal to 20, 15, or 10 pixel (px) for a, b and c respectively. We found that a radius equal to 15 pixel was the minimum 
required to correctly follow the ventricle’s tissue and, then, to identify the cardiac beats. n = 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 3.1.2. Marker’s trajectories and the related velocity vectors obtained at different acquisition 
rates. The rate of 500 fps (a) gave the best trajectory details, the rates of 250 (b), 125 (c), 100 (d), and 50 (e) could be 
considered acceptable, whereas the other lower rates (≤25 fps in f) were significantly affected by the aliasing phenomenon 
with loss of trajectory details and were excluded from this study. 
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Supplementary Figure 3.1.3. Reproducibility of the acquired data in three different rat hearts. (a) Maximum velocity 
module (pixel/s) monitored every 10 min for 1 h at 1000 fps. (b) Same as (a) for kinetic energy (pixel2/s2). (c) Same as (a) 
for acceleration module (pixel/s2). (d) Same as (a) for maximum displacement module (pixel). Marker radius = 60 pixel. n = 
3.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 3.1.4. Evaluation of the kinetic energy during the periodic motion of a pendulum. (a) First 
acquired image of the pendulum at the highest point. Scale bar = 1 cm. (b) Trajectories and accelerations during five seconds 
of recording (with a maximum inaccuracy of three pixels in the y direction). (c) Coordinate x vs. time. (d) Kinetic energy at 
the highest point (ca. zero, Ek min), at the intermediate point (Ek int, p<0.05) and at the lowest point (maximum kinetic energy, 
Ek max, p<0.001). The statistics was calculated with one-way ANOVA. Data are showed as mean ± SEM. n = 10.  
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Supplementary Figure 3.1.5. Numerical simulation results of epicardial transmembrane (V) and extracellular (UE) 
potential distributions. (a) V distribution at t = 120 ms after the onset of stimulation in the healthy tissue (HEALTH). (b) 
V distribution at t = 120 ms after the onset of stimulation in the tissue with transmural ischemia (ISCH). (c) UE distribution 
at t = 120 ms after the onset of stimulation in the healthy tissue. (d) UE distribution at t = 120 ms after the onset of stimulation 
in the tissue with transmural ischemia. Numbers at the bottom of each panel represent the minimum value, the potential step 
and the maximum value respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 3.1.6. Functional parameters of human beating hearts. (a) Mean ejection fraction (EF%, left, 
**p<0.01) and mean fractional shortening (FS%, right, p>0.05) of seven patients before and after CABG. (b) Acceleration 
module, kinetic energy,  maximum velocity module and maximum displacement module before (white) and after (black) 
CABG (p<0.05 only for the acceleration module; the p-value was calculated from Student’s t-test, normal distribution was 
checked by means of the Kolmogorov-Smirnov test). 
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Supplementary Figure 3.1.7. Kinetic energy related to the Frank-Starling effect following an AV block. (a) Video 
cardiogram (ViCG) for the marker displacement of spontaneously beating rat heart with an AV block between the third and 
the fourth beat; red arrow: mechanically induced AV block (20 kPa of air pressure delivered for 1 s). (b) Related kinetic 
energy measured for each cardiac cycle. Black dots: single beat kinetic energy measured for each cycle. Red dot: single beat 
kinetic energy after AV block. (c) Same as (a) for spontaneously beating human heart (patient #1). Red arrow: spontaneous 
AV block. (d) Related kinetic energy measured for each human heartbeat. Red dot: single beat kinetic energy after AV block. 
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The publication on Scientific Report led to an increased interest for Vi.Ki.E. 
applications in more complex cases, like congenital heart diseases, and especially 
in the Right Ventricle evaluation thanks to the direct “sight contact” of the camera 
with it. Therefore, a pilot study on the Right Ventricle evaluation, in hearts affected 
by Tetralogy of Fallot, was set up and published on Interactive Cardiovascular and 
Thoracic Surgery. 
 
3.2. Real-time video kinematic evaluation of the in situ 
beating right ventricle after pulmonary valve 
replacement in patients with tetralogy of Fallot: a 
pilot study [29]. 
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3.2.1. Abstract 
 
- Objectives. 
The timing for pulmonary valve replacement (PVR) after tetralogy of Fallot repair 
is controversial, due to limitations in estimating right ventricular dysfunction and 
recovery. Intraoperative imaging could add prognostic information, but 
transesophageal echocardiography is unsuitable for exploring right heart function. 
Right ventricular function after PVR was investigated in real time using a novel 
video-based contactless kinematic evaluation technology (Vi.Ki.E.), which 
calculates cardiac fatigue and energy consumption. 
- Methods.  
Six consecutive patients undergoing PVR at 13.8 ± 2.6 years (range 6.9–19.8) after 
the repair of tetralogy of Fallot were enrolled. Mean right ventricular end-diastolic 
and end-systolic volume at magnetic resonance imaging were 115.6 ± 16.2 ml/m2 
and 61.5 ± 14.6 ml/m2, respectively. Vi.Ki.E. uses a fast-resolution camera placed 
45 cm above the open chest, recording cardiac kinematics before and after PVR. An 
algorithm defines cardiac parameters, such as energy, fatigue, maximum 
contraction velocity and tissue displacement. 
- Results. 
There were no perioperative complications, with patients discharged in satisfactory 
clinical conditions after 7 ± 2 days (range 5–9). Vi.Ki.E. parameters describing right 
ventricular dysfunction decreased significantly after surgery: energy consumption 
by 45% [271 125 ± 9422 (mm/s)2 vs 149 202 ± 11 980 (mm/s)2, P = 0.0001], cardiac 
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fatigue by 12% (292 671 ± 29 369 mm/s2 vs 258 755 ± 42 750 mm/s2, P = 0.01), 
contraction velocity by 54% (3412 ± 749 mm/s vs 1579 ± 400 mm/s, P = 0.0007) 
and displacement by 23% (27 ± 4 mm vs 21 ± 4 mm, P = 0.01). Patients undergoing 
PVR at lower end-diastolic volumes, had greater functional recovery of Vi.Ki.E. 
parameters. 
- Conclusion. 
Intraoperative Vi.Ki.E. shows immediate recovery of right ventricular mechanics 
after PVR with less cardiac fatigue and energy consumption, providing novel 
insights that may have a prognostic relevance for functional recovery. 
 
 
3.2.2. Introduction  
 
Pulmonary regurgitation (PR) is the most common sequela late after repair of 
tetralogy of Fallot (ToF) [74]. The resulting chronic right ventricle (RV) volume 
overload leads to varying degrees of ventricular dilatation and dysfunction, which 
are associated with arrhythmias, cardiac failure and premature death [74]. While 
pulmonary valve replacement (PVR) has been shown to be effective in resolving 
PR [75], late results after surgery have not been uniformly associated with clinical 
improvement [76]. Although to some clinicians, this observation would suggest that 
the current indications for PVR may be excessively conservative, leading to 
intervention when irreversible RV dysfunction has ensued [77], others object that a 
prognosis without PVR may be better in select patient cohorts, due to the additional 
morbidity associated with PVR surgery [78]. Therefore, the indication and timing 
for PVR remain a matter of debate. 
 
The current international guidelines for PVR after ToF repair focus on RV 
functional deterioration, even in asymptomatic patients [79]. 
 
However, there is mounting evidence that load-dependent and load-independent 
indices of RV function assessed by cardiac magnetic resonance (CMR), may be 
instrumental in guiding indication and timing for PVR [80]. Accordingly, both RV 
97 
 
end-diastolic volume (EDV) and RV end-systolic volume (ESV), including ejection 
fraction, are currently utilized to assess the correct timing of PVR [81]. However, 
controversy remains on threshold values due to often unpredictable outcomes after 
PVR. This has stimulated a quest for alternative clinical and experimental methods 
to investigate the RV function, in patients with chronic PR after ToF repair [82-84]. 
Theoretically, a technology able to evaluate RV performance during PVR may track 
functional changes, and ultimately aid in determining the best timing for PVR, in 
the future. We recently described an original method to elaborate high temporal and 
spatial resolution parameters of ventricular function in real time during open-chest 
surgery, using video kinematic recordings [28]. Briefly, this innovative technique 
was validated in our previous work [28], in which its algorithm efficiency and 
quality were evaluated by comparing the data obtained from: the cardiac electro-
mechanical coupling model; the pendulum harmonic motion; the spatial and 
temporal resolution and longitudinal assessment of the kinematic parameters and 
the contraction force by placing a known mass onto the epicardium of a beating rat 
heart. This pilot study aims to assess safety and efficacy of intraoperative kinematic 
evaluation to describe acute RV functional changes in patients undergoing PVR late 
after ToF repair. 
 
3.2.3. Materials and Methods 
 
The study was approved by the Institutional Review Board (# 847CESC Protocol # 
13371), and all patients signed an informed consent. Selection criteria for the study 
were (i) PR after transannular patch repair of ToF with pulmonary stenosis; (ii) 
symptomatic patients with severe PR or asymptomatic patients with evidence of 
progressive severe RV dilatation or dysfunction [79]; (iii) PVR using stented bio 
prostheses; and (iv) feasibility of PVR normothermic cardiopulmonary bypass on 
the beating heart. The latter criterion was introduced to eliminate the influence of 
intraoperative myocardial ischemia on postoperative cardiac kinematics. 
Furthermore, this criterion was also adopted to closely replicate potential 
advantages of transcatheter PVR, when no additional myocardial ischemia was 
involved. Between November 2016 and February 2018, 6 consecutive patients were 
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enrolled. All patients underwent preoperative CMR and transthoracic 
echocardiographic evaluation. Demographic and laboratory variables are reported 
in Table 3.2.1. 
 
Table 3.2.1: Demographic and laboratory variables. BSA: body surface area; CMR: cardiac magnetic resonance; LVEF: 
left ventricular ejection fraction; NYHA: New York Heart Association; PR: pulmonary regurgitation; PVR: pulmonary valve 
replacement; RBBB: right bundle branch block; RVEDVi: right ventricular end-diastolic volume index; RVEF: right 
ventricular ejection fraction; RVESVi: right ventricular end-systolic volume index; SR: sinus rhythm; ToF: tetralogy of Fallot 
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- Surgical methods. 
All PVR procedures were performed by 1 surgeon (G.B.L.). Patients underwent 
PVR via repeat median sternotomy, using aortic and bicaval cannulation and under 
normothermic (36°C) cardiopulmonary bypass on the beating heart. Video 
kinematic recordings were focused on the apical trabecular component of the RV, 
in line with previous evidence showing this portion as the one bearing most of the 
chronic volume overload [33]. (Fig. 3.2.1A). All patients underwent postoperative 
transthoracic echocardiographic evaluation. 
 
 
Figure 3.2.1. Video kinematic results obtained pre- and post-pulmonary valve replacement (PVR). (A) Marker position 
(red circle) on the patient’s heart (RV) during open-chest surgery. (B) Upper panel, marker trajectories (black lines with 
ticks) and acceleration (pink arrows) pre-PVR. Middle panel, video cardiogram in x-axis pre-PVR. Lower panel, video 
cardiogram in y-axis pre-PVR. (C) Same as (B) but post-PVR. AAo: ascending aorta; Black dashed circle: effective area of 
analysis; RA: right atrium; RV: right ventricle. 
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- Experimental Protocol. 
For each patient, a high-speed camera (Basler acA1300-200um USB 3.0 with the 
ON Semiconductor PYTHON 1300 CMOS sensor, Ahrensburg, Germany, 
equipped with Edmund Optics 6 mm compact fixed focal length lens, Barrington, 
NJ, USA) was placed approximately 0.4 m above the heart during ToF surgery and 
4 videos of 5 s at 200 FPS with a resolution of 1280 × 1024 and a quality of 10p 
were recorded at 2 time points. Compared to the previous study [28], this camera 
and the lenses were specifically chosen for human hearts with the intention of 
increasing the field of view and assessing the RV kinematics globally. The first 
recording (pre-PVR) was after chest opening, the second one (post-PVR) around 
30 min after weaning from cardiopulmonary bypass exit. In the post-PVR 
recording, great care was taken to reproduce the same hemodynamic conditions 
observed in the pre-PVR, including central venous pressure, systolic arterial blood 
pressure, heart rate and identical ventilator settings. No patient required inotropic 
support and only one required intravenous antiarrhythmic therapy, as specified 
below (case #3). The videos were acquired on a high-performance PC (Intel core 
i7-6700HQ 3.5 GHz, 16GB DDR4 2133 MHz SDRAM, 1TB HDD 7200 RPM 
With 128GB SSD PCIE ×4) by using an USB 3.0 cable through the camera’s own 
software (Pylon 5 Camera Software Suite 5.0.5 for Microsoft Windows, 
Ahrensburg, Germany). 
 
- Video Kinematic Evaluation of right ventricle function. 
The videos were evaluated by using the Video Spot Tracker software (VST, 
CISMM, Computer Integrated Systems for Microscopy and Manipulation, UNC 
Chapel Hill, NC, USA), allowing a virtual marker to be placed on the first frame of 
the video, which follows the light spots on the epicardial surface, tracking the 
spatial–temporal coordinates x, y and t of that marker in each frame (Fig. 1A and 
Video 1). Afterwards, a custom-made algorithm [31] implemented with MATLAB 
Programming Language (The MathWorks, Inc., Natick, MA, USA) analyses these 
coordinates, evaluates video cardiograms (ViCGs) and presents the following 
physical quantities: 
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Displacement: estimates instantaneous movement of the cardiac tissue; 
Contraction velocity: estimates instantaneous velocity of the cardiac tissue; 
Force: estimates cardiac fatigue (instantaneous acceleration); 
Energy: estimates the kinetic energy during cardiac cycle (it follows the classical 
and Hamiltonian mechanics for kinetic energy ½ mv2) [28]. 
 
The algorithm presents the raw data in pixels and we reported these in SI-accepted 
unit (m) to provide useful information to surgeons. In the laboratory, we 
reconstructed a transformation pixel-to-mm curve (r2 = 0.9977) by placing the 
camera at different heights, from 0.05 to 0.6 m with 0.05 m step, above a millimetre 
paper (Supplementary Material, Table). 
 
Of note, all scientists involved with experimental data acquisition and interpretation 
were blinded to preoperative and postoperative clinical and laboratory data. 
 
- Statistical analysis. 
Data are presented as mean ± SEM. The normality of the data was assessed with the 
Kolmogorov–Smirnov test. The Student’s t-test with Welch’s correction and 
cumulative distribution with the Kolmogorov–Smirnov test were performed. A 
value of P<0.05 was considered significant. The programme GraphPad v.6 
(GraphPad Software, Inc., La Jolla, CA, USA) was used for analysis and results. 
 
3.2.4. Results  
 
- Clinical outcome 
All patients underwent surgical PVR on the beating heart: 4 patients received a 23-
mm, 1 patient a 21-mm and 1 patient a 25-mm stented bio prosthesis. There were 
no perioperative complications, except for 1 patient experiencing reversible 
subclinical hepatic dysfunction. Patients were discharged after a mean of 
7.0 ± 2.0 days (5–9 days) of hospitalization. Transthoracic echocardiogram prior to 
discharge documented the recovery of normal RV dimensions in 5 out of 6 patients 
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(83%), preserved (>50%) right ventricular ejection fraction (RVEF) in 3 out of 6 
patients and mildly reduced (>40%) RVEF in 3 out of 6 patients. On Doppler 
examination there was absence of PR in all patients and a mean peak trans-
prosthetic pulmonary valve gradient of 16.5 ± 7.1 mmHg. During a mean follow-up 
of 8.5 ± 4.5 months (2–15 months), all patients were in New York Heart 
Association (NYHA) I, except 1 patient in NYHA II. No patient experienced 
adverse cardiovascular events, and all were in regular sinus rhythm, free from oral 
anticoagulation. The follow-up echocardiogram was similar to that taken before 
discharge, with a mean peak trans-prosthetic pulmonary valve gradient of 
14.5 ± 7.9 mmHg and preserved RVEF in 5 out of 6 patients. 
 
- Intraoperative video kinematic evaluation of right ventricle function in 
patients with tetralogy of Fallot 
The qualitative and quantitative results of the 6 patients were extremely 
homogeneous, except for 1 patient (#3), who exhibited counterintuitive 
experimental outcomes. Intraoperatively, this patient showed atrial ectopic 
tachycardia after PVR, which was initially refractory to antiarrhythmic therapy and 
eventually subsided 6 h after surgery. 
 
From a qualitative point of view, trajectories and ViCGs differed between pre- and 
post-PVR condition in all patients (Fig. 3.2.1). In detail, all trajectories showed 
irregular and chaotic patterns (Fig. 3.2.1B, upper panel) prior to PVR. The same 
occurred for ViCGs, where systolic and diastolic phases were difficult to 
differentiate because of background noise in both x and y axes (Fig. 3.2.1B, middle 
and lower panels). On the contrary, trajectories showed regular, overlapped and 
well-preserved patterns after PVR (Fig. 3.2.1C, upper panel). The ViCGs displayed 
both systolic and diastolic phases and we identified less noise in both x and y axes 
(Fig. 3.2.1C, middle and lower panels). Moreover, marker displacement in 
trajectories and ViCGs amplitude decreased after PVR when compared to before 
PVR. 
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From a quantitative point of view, all kinematic parameters significantly decreased 
(Fig. 3.2.2A) after PVR when compared to before PVR. On an average, 
displacement decreased by 23%, maximum contraction velocity by 54%, force by 
12% and energy by 45% (Fig. 3.2.2A). Regarding the mechanical performances of 
individual patients, we noted (Fig. 3.2.2B) that all patients showed a decreasing 
trend for all parameters, except for patient #3 who exhibited an increasing trend. 
Prior to PVR, patient #6 showed the highest values for each parameter and the 
greatest percentage decrease after PVR. In particular, patient #6 values after PVR 
were greater than the rest of the study population, and, even though these exhibited 
the greatest decrease, the final parameter values remained 2-fold higher than pre-
PVR values from the rest of the study population. 
 
 
Figure 3.2.2. Kinematic 
parameters in tetralogy of Fallot 
patients. (A) Pre-PVR (black 
columns) was recorded at the chest 
opening before aortic cannulation. 
Post-PVR (white columns) was 
recorded after the surgery and 
protamine sulphate infusion. Data 
are shown as mean ± SEM. *P < 0.05 
versus pre-PVR, ***P < 0.001 
versus pre-PVR. (B) Visual 
representation of video kinematic 
evaluation parameters, trends for 
each patient pre- and post-PVR. 
PVR: pulmonary valve replacement; 
SEM: standard error of the mean. 
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To suggest possible clinical correlations, the acquired RV kinematics parameters 
were compared with CMR, the gold standard RV imaging technique. Thus, we 
plotted RVEDV index (RVEDVi) versus energy (Fig. 3.2.3, upper panel) and force, 
a surrogate for cardiac fatigue (Fig. 3.2.3, lower panel), because these kinematic 
parameters exhibit the strongest clinical implications. In both graphs, patients 
undergoing surgery with an RVEDV below 129 ml/m2 showed a consistent 
decrease in parameter values after PVR, in line with recovery of minimal 
contraction energy and cardiac fatigue. Patient #6, who underwent PVR with an 
RVEDVi of 183 ml/m2 (a value currently representing standard indication for 
surgery) also displayed lower values after PVR with the greatest decrease by far. 
However, after PVR, energy and force (cardiac fatigue) values in this patient 
remained higher than the corresponding parameters prior to PVR in the remainder 
of the study population. 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.3. Correlation between cardiac 
magnetic resonance and right ventricle 
kinematic parameters. (A) Graph displaying the 
relation between RVEDV and energy. Colours 
represent different patients (see legend), circle is 
pre-PVR and diamond is post-PVR. (B) Same as (A) 
but for force. PVR: pulmonary valve replacement; 
RVEDV: right ventricular end-diastolic volume. 
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3.2.5. Discussion 
 
Although PVR leads to prompt resolution of PR occurring after ToF repair [75], 
clinical improvement after PVR is not always predictable [76, 78, 79], leading to 
controversy over indications and timing for surgery. 
 
Therefore, in addition to clinical observations using meta-analyses [75], propensity 
matched [78] and prospective [77] studies, efforts have been made to devise 
experimental models [82-84] able to unravel pathophysiology of the RV following 
PVR. 
 
In this pilot study, a novel method to describe real time in vivo cardiac kinematics 
was experimentally applied to offer insight into acute changes of RV properties 
associated with resolution of volume overload by surgical PVR. This technique was 
previously applied, in patients undergoing surgical myocardial revascularization 
[28]. 
 
The original experimental approach is a video-based and contactless technique, 
which can describe precise cardiac kinematic information during open-chest 
procedures. This technology is versatile, as it may be applied for both basic and 
clinical research, in conjunction with standard monitoring procedures, without 
interfering with open-chest cardiac surgery. In patients undergoing surgical 
myocardial revascularization [28], this technique was able to detect fine contraction 
of the ischemic/reperfused cardiac tissue areas, which are poorly explored by 
conventional transesophageal echocardiography. In this study, we focused our 
attention on RV pathophysiology. 
 
The results of the current experimental study, demonstrate that in patients with 
previously operated ToF, RV preload reduction by PVR allows: (i) decrease of 
contraction force (cardiac fatigue) by 12%; (ii) decrease of energy by 45%; and (iii) 
decrease of maximum contraction velocity and displacement (instantaneous 
velocity and instantaneous movement of the cardiac tissue, respectively), because 
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the reduction of force and energy leads to less RV epicardial movement and 
velocity. One plausible and expected mechanism that could explain this trend is 
related to the Frank–Starling law: a decrease in RV preload generates a decrease in 
myocardium stretch (less tension development) and, consequently, a decrease in 
actin–myosin crossbridge activity leading to less cardiac force and kinetic energy 
[85]. 
 
The pilot study herein provides, for the first time, evidence that PVR may afford 
immediate recovery of RV functional properties in children and young adults late 
after ToF repair. Therefore, this work allows one to take the recent findings by Heng 
et al. [77] on very early (on average 10 days) RV volume recovery at CMR in adults 
undergoing PVR for chronic PI after ToF on step further. It is noteworthy that when 
applying standard CMR criteria for PVR, early and late mortality are not negligible 
and the rate of adverse cardiovascular events (death, VT) does not correlate with 
either EDV or ESV indices [77, 78]. This suggests that current RV threshold 
volumes at preoperative CMR will not reliably predict clinical outcome, whereas 
decline in systolic function (RVEF) may [77, 78, 81]. Surprisingly, the same 
observations have been made even when using more proactive criteria to refer for 
PVR [78]. The latter finding may lead one to consider conservative management 
preferable rather than PVR in patients with PR after repaired ToF. Alternatively, it 
can be hypothesized that even the use of proactive CMR criteria to refer ToF 
patients for PVR may be too restrictive to favorably influence late prognosis. 
 
Indeed, evidence by Frigiola et al. [86] suggests that PVR, when performed in 
children and adolescents (younger than 18 years old) and with more aggressive 
CMR indications (RVEDVi <150 ml/m2), may be associated with negligible early 
and late mortality. Furthermore, their surgical referral policy may allow 
normalization of RV volumes, improvement in biventricular function and 
normalization of VE/VCO2, a parameter of exercise capacity, which best reflects 
everyday requirements [86]. 
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Our patient population differs in many ways from most large clinical series on PVR 
late after ToF repair [75-78, 80, 81]. First and foremost, the average age at primary 
ToF repair was in the first 3 months of life, representing current standard timing for 
infant repair, and the average age at PVR was in the early teenage years. On the 
other hand, most published series report on patients in the third and fourth decade 
of life undergoing PVR 20–30 years after originally having had ToF repair at a 
preschool or school age. Therefore, exposure to the consequences of chronic RV 
overload had significantly shorter duration in our series. Furthermore, the 
underlying diagnosis in this study was restricted to ToF with pulmonary stenosis, 
whereas prior series encompassed a variety of cardiac defects, associated with ToF, 
including pulmonary atresia. The latter often imply more complex surgery, repair 
using a period of myocardial ischemia and the use of extra-cardiac conduits, all 
factors that may adversely affect RV function. In addition, average RV volumes at 
preoperative CMR in our series were well below even proactive criteria for PVR in 
older ToF patients, although closer to the ones reported by Frigiola et al. [86] on 
PVR in adolescent ToF patients. Finally, and most importantly, unlike most other 
series, we selected only patients who could undergo beating heart PVR on 
normothermic cardiopulmonary bypass. Therefore, the additional influence of RV 
dysfunction due to myocardial ischemia was eliminated in our study. It is 
noteworthy, that the series with clinical and CMR variables similar to ours also 
resorted to routine beating heart PVR [86]. The feasibility of beating heart PVR is 
important, as prior studies have surmised that failure of PVR to affect mid-term 
clinical outcome might also be due to the additional surgical trauma incurred during 
the procedure [75, 76, 78], thus advocating wider use of transcatheter PVR. Based 
on this hypothesis, we are witnessing a trend towards recommending the lowering 
of CMR thresholds for PVR when transcatheter intervention is possible [87]. 
 
This study suggests a correlation between RV volumes at CMR and contraction 
force, index of cardiac fatigue, and energy even in patients with preoperative 
RVEDVi lower than current ‘proactive’ recommendations for surgery (115 vs 
152 ml/m2). This observation is in line with prior experimental findings using 
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cardiac catheterization and CMR, where a rapid decline in RV power and efficiency 
are seen at critical values of 139 ml/m2 RVEDV and 75 ml/m2 RVESV index [88]. 
 
3.2.6. Limitations 
 
As a pilot study, the current work is limited by the small cohort size. We focused 
our attention on young patients with ToF undergoing PVR in a single centre. 
Moreover, our observations were restricted to the intraoperative acute phase of RV 
changes following PVR. Both circumstances hamper the ability of this study to 
generate experimental indices, which may reflect its prognostic clinical value. A 6-
month postoperative CMR is currently underway to ascertain whether video 
kinematic parameters may predict late RV remodelling. 
 
A technical limitation of video kinematic evaluation is related to the use of a 2-
dimensional camera (for which depth is obviously missing) in acquiring the 3-
dimensional cardiac phenomenon. Nevertheless, the algorithm is already 
implemented for the 3-dimensional motion. Employing a second camera in the 
operating room will be the next upgrade. 
 
Finally, although video kinematic evaluation may display limited acute prognostic 
ability in ToF patients undergoing elective PVR, as the perioperative course of these 
patients is generally uncomplicated, this novel technology is currently being tested 
in other operative settings, far more commonly exposed to acute perioperative RV 
failure, such as staged palliation of single RVs (i.e. aortic or mitral atresia) and 
LVAD implantation in cardiomyopathies. 
 
3.2.7. Conclusions 
 
Video kinematic analysis is a safe, contactless and valid intraoperative technique, 
which demonstrates prompt improvement of RV functional properties through the 
reduction of cardiac fatigue and kinetic energy in select ToF patients after PVR. 
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3.2.8. Supplementary data 
 
Supplementary Table: Echocardiographic Findings: 
N=6 Preoperative 
TTE 
Intraoperative 
TEE 
Postoperative 
TTE 
    
No PR - 6 6 
Mild PR - - - 
Moderate PR 1 - - 
Severe PR 5 - - 
Peak transpulmonary pressure (mmHg) 22±18.9 - 16.5±7.1 
No RV dilation  - 4 5 
Mild RV dilation - 1 1 
Moderate RV dilation  2 1 - 
Severe RV dilation 4 - - 
No RV dysfunction 2 4 5 
Mild RV dysfunction 1 2 1 
Moderate RV dysfunction 3 - - 
Severe RV dysfunction - - - 
TEE, transesophageal echocardiogram; TTE, transthoracic echocardiogram; PR, pulmonary regurgitation; RV, right 
ventricular. 
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The study on patients with Tetralogy of Fallot, reported above, primarily takes into 
consideration the average kinematic behavior of the RV in all the patients. 
However, focusing on the single patient’s behavior, it can be noted that patient #3 
suffered from an increase in all the mechanical parameters that can be considered 
as a “suffering” or “struggling” heart. The patients, however, was dismissed without 
any complications and in the average dismiss time. 
This unexpected behavior was clarified examining what happened in the acute 
phase of the surgery.  
It was noted that the patient in the Post-PVR time-point showed a qualitative 
improvement compared to Pre-PVR (Figure 29). It was also noted that the patient 
suffered from an atrial ectopic tachycardia in the Post-PVR time-point, as visible in 
the number of beats in the ViCGs (Figure 29). The hypothesis was that the heart 
rate could modify the heart mechanical behavior leading to an increase in the 
Vi.Ki.E. parameters. 
 
Therefore, an experimental protocol to pace a rat heart at different rates and evaluate 
its mechanical behavior (see chapter 3.3) was set up. 
Figure 29. Mechanical parameters of patient #3. Top panel: trajectories and ViCGs before the pulmonary valve 
Replacement (PVR). Bottom panel: same as Top but after the PVR. To note that after PVR the number of beats is highly 
increased. Even if the trajectories and ViCGs Post-PVR are qualitative better compared to Pre-PVR the quantitative data 
was opposite of what we expected. 
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3.3. In-situ optical assessment of rat epicardial kinematic 
parameters reveals frequency-dependent mechanic 
heterogeneity related to gender [30]. 
 
 
 
3.3.1. Abstract 
 
- Background 
Gender-related cardiac mechanics following the electrical activity has been 
investigated from basic to clinical research, but results are still controversial. The 
aim of this work is to study the gender related cardiac mechanics and to focus on 
its heart rate dependency. 
 
- Methods 
We employed 12 Sprague Dawley rats (5 males and 7 females) of the same age and, 
through a novel high resolution artificial vision contactless approach, we evaluated 
in-situ cardiac kinematic. The hearts were paced on the right atria appendage via 
cathodal stimuli at rising frequency. 
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- Results 
Kinematic data obtained at rising pacing rates are different between male and 
female rat hearts: male tended to maintain the same level of cardiac force, energy 
and contractility, while female responded with an increment of such parameters at 
increasing heart rate. Female hearts preserved their pattern of contraction and 
epicardial torsion (vorticity) at rising pacing rates compared to male. Furthermore, 
we observed a difference in the mechanical restitution: systolic time vs. diastolic 
time, as an index of cardiac performance, reached higher value in male compared 
to female hearts. 
 
- Conclusion 
Our innovative technology was capable to evaluate in-situ rat epicardial kinematic 
at high stimulation frequency, revealing that male preserved kinematic parameters 
but varying the pattern of contraction/relaxation. On the contrary, female preserved 
the pattern of contraction/relaxation increasing kinematic parameters. 
 
 
3.3.2. Introduction 
 
The relationship between protection from cardiovascular diseases (CVDs) and 
gender has fascinated researchers and cardiologists for decades. The reason is 
strictly related to the presence of female and male hormones, targeting their effects 
almost in all part of the cardiomyocyte: ion channel repertoire [89, 90], receptors 
[91], calcium handling machinery [92], mitochondria [93], intracellular pathways, 
genome [94] and epigenome [95]. It emerges that cardiac electrophysiology is, 
undeniably, affected by estrogen and testosterone [96], having effects on all phases 
of the action potential. This would suggest a possible “protection” against the 
progression towards CVDs for female in premenopausal age compared to male 
hearts. Nonetheless, all that glitters is not gold. Bazett in 1920 suggested how both 
sex difference and heart rate (HR) have an impact on the ECG (and he further 
developed the famous correction QTc formula that report his name). Women have 
a long QT in respect to men and this exposes the female at risk of some life-
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threatening arrhythmias, such as torsade de pointes especially when is drug-induced 
[97]. Park et al. [98] elegantly summarized the physiological divergences between 
male and female heart. Moreover, at the single cell level, numerous studies did not 
observe gender difference in the peak of Ca2+ current except Farrell et al. [99] that 
demonstrated significant modifications via voltage clamp. Cellular contraction has 
also been taken into account by numerous investigations. Rosenkranz-Weiss et al. 
reported that female rat ventricular myocytes display high-level of myosin heavy 
chain (MHC) as well as upregulation of actin mRNA compared to males [100]. 
Notably, they found no difference in the α-to β-ratio of MHC proteins, suggesting 
that those sex differences are abolished after post-translational modifications. Petre 
et al. [101] and Schwertz et al. did not find any gender-related difference in terms 
of force of contraction in ventricular trabeculae. In detail, Schwertz et al. [102] 
found that ATPase activity was higher in female rats at any given extracellular Ca2+ 
concentration compared to male, suggesting that the female contractile machinery 
had a greater Ca2+ sensitivity. Experimentally, the single cell contraction is smaller 
in female ventricular myocytes compared to male especially when those cells are 
paced at rapid rates [103]. This would indicate that high stimulation frequency may 
highlight the gender difference in cardiac performance. Some authors showed an 
increment in isolated ventricular myocyte contraction [104], while others reported 
a reduction [105]. A robust evidence regarding the role of female hormone on 
cardiac activity has been observed in female rats undergoing ovariectomy. To note 
such differences were completely reversed when 17-β-estradiol was replaced. 
Androgen receptors are usually present in cardiac tissue and study efforts were 
mostly focused on their action on intracellular Ca2+ handling machinery [106] rather 
than contractile performance. Few studies have been performed at multicellular 
cardiac level after gonadectomy and reported a decrement in the maximum 
contraction and the peak of Ca2+. Studies on papillary muscle [102] recapitulated 
the evidence observed at single cell level, i.e. the greater affinity of female 
myofibrils to Ca2+, demanding less extracellular Ca2+ for evoking the same force of 
contraction in comparison to male. On the contrary, the same authors reported that 
in the Langerdorff perfused heart, male generated a greater ventricular pressure 
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compared to female. Such disparate findings indicate that methodological 
preparations influenced gender dissimilarity. 
 
Based on the observations above, it is evident that rodents are an appropriate animal 
model for studying the relationship between cardiac performance and gender [107]. 
In particular, rodent models may be well suited for dissecting the biophysical 
mechanisms underlying the propensity to develop CVDs. In spite of the great efforts 
and the results obtained at single cell and tissue levels, in-vivo investigations on 
gender-related ventricular kinematic are lacking. We are aware that canonical in-
vivo gender-related data are merely analyzed from echocardiography [108], cardiac 
MRI and SPECT [109] exquisitely describing the heart global mechanical function. 
Unfortunately, these imaging techniques provide only minimal information on 
kinematic. 
 
In this paper, we adopted the optical-image based technology called Video 
Kinematic Evaluation (Vi.Ki.E.) [28, 31, 59], completely developed in our 
laboratory, to evaluate in-situ high resolution ventricular tissue kinematic in male 
and female beating hearts, paced at different frequencies. 
 
We observed a frequency-dependent increment of epicardial ventricular 
contractility, force and kinetic energy in female rat hearts compared to male. Female 
rats tended to preserve their pattern of contraction and the total perimeter of 
trajectories at different basic cycle lengths (BCL) resulting in less heart torsion 
compared to male. Sex difference does not influence the systolic area/diastolic area 
(S/D area) but it denotes a consistent variation in systolic time/diastolic time (S/D 
time) between the two groups. Data from our innovative optical-based and 
contactless technique indicate a profound gender difference in the heart mechanics, 
opening avenues for further evaluation in the clinical setting. 
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3.3.3. Materials and methods 
- Experimental animals 
The study population consisted of 12 Sprague Dawley rats (5 males and 7 females) 
bred in our animal facility (approved protocols: 281/2017, 989/2017). The study 
was conformed to Italian (D.L.4/3/2014) and European guidelines (2010/63/UE). 
Rats, 6 months old weighting 250–275 g, were anesthetized with 0.20 mg/kg ip of 
a mixture of tiletamine hydrochloride and zolazepam hydrochloride (Zoletil; Virbac 
S.r.l., Carros, France) + 0.15 mg/kg ip medetomidine hydrochloride (Domitor; 
Orion Corporation, Espoo, Finland). The heart was exposed through a median 
thoracotomy and suspended in a pericardial cradle under artificial ventilation 
(RoVent® Small Animal Ventilator, Kent Scientific, CT, USA). Body temperature 
was maintained constantly at 37 °C with heath lamp radiation and further doses of 
anesthetic was administered as needed during the experiment. This type of 
anesthesia invariably suppressed the sympathetic tone in rodents and so our results 
are not biased by the autonomous nervous system [110]. Animals where sacrificed 
with a lethal injection of sodium pentothal as indicated in the protocols. 
 
- In-vivo atrial stimulation 
The heart was stimulated with a cathodal suprathreshold train of stimuli (10 Vpp) 
at different basic cycle length (BCL: 390 ms, 330 ms, 290 ms, 260 ms, 230 ms, 
210 ms, 190 ms, 170 ms, 160 ms) by driving the right atrium with a silver electrode 
(0.05 mm) with one end connected to a stimulus generator (SIU-102, Warner 
Instruments CT, USA) and the other hooked to the atrial auricle appendage (Fig. 
1A). The current return silver electrode has been placed in the right forearm. The 
stimulus generator was triggered by a function generator (Aim-TTi TG310, RS 
Components, Milano, IT).  
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Fig. 3.3.1. Schematic representation of the experimental setup. A. The heart (red cartoon) is exposed after median 
thoracotomy. One end of the stimulating electrode (blue line) is hooked on the Right Atrial (RA) auricle appendage to perform 
atrial stimulation, while the other end is connected to a stimulus generator (black rectangular box). The current return 
electrode (green line) is placed on the right forearm. The high-speed camera is placed perpendicular to the heart to record 
anterior epicardial kinematic. The grey shaded region represents the video camera field of view. The LED is placed beside 
the camera. The yellow shaded region represents the light beam. RV, Right Ventricle; LV, Left Ventricle; dashed red line, 
interventricular septum. B. Stack of images of rat hearts recorded at 1280 × 1024 pixel at 500 fps. Red target represents the 
virtual marker positioned in that frame. C. Example of the marker movement in x coordinate during 2 s recording. The light 
blue rectangular indicates the diastolic phase, while the light green rectangle indicates the systolic phase. D. Example of 
trajectories in x-y plane drawn by the marker in 2 s recording. Each loop represents a single cardiac cycle. The light blue and 
the light green triangles represent the diastolic and systolic phases, respectively. Red arrows indicate the direction of the 
cardiac cycle. 
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- In-situ optical assessment of kinematic parameters 
To evaluate cardiac kinematic parameters, 2 s videos with the temporal resolution 
of 500 fps (Fig. 3.3.1B) were acquired for each BCL, with a spatial resolution of 
1280 × 1024 pixel. The camera (Baumer HXC13, Baumer Italia S.r.l., Milano, 
Italy) was connected with full CameraLink® interface to a frame grabber 
acquisition board PCIe 1433 (National Instruments, Assago, Italy) and placed at 
20 cm above the heart. The camera was equipped with a macro-objective Kowa 
Industrial Lenses LM35XC, F = 1:2.0, f = 35 mm, picture size 13.8–18.4 mm (RMA 
Electronics, Hingham, MA, USA). The acquisition board was integrated into a 
Workstation HP Z220 (Crisel Instruments, Roma, Italy) with 24 GB RAM and the 
acquisition software was custom made in LabVIEW 2013 Visual Programming 
Language (National Instruments, Assago, Italy). Only videos with observed 1:1 
capture were included in the final analysis. 
 
The videos were elaborated by Video Spot Tracker, an open source software (VST, 
CISMM, Computer Integrated Systems for Microscopy and Manipulation, UNC 
Chapel Hill, NC, USA), that enables to place a virtual marker (Fig. 1B, red target) 
with a chosen kernel on the first video frame. The marker follows the light spots 
onto the epicardial surface and tracks its coordinates in x and y for each frame. The 
movement of the light spot is a function of the surface curvature and because it 
moves back and forth from apex to base during cardiac cycle, it can be assumed as 
the direct deformation of the epicardial tissue (Supp. Video 1). Afterwards, a 
custom-made algorithm [28] implemented with Matlab Programming Language 
(The MathWorks, Inc., Natick, MA, USA) analyzes these coordinates (Fig. 3.3.1C), 
draws the trajectories (Fig. 3.3.1D) and returns the following kinematic parameters 
[28]: i) Contractility, expressed in [mm/s], as the average of the maximum module 
of epicardial velocity for each systolic phase; ii) Force, expressed as [mm/s2], as the 
average of cardiac force expended over the entire cardiac cycle during the 
acquisition period; iii) Energy, expressed as [mm/s]2, as the average of the cardiac 
kinetic energy expended over the entire cardiac cycle during the acquisition period. 
Here we included the novel parameter of trajectory (perimeter, corrected for the 
number of beats) that measures the marker path length during cardiac cycles. We 
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took advantage of a MathWorks tool named Particle Image Velocimetry (PIV; 
https://it.mathworks.com/matlabcentral/fileexchange/27659-pivlab-particle-
image-velocimetry-piv-tool) as previously used from us [28] and others [111] for 
the evaluation of the epicardial torsion. Kinematic data are expressed in the standard 
SI unit following a conversion: we reconstruct a transformation pixel-to-mm curve 
by placing the camera at different heights above a graph paper (data not shown). 
 
- Systolic and diastolic area and time 
We have extracted from the last complete cardiac cycle of the recorded video the 
maximal relaxation area (during the diastole) and the minimal contraction area 
(during systole) for each BCL. Areas were evaluated using a dedicate plug-in from 
Fiji (ImageJ 9.0, National Institutes of Health, USA) by selecting the frames 
displaying the maximum relaxation and maximum contraction. Moreover, the 
systolic and diastolic times were evaluated from the videos as the time interval 
between the maximum relaxation and maximum contraction and vice-versa, 
respectively. 
 
- Statistical analysis 
All data are presented as mean ± standard error of the mean (S.E.M.). The normality 
of the data was assessed with the Kolmogorov-Smirnov test. Kruskal Wallis test 
and 2-way ANOVA were performed. A value of p < 0.05 was considered 
significant. The program GraphPad v.6.0 (GraphPad Software, Inc., La Jolla, CA, 
USA) was used for the statistical analysis and results display. 
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3.3.4. Results 
 
We evaluate via Vi.Ki.E. technology the global epicardial kinematics at different 
BCL ranging from 390 ms to 160 ms. We observed that male hearts tend to maintain 
the same contractility, force and energy (Fig. 3.3.2A), while female rat hearts tend 
to increase the same parameters at the rising stimulation frequency (Fig. 3.3.2B). In 
detail female epicardial force and energy displayed a significant increasing trend 
(p = 0.0019 and p = 0.017 respectively). During our experimental protocol, we 
noticed that, from BCL = 230 ms onward, an increase of the kinematics parameters 
occurred in all animals. After this time-point we noticed different trends between 
male and female. Therefore, we studied in deep the gender-related mechanical 
behaviour in the following timepoints (BCL: 230 ms, 210 ms, 190 ms, 170 ms) that 
resemble the range of rat physiological HR. We highlighted this difference in Fig. 
3.3.3 with representative experiments that display trajectories and coordinates for 
both male (black) and female (red). As it can be noticed male trajectories (Fig. 3.3.3 
A-A3 top panels) varied at each BCL indicating different patterns of contraction. 
On the contrary, female trajectories 
(Fig. 3.3.3 B–B3 top panels) are 
preserved at each BCL for every 
cycle. The bottom panels in Fig. 
3.3.3 A-B display the keeping of 1:1 
capture for each cardiac cycle at 
increasing HR. 
 
 
 
 
 
Fig. 3.3.2. Effect of the rising frequency of 
stimulation on epicardial kinematic 
parameters. Graphs displaying relationship between 
epicardial kinematic parameters and basic cycle length 
(BCL) for male (black) and female (red). Trend 
comparison between male and female for: Contractility 
(A), Energy (B) and Force (C). Data are shown as 
Mean ± S.E.M. *p < 0.05, **p < 0.01. 
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Fig. 3.3.3. Contraction patterns at different stimulation frequencies. Examples of male rat heart (black) and female rat 
heart (red) trajectories and coordinates at four different basic cycle length (BCL). A, A1, A2, A3: male trajectories (top 
panels) and respective coordinates vs. time (bottom panels) at 230 ms, 210 ms, 190 ms and 170 ms respectively. B, B1, B2, 
B3: same as A, but for female rat heart. 
 
- Frequency of epicardial torsion obtained via Particle Image Velocimetry 
In order to provide a global information of epicardial torsion following the gender-
related pattern of contraction observed in Fig. 3.3.3, we sought to evaluate, for each 
BCL, the cardiac vorticity by analyzing the videos with PIV (Fig. 3.3.4A). Fig. 
3.3.4B shows that cardiac vorticity parameters display an increasing trend 
statistically significant for both gender during the stimulation protocol (p = 0.0006). 
Moreover, the male trend was statistically significant compared to female trend 
(p < 0.0001). 
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 Fig. 3.3.4. Epicardial torsion observed by Particle Image Velocimetry. A: Upper panel. Six consecutive frames (step: 
2 ms) of Particle Image Velocimetry (PIV) evaluation. The colored arrows represent the velocity vectors; the vector module 
and colors represent the different epicardial velocities. Bottom panel. Epicardial vorticity parameter (Hz) in 2 s recording. 
The green rectangle highlights the six frames displayed in top panel. B: Relationship between the mean Vorticity parameters 
and basic cycle length (BCL) in male (black) and female (red) rat hearts. Data are shown as Mean ± S.E.M. ***p < 0.001. 
 
- Geometrical spatiotemporal variation at different BCL 
The dissimilarity of contraction patterns in male rats at rising frequency suggested 
that the frequency-dependent epicardial deformation can be related to gender. We 
sought to investigate the mechanical behaviour at different BCL for both trajectory's 
perimeter and the maximal contraction (systolic) and maximal relaxation (diastolic) 
areas. As expected, the data displayed a not-preserved perimeters (Fig. 3.3.5A) 
(ranging from 5.890 ± 0.5597 mm to 3.747 ± 0.3422 mm) over different BCL in 
male rat hearts (black) compared to female (red) (ranging from 4.220 ± 0.1566 mm 
to 4.566 ± 0.8934 mm). The male epicardial areas (Fig. 3.3.5B) during maximal 
systolic and diastolic phases were higher compared to female rat hearts (by ca. 
11%); however male areas were more statistically spread at higher frequency in 
contrast to female, suggesting once more a preservation of the mechanical 
phenotype of cardiac beating over different BCL in female rats.  
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Fig. 3.3.5. Relationship between perimeter and 
area vs basic cycle length. A: Male (black) and 
female (red) perimeter corrected for the number of 
acquired cardiac cycles for each basic cycle length 
(BCL). B: Average systolic and diastolic area for 
each BCL in both male (black) and female (red). 
Diamond: diastole; Triangle: systole. Data are 
shown as Mean ± S.E.M. 
 
 
 
 
 
 
 
 
 
- Rising stimulation frequency unmasks gender difference at the single 
cardiac cycle 
We thus recognized that sex differences can be also investigated during the single 
cardiac cycle extracted from different BCL. Therefore, we plotted the S/D time for 
both male and female rats beating hearts at rising frequencies of stimulation (Fig. 
3.3.6). We demonstrated that while S/D area was preserved for both male and 
female hearts (average male 0.737 ± 0.026, average female 0.753 ± 0.029), 
paradoxically the S/D time differed (Fig. 3.3.6). In the male rats we observed a 
significant increasing trend (from 0.359 ± 0.029 at 390 ms to 0.913 ± 0.049 at 
160 ms, p < 0.0001). A significant increasing trend has also been observed for the 
female rat S/D time (from 0.357 ± 0.031 at 390 ms to 0.815 ± 0.067 at 160 ms, 
p < 0.0003). The S/D time data suggest a different gender-related mechanical 
restitution at high pacing rates.  
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Fig. 3.3.6. Mechanical restitution of systolic/diastolic time. Simultaneous plot of systolic/diastolic time (S/D time) in both 
male (black) and female (red) rat hearts. Data are shown as Mean ± S.E.M. **p < 0.001, ***p < 0.0001. 
 
3.3.5. Discussion 
 
In this study, we applied our high spatial and temporal resolution video kinematic 
technology to understand the gender-related response of epicardial mechanics 
during atrial pacing. An additional goal was to examine whether female propensity 
to cardiac protection against CVDs can be unraveled thanks to our optical-based 
experimental protocol. From a physiological standpoint it is well known that female 
has low BMI, low LVED pressure [112] but higher velocity of contraction 
suggesting that women are in constant hyperdynamic state [113]. In clinical 
research, sex difference in cardiac performance is unmasked during physiological 
exercise [114] and with RA pacing during cardiac catheterization [115]. At the 
pathological level, gender has an influence on the manifestation of myocardial 
infarction [116], with the incidence of ischemic heart disease being much lower in 
premenopausal women than age-matched men [117]. However, the incidence of 
CVDs after menopause exceed that of men [118]. Only recently, sex differences 
have been considered in clinical and preclinical studies for CVDs (Consideration 
of Sex as a Biological Variable in NIH-funded Research, 2015). It is also known 
that sex differences in ventricular mechanics occur during acute physiological 
challenges, exacerbated by adrenergic stimulation [119]. In this work, we showed 
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that in-situ female beating hearts tended to show a “kinetic reservoir” due to a 
possible female hyperdynamic state [113] in terms of contractility, energy and force 
that can be expended at lower BCL in accordance with the positive role exerted by 
estrogens on the excitation-contraction machinery [89]. However, we cannot 
exclude the gender-related difference in the excitation-contraction (EC) coupling 
machinery including the SERCA activity [99, 120]. In agreement to Williams et al. 
we would expect, for female hearts, an acute ventricular mechanical adaptation to 
the rising pacing rate. We also notice that female rats data dispersion occurred at 
high frequency of stimulation according to what has been measured in human 
females during exercise by Bombardini et al [114]. Moreover, our video kinematic 
technology captured a change in the mechanical pattern of epicardial mechanics 
(trajectories) for male hearts starting from BCL = 230 ms, whereas female hearts 
trajectories seem to be unaltered at rising frequency of stimulation. This is further 
confirmed by PIV and trajectory perimeter analysis where the epicardial vorticity 
and perimeter variation were higher in male compared to female. Because our 
technique can be applied during open chest surgery [28] we investigated whether 
such changes may impact on the area of contraction of maximal ejection (systolic 
phase) and on the area of relaxation of maximal ventricular filling (diastolic phase). 
Epicardial area changes during heart stimulation and it is an index of ventricular 
ejection and filling [121], reflecting the Frank-Starling mechanism which leads to 
inotropic effect. Accordingly, the systolic and diastolic areas (bigger for male in 
respect to female, as expected) tended to decrease in male at increasing frequency 
of stimulation, whereas they seem to be preserved in female. This would suggest 
that the acute cardiac mechanical adaptation observed in male is necessary to 
compensate the nonappearance of the “kinetic reservoir” hypothesized in female rat 
hearts. 
 
One of the echocardiographic index used in clinics is the ratio between systolic and 
diastolic time intervals [122]. This parameter, together with the rising frequency of 
stimulation, can provide the mechanical restitution of the heart [123]. Vi.Ki.E. can 
be adopted to measure S/D time at high temporal resolution extracted from our 
coordinates in x and in y. We observed a rising S/D time ratio in both male and 
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female hearts displaying the difference in mechanical restitution. Moreover, the 
tendency to reach important quasi-pathological values for S/D time ratio, i.e. > 1.0 
has been observed only in male rats, which is in accordance to the major masculine 
CVDs-susceptibility observed in humans. 
 
3.3.6. Conclusions and limitations 
 
Our video technology unmasked gender-related kinematic cardiac differences in-
situ, displaying two different mechanisms of adaptation for male and female heart 
at increasing frequency. Male hearts tended to change their intrinsic spatiotemporal 
pattern of contraction/relaxation at the rising frequency of stimulation and to 
preserve their kinematics for all BCL. Female hearts denoted an opposite trend 
tending to preserve the spatiotemporal pattern and modify their kinematic response 
at different BCL. Our results are limited by the absence of the z-dimension and we 
recapitulate a 3D phenomenon in a 2D analysis. However, this precise and 
repeatable approach is useful to simplify the analysis without losing the main goal 
of the study and allow us to make comparison between several experimental sets. 
Future technological implementation will aim to introduce a second high-speed 
camera together with a PV-loop, a pressure catheter for peripheral resistance 
measurement and echocardiographic investigation for simultaneous acquisition of 
3D epicardial kinematics and cardiac function. 
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3.4. Unpublished Results 
 
In this chapter, all the data not yet published, deriving from the evaluation of 
different pathologies will be reported and discussed.  
 
3.4.1. Tetralogy of Fallot 
 
To confirm the positive results from the pilot study, and to take part in the debate 
on RVEDV thresholds for surgery, the Vi.Ki.E technology was then applied to adult 
patients.  
 
Results 
Six adult patients, undergoing PVR, were enrolled from March 2018 to November 
2018 with an average age of 41.7±21.7 years. Three of these patients suffered from 
atrial fibrillation and also underwent the surgical maze protocol. The same 
statistical analysis approach of the previous work was adopted to assess the acute 
effect of the surgery on Vi.Ki.E. evaluation.  
Figure 30 shows the mean parameters of the entire 12 patients’ population before 
and after PVR; all parameters significantly decrease after PVR 
Figure 30. Vi.Ki.E. most valuable 
clinical parameter in ToF patients. 
Average mechanical parameters in 12 
ToF patients Pre-PVR (RED columns) 
and Post-PVR (GREEN columns). 
Data are shown as mean ± SEM.  
* = p<0.05 
*** = p<0.001 
  
127 
 
However, the study population consisted of two main groups, the young and adult 
patients. Therefore, the data was evaluated individually for each group to 
investigate possible differences of the surgical impact. Figure 31 shows what has 
been found. 
 
The data subdivision in the two groups highlighted that, although for the young 
patients (Figure 31 solid colors) the recovery was significant (except for the Force), 
it was lower than the adult group (Figure 31 shaded colors) in which it was 
significant for all set of parameters. However, in the adult group the overall 
recovery was lower compared to the young group, with the Post-PVR values often 
twofold higher than young Post-PVR values.  
  
Figure 31. Vi.Ki.E. most valuable clinical 
parameter in young and adult ToF 
patients. Average mechanical parameters 
in 5 young patients (solid colors), and in 7 
adult patients (shaded colors). RED 
columns (solid and shaded) Pre-PVR. 
GREEN columns (solid and shaded) Post-
PVR. 
Data are shown as mean ± SEM.  
## = p<0.01 compared to Pre-PVR in young 
* = p<0.05 compared to Pre-PVR in adults 
** = p<0.01 compared to Pre-PVR in adults 
*** = p<0.001 compared to Pre-PVR in 
adults 
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As it concerns the single patient evaluation, Figure 32 shows that the young group 
(Figure 32, Purple), undergoing surgery below the clinical suggested threshold of 
RVEDV > 150ml/m2, had a very small recovery in terms of Energy and Force 
between Post-PVR (Figure 32, Circle) and Pre-PVR (Figure 32, Rhombus). 
However, the data distribution is less spread for young patients than for the adult 
ones who, on the contrary, underwent surgery at the suggested threshold of RVEDV 
> 150ml/m2 (Figure 32, Yellow). An exception could be made for Patient #3 
(highlighted in the graph) whose intraoperative tachycardia influenced the 
mechanical parameters 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 32. Correlation between MRI parameter RVEDV and Vi.Ki.E. clinical 
marker parameters in ToF patients. Average mechanical parameters in young patients 
(Purple) Pre-PVR (Circle) and Post-PVR (Rhombus), and in adult patients (Yellow) Pre-
PVR (Circle) and Post-PVR (Rhombus). Red circle Highlight the Patient #3 that suffers 
of an intraoperative tachycardia influencing the mechanical parameters. It is added in 
the graph only for visual purpose. 
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Discussions 
The most interesting and pivotal part of the study concerns the debate about the 
timing for PVR. There are two way of thinking, some clinical equips are more 
“conservative” awaiting until the pathology reaches an advanced stage, and others, 
with a more “aggressive” approach, assert the importance to perform surgery as 
soon as possible to avoid cardiac remodeling and impairment through years.  
One of the used parameters in the ESC guidelines to time the PVR is the MRI 
RVEDV threshold at 165ml/m2. However, there are some studies showing that this 
value could be too high and the patient could be in a late stage of the pathology 
[86], but even this is a matter of debate. In this study, patients above and under this 
threshold were enrolled. What it has been noticed, comparing the most valuable 
Vi.Ki.E. clinical parameters (Energy and Force) with the RVEDV distribution, it 
was that patients under the 150ml/m2 had a very small recovery and parameters 
distribution. On the contrary, patients above 150ml/m2 showed a high intra-surgery 
recovery. However the overall recovery was far from the basal recovery, with 
values often twofold higher compared to those who underwent PVR under the 
threshold. To note, the data distribution was very high.  
Moreover, the conventional intervention (i.e. above 150ml/m2) denoted advantages 
in terms of patient’s recovery compared to those operated early.  However, the 
overall recovery is far from the baseline reached by the patients operated earlier. 
This could lead to the development of future cardiac pathologies or re-
hospitalization. On the contrary, the unconventional intervention (i.e. below 
150ml/m2) has a little impact on the cardiac functionality but could be performed, 
as a prevention, to avoid possible future cardiac pathologies. In particular the 
baseline parameters are drastically lower in those patients rather than in patients 
operated with the conventional surgery. The follow-up monitoring of those patients, 
in the next 5 to 10 years, as well as this study (and the further ones), could lead to 
a reduction of the actual threshold for the surgery and the amelioration of the 
patients’ outcomes.  
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3.4.2. Hypoplastic Heart Syndrome 
 
The increasing Vi.Ki.E. trust and attractiveness in the clinical approach led to the 
testing the of the technology in more complex pathologies, such as the patients 
suffering from ventricular hypoplasia (Hypoplastic Heart Syndromes HHS or 
univentricular patients).  
 
Results 
A total of 6 patients were enrolled for this preliminary study. Four suffered from 
Hypoplastic Left Heart Syndrome (HLHS), while the other 2 suffered from 
Hypoplastic Right Heart Syndrome (HRHS). Since the patients were in different 
surgical repair stages, the data are presented, at first, as total mean to highlight the 
global mechanical behavior, and later data were divided and analyzed separately 
following the 2 surgical stages: GLENN and FONTAN. 
Figure 33. Vi.Ki.E. qualitative data in patients with Hypoplastic Left Heart Syndrome, divided by surgical stages. 
Most explanatory patients at GLENN and FONTAN surgical stages. GLENN, left column is before the surgery. Right 
column is after the surgery. A. Hearts with marker (yellow circle) showing the tracked area. B. Trajectories of the yellow 
marker. C. ViCGs in x axis D. ViCGs in y axis. FONTAN, same as GLENN. 
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Figure 33 shows the qualitative parameters in HLHS hearts at different surgical 
stages. In the GLENN stage, the trajectories after the surgery (right column) appear 
less compressed and, even if shifted, they appear conserved compared to those 
before the surgery. However, it is not possible to state the same for the ViCGs that, 
after the surgery, appear less conserved in both x and y axes resulting very 
challenging to evaluate compared to those before the surgery. In the FONTAN 
stage, as it concerns the trajectories, at first sight, they could be considered both 
good. However, they differ because the “+” distribution (indicating the marker 
position in each frame) after the surgery is more homogeneously distributed along 
the trajectory compared to the one before the surgery. To stress the difference, it 
can be noted that before the surgery the “+” are mostly concentrated in the bottom 
left corner, meaning the presence of the marker in that region for a long period of 
time during the cardiac beats. As it concerns the ViCGs, it can be noted that after 
the surgery they are very readable and, even if somehow noisy, easy to evaluate. 
 
- HLHS Patients 
Figure 34 shows the mean parameters of all HLHS patients. While there is a 
significant reduction for the Energy, the other parameters remain unchanged.  
Figure 34. Vi.Ki.E. most valuable 
clinical parameter in HLHS patients.  
Average mechanical parameters in 
HLHS patients. RED columns show 
Pre-Surgery. GREEN columns show 
Post-Surgery.  
Data are shown as mean ± SEM.  
* = p<0.05  
 
* 
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As it concerns the different surgical stages of patients, 2 of them underwent GLENN 
repair, while the other 2 underwent FONTAN repair. In Figure 35, it is highlighted 
the different surgical impact of the procedure on patients. In fact, while the GLENN 
repair does not show any mechanical difference, the FONTAN repair shows 
significant reduction in Maximum Contraction velocity and Energy consumption.  
Figure 35. Vi.Ki.E. most valuable clinical parameter in HLHS patients sorted by different clinical stages.  
Average mechanical parameters in HLHS patients sorted by GLENN repair (left column) and FONTAN repair (right 
column). RED columns show Pre-Surgery. GREEN columns show Post-Surgery.  
Data are shown as mean ± SEM.  
* = p<0.05  
** = p<0.01  
 
** 
* 
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- HRHS Patients  
The pathophysiology of HRHS is rarer than HLHS. Furthermore, only 2 patients 
were enrolled in the study, 1 of them was in GLENN surgical stage and the other 
one was in FONTAN surgical stage. As for HLHS, Figure 36 shows the average 
mechanical behavior of the heart in both patients, while Figure 37 highlights the 
single patient mechanical impact of the surgery (qualitative data are similar to 
HLHS furthermore they are not shown). 
 
As it can be noted, there are no differences in the average mechanical parameters 
before and after the surgery, except for the Force that is significantly reduced. 
Regarding the different surgical stages (Figure 37), it can be noted that, while Force 
and Energy consumption significantly decrease in the GLENN patient after the 
surgery, the FONTAN stage does not show any relevant changes in the parameters. 
  
  
* 
Figure 36. Vi.Ki.E. most valuable 
clinical parameter in HRHS patients.  
Average mechanical parameters in HRHS 
patients. RED columns show Pre-Surgery. 
GREEN columns show Post-Surgery.  
Data are shown as mean ± SEM.  
* = p<0.05  
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Figure 37. Vi.Ki.E. most valuable clinical parameter in HRHS patients sorted by different clinical stages.  
Average mechanical parameters in HRHS patients sorted by GLENN repair (left column) and FONTAN repair (right 
column). RED columns show Pre-Surgery. GREEN columns show Post-Surgery.  
Data are shown as mean ± SEM.  
* = p<0.05  
* 
* 
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Discussions 
The hypoplastic heart syndrome is a rare congenital disease with a very dangerous 
pathophysiology incompatible with life until two decades ago. Nowadays the 
surgical approach is the only way to survive, and it requires three or more surgeries 
in the first three years of life. In this thesis, 4 patients with hypoplastic left ventricle 
and 2 patients with hypoplastic right ventricle were evaluated. Patients were taken 
in different surgical stages (GLENN and FONTAN) and no one was followed since 
the Norwood stage, thus it is difficult to assess the heart behavior. However, some 
interesting speculation can be made. In the HLHS, the GLENN surgery seems to 
have a low impact on the cardiac mechanics, probably due to the deviation of the 
Superior Vena Cava (SVC) flux into the pulmonary artery during the surgery. The 
SVC is responsible for about 20% of the venous flux returning to the right atrium. 
Nevertheless, the importance of this step is well known for its crucial effect on the 
pulmonary vasculature development able to manage the entire venous blood flow 
after the FONTAN step. As a matter of fact, in the FONTAN surgical step, the 
Inferior Vena Cava (IVC) is deviated into the Pulmonary Artery, finally separating 
the venous and the arterial fluxes. In this step the ventricle is unloaded because the 
IVC brings about 80% of the venous system to the Right Atrium. The Vi.Ki.E. 
parameters are in line with this physiological state showing a reduction in all the 
parameters. 
As it concerns the two patients with right hypoplastic ventricle, the data are similar 
to those with left hypoplasia. The main difference is that the GLENN surgery seems 
to have a stronger impact on the ventricle mechanic, while the FONTAN does not 
show any changes. With only one patient for each repair stage, it is very hard and 
inaccurate to assess some hypothesis, however, the difference could be related to 
the different ventricle roles. In the HLHS the RV becomes the systemic ventricle, 
but it does not have the histological properties to perform this task. The RV is, 
indeed, sensible to the load. In the HRHS, the LV is the systemic ventricle perfectly 
fitting its task. The LV is sensible to the pressure and less sensible to load compared 
to RV. The different histological and mechanical properties of LV and RV could 
lead to the different behaviors observed during surgical steps. However, these 
theories need more studies to be confirmed or retracted. 
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3.4.3. Treatments for the Heart Failure 
 
The high Vi.Ki.E. capability to finely evaluate the RV and to provide interesting 
intraoperative data on the heart mechanics in an innovative contactless fashion, led 
to apply this technology on the “holy grail” of the heart pathologies: the heart 
failure. Patients with heart failure have a high percentage of death [124] and the 
only ways to survive are the Ventricular Assist Devices (VAD) implantation and/or 
the Heart Transplantation (HT). Vi.Ki.E. was tested on both pathologies and 
surgeries. In the LVAD implantation, the importance of the RV evaluation is related 
to the statistics, showing that one out of four patients suffers from a RV overload 
after LVAD implantation and a consequent RV failure. For the HT, the importance 
of stating a healthy mechanical behavior after hours of stunning/hibernated 
myocardium, was the main goal of the Vi.Ki.E. evaluation. In the following two 
chapters data regarding patients who underwent LVAD implantation and HT will 
be shown. 
 
3.4.3.1 Left Ventricular Assist Device (LVAD) implantation 
Results 
In this preliminary study on LVAD implantation (Heart mate III™), 5 patients were 
enrolled with an average age of 52.6±17 years. As for the previous surgeries, the 
same epicardial area was tracked before and after the surgery as shown in Figure 
38 A. The Vi.Ki.E.  trajectories and ViCGs, which represents the qualitative data 
of the technique, are displayed in Figure 38 B and C-D, respectively. As it can be 
noted, the ViCGs after the Heart Mate III™ implant (Figure 38, right panels) 
display more noise than those before the surgery (Figure 38, left panels). The same 
occurs for the trajectories where, after the implant, the marker movement is random, 
shrunk and not overlapped (Figure 38, right panel) compared to the one before the 
surgery (Figure 38, left panel). The quantitative data, shown in Figure 39, highlights 
a significant reduction of all the mechanical parameters following LVAD 
implantation. 
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Figure 38. Vi.Ki.E. qualitative data in patients with left ventricular assist device implant. Most explanatory 
patient with LVAD implant. Left column is before the implant. Right column is after the implant. A. Hearts with 
marker (yellow circle) showing the tracked area. B. Trajectories of the yellow marker. C. ViCGs in x axis D. ViCGs 
in y axis.  
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Discussions 
The assist devices are small turbines sucking the blood from the LV apex and 
carrying it directly in the Aorta, therefore bypassing the LV. The VAD implantation 
could be a destination therapy or a palliative before the heart transplantation. One 
of the main issues during the surgery, apart from bleeding and often the risky 
patient’s conditions, is that, once the VAD is turned on, about 30 to 40% of patients 
develop an acute RV overload with a consequent failure that can lead to death [7]. 
The restoring of the arterial flux velocity to a more physiological condition, due to 
the VAD implant, in most cases unload the RV ventricle since the LV request of 
blood supply form the pulmonary circulation is restored, thus restarting the venous 
circulation. However, in some cases, although the patient does not show any 
pulmonary hypertension before surgery (that is an ESC guideline pre-request for 
surgery), the starting of the VAD can lead to an acute engulf in the pulmonary 
circulation with a consequent pulmonary hypertension and RV overload.  
During the video kinematic evaluation of the LVAD patients in this work both the 
situation mentioned above were encountered. 
Figure 39. Vi.Ki.E. most valuable 
clinical parameter in LVAD patients.  
Average mechanical parameters in LVAD 
patients. RED columns show Pre-Implant. 
GREEN columns show Post-Implant.  
Data are shown as mean ± SEM.  
** = p<0.01  
*** = p<0.001  
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Five out of Six patients enrolled in this study showed a mechanical RV unload and 
a consequent decrease in all the Vi.Ki.E. parameters after the Heart Mate III™ 
implant with a good clinical outcome. The sixth patient will be presented later on 
as Case Study Patient #2.  
 
3.4.3.2. Heart Transplantation evaluation 
Heart transplantation is probably one of the most challenging and delicate heart 
surgeries. It requires a very skilled equipe, time and a deep functional parameter 
monitoring. The possibility to have an intraoperative contactless technology able to 
help surgeons in the assessment of the heart mechanics, could be important for the 
patient’s health/recovery as well as the comprehension of phenomena like the 
stunning/hibernated myocardium. The importance to evaluate a healthy heart could 
set the basis for physiological/pathological thresholds usable in the operating rooms 
as a comparison for the good recovery of the patients’ heart after the surgery.  
 
Results 
Figure 40 shows the marker positioning (A, yellow circle) on the two different 
epicardial surfaces before (Left Column), and after (Right column) the transplant. 
As it concerns the Vi.Ki.E. trajectories (Figure 40 B, left and right panels) it can be 
noted that the implanted heart shows a more organized and stable pattern of 
contraction, even if shifted compared to those of the failing heart. As it concerns 
the ViCGs (Figure 40 C-D left and right panels), it can be noted that after the 
implant of the healthy heart (right panels), show less noise than the failing one (left 
panels) in both x and y axes. Furthermore, they are easy to evaluate.  
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Figure 40. Vi.Ki.E. qualitative data in patients with transplanted heart. Most explanatory patient with 
transplanted heart. Left column is the failed heart before the explanation. Right column is healthy heart after the 
implant. A. Hearts with marker (yellow circle) showing the tracked area. B. Trajectories of the yellow marker. C. 
ViCGs in x axis D. ViCGs in y axis.  
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The quantitative data of the 2 patients presented in this chapter will be individually 
shown in a HT performed on a patient with a LVAD and in a HT due to a failing 
heart. 
 
- Patient#1 (58 years), VAD_Bridge to Transplant 
Figure 41 shows the parameters of the failing heart with a LVAD implanted (RED 
columns), and the parameters of the healthy heart (GREEN columns). As it can be 
noted, the mechanical parameters of the implanted heart are all higher than those of 
the failing heart even if helped by the Herat Mate III™. There is no statistical 
significance in the data since the patient was in a dangerous state, thus the video-
recording was limited to let the surgery proceed, thereby invalidating the statistics. 
  
Figure 41. Vi.Ki.E. most valuable clinical 
parameter in a transplanted patient 
previously implanted with LVAD. RED 
columns show failed heart with Heart mate 
III implanted. GREEN columns show the 
healthy heart implanted. To note the 
absence of statistical significance in the 
parameters due to the reduced numbers of 
video recording in the LVAD heart. The 
patient was in a critical state and only 2 
recording have been taken thereby 
impacting on statistics. 
Data are shown as mean ± SEM.  
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- Patient#2 (56 years) 
Figure 42 shows the parameters of the failing heart (RED columns), and the 
parameters of the healthy heart (GREEN columns). As it can be noted, the 
mechanical parameters of the implanted heart are all significantly higher than those 
of the failing heart.  
 
 
Discussions 
The importance of the evaluation of a non-pathological heart will provide important 
physiological/pathological thresholds that could be extremely useful for clinicians 
in the operating room, as an outcome comparison to the basal parameters of a 
healthy heart.  
In this preliminary study, only 2 patients were enrolled in two different stages. One 
of them was a patient with VAD implanted that obtained the HT. The other one was 
a patient with a failing heart due to post-ischemic dilatative cardiomyopathy. As 
expected, all the mechanical parameters increased in the implanted hearts compared 
Figure 42. Vi.Ki.E. most valuable clinical 
parameter in a transplanted patient. 
RED columns show failed heart. GREEN 
columns show the healthy heart implanted.  
Data are shown as mean ± SEM.  
* = p<0.05  
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with failing ones. However, the implanted hearts, in both cases, suffered from a 4-
hour ischemia and hibernation. A deep myocardium hibernation requires a lot of 
time to recover, moreover, this procedure is fastened by the administration of 
inotropic drugs. All these conditions can impair the mechanical evaluation with 
misleading interpretations. Furthermore, the obtained data needs to be handled with 
care. 
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3.4.4. Case studies 
In this paragraph, it will be presented data from 2 patients with inauspicious 
prognosis unfortunately leading them to death for post-surgical complications.  
 
Results 
The first case presented is a patient with congenital valvolopathy of both the 
tricuspid and the pulmonary valves (Case Study Patient #1). The patient underwent 
surgical valvotomy at the age of 4. During years, the patient developed moderate 
tricuspid insufficiency, pulmonary, and arterial hypertension leading to an RV heart 
failure. The physiopathology of this patient is somehow similar to the Tetralogy of 
Fallot, so the results obtained by Vi.Ki.E. were compared to those from the ToF 
study.  
 
Figure 43 shows both the qualitative and quantitative parameters of the Case Study 
Patient #1. As it concerns the qualitative parameters, it is detectable that there are 
no differences both in trajectories and ViCGs before and after the valves’ 
Figure 43. Vi.Ki.E. qualitative and quantitative data in case study patient#1. Upper panels: Trajectories (left) 
and ViCGs in x axis (middle) and y axis (right) before the replacement of both tricuspid and pulmonary valves. Middle 
panels; same as upper panels but after the replacement of the valves. Bottom panels; quantitative parameters before 
(Red columns) and after (Black) the valve replacements.  
Data are shown as mean ± SEM.  
* = p<0.05  
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replacement. In fact, in the trajectories before the surgery, the “+” density is in the 
right top corner showing that the marker was “stuck” in that area, sometimes 
moving in a random way. The same occurs in the trajectories after the surgery, 
where the “+” density is in the bottom right corner of the graph. The ViCGs show 
a very noisy signal with very high spikes that shrink the scale of the graph, making 
it very hard to evaluate. The same behavior occurs in the quantitative data, where 
the parameters after the surgery are higher than those before the surgery but only 
the cardiac fatigue increased significantly.   
 
Discussions 
In the Case Study Patient #1, with a physiopathology comparable with the Tetralogy 
of Fallot, all the parameters increased after the PVR suggesting a worsening in the 
patient’s condition due to an augmented cardiac fatigue and energy consumption. 
The patient was in a critical state even before the surgery due to an elevated degree 
of valvulopathy. Unfortunately, this patient died some days after surgery in the 
intensive care unit. 
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The second case study patient (Case Study Patient #2) is a patient with a post-
ischemic dilatative cardiomyopathy due to an unhealthy diet and smoke abusing. 
Therfore, the patient was scheduled for LVAD implantation.  
 
Results 
Figure 44 shows both the qualitative and quantitative parameters of the Case Study 
Patient #2. The trajectories before the Heart Mate III™ implant (Top panel, left) 
are well conserved and overlapped.  After the implant, the trajectories are totally 
randomized (Middle panel, left). As it concerns ViCGs, it can be noted that before 
the LVAD implant, both x and y axes are easily readable and evaluable (Top panel, 
middle and right). Instead, VICGs after the VAD implant present spikes and, in 
some cases, are difficult to interpret. As it concerns the quantitative parameters it 
can be noted that the mechanical functioning of the heart is impaired with a higher 
ATP consumption and cardiac fatigue. Once again, the lack of statistical 
significance is due to a limited number of recordings caused by the patient’s 
conditions. 
Figure 44. Vi.Ki.E. qualitative and quantitative data in Case Study Patient#2. Upper panels; 
Trajectories (left) and ViCGs in x axis (middle) and y axis (right) before the LVAD implant. Middle panels; 
same as upper panels but after the LVAD implant. Bottom panels; quantitative parameters before (Red 
columns) and after (Black) the LVAD implant. 
Data are shown as mean ± SEM.  
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Discussions 
As stated before a good outcome for LVAD patients is the reduction of all the 
Vi.Ki.E. parameters, since the restored blood flow in the pulmonary circulation and 
the consequent RV unloading. The Case Study Patient #2, however, showed a 
consistent increase of all the mechanical parameters, with a consequent bad 
outcome that worsened during the following days, until the patient, unfortunately, 
passed away.   
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4. DISCUSSIONS 
 
During this Ph.D. period, the Vi.Ki.E. technology has proven a widespread use in 
the clinical field showing a high capabilities to obtain real-time and post-processing 
data from different cardiac pathologies. However, it is essential to discuss “how” 
and “why” a parameter trend could be, in some cases, an improvement, and in others 
could lead to death. Furthermore, the pathophysiological background of the patients 
is crucial and must be taken into account for data interpretation. In this chapter the 
discussion of all the followed surgeries will be merged and summarized.  
 
4.1. CABGs 
 
The pathophysiology of patients in need of coronary bypass lies in the lumen 
reduction of the coronaries usually due to atherosclerotic plaque formation. This 
leads to a decrease in the downstream blood flow, with a consequent ischemia in 
that region. An ischemic region is less contractile due to the decrease of oxygen 
supply, which implies a decrease in the cardiomyocytes ATP production, leading 
to a smaller ejection fraction, and, consequently, to the patients’ fatigue and the 
well know retrosternal pain. The more the arteries are occluded the higher the 
probability that patients will suffer from stroke or cardiac infraction.  
In the Vi.Ki.E. first work [28], it was performed an evaluation in normal rat hearts 
after the sternotomy and pericardial suspension. The anterior descending aorta was 
ligated for 12 minutes, and then it was performed a second kinematic evaluation. 
Finally, the ligation was removed, and a Vi.Ki.E. evaluation was performed after 
12 minutes of reperfusion. Data showed a drastic reduction of all mechanical 
parameters after ischemia and a recovery after the reperfusion. However, the heart 
mechanic after reperfusion was still impaired and did not totally recover compared 
to the data before the ischemia. 
Moving to the patients the same behavior was noticed. The first recording was 
performed at the chest opening in a pathophysiological stage comparable to the rat 
ischemic time-point. After the surgery, a re-evaluation of the heart showed an 
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increase in all the parameters compared to the pathological stage before the surgery. 
It was hypothesized that, with a restored blood flow and optimal oxygen supply, the 
ischemic area recovered due to the augmented ATP formation/consumption and 
consequently the myocardium mechanics ameliorated. Moreover, also the Echo EF 
showed data which ranges around normal values after the surgery. 
 
4.2. ToF 
 
As it concerns the Tetralogy of Fallot physiopathology, the focus and the 
hypothesis-driven approach was completely different compared to CABGs. ToF is 
a congenital heart disease consisting of four simultaneous pathological states 
(whence tetralogy). ToF patients undergo surgery multiple times, depending on the 
development degree of the pulmonary circulation. Once the pulmonary circulation 
is full developed, the child is ready to correct the pathology through the surgery 
with the pulmonary valve replacement (PVR).  
In this work all the patients were in the PVR stage, at different ages as stated before. 
The defects corrected at this stage are the Pulmonary valve stenosis/hypoplasia and 
the consequent RV hypertrophy. Removing the stenosis, thanks to the new synthetic 
pulmonary valve, the RV pressure will decrease with a better blood outflow leading 
to a proper RV unload.  
What Vi.Ki.E. stated, as soon as the valve was replaced, was that all the RV 
parameters drastically decreased. In detail, the cardiac fatigue (an index of Starling 
effect) decreased due to the reduced pressure in the RV after PVR and the removal 
of the related hypertrophy. Energy consumption was reduced as well since the 
myocardium restored a healthy beat reducing its fatigue and thus ATP expenditure. 
Finally, the maximum contraction velocity was reduced due to the ventricular 
unload and fatigue reduction (reduced Starling effect).  
The data obtained with Vi.Ki.E. did not unravel anything new; it is noteworthy that 
the unloading of the ventricle leads to a reduction in the parameters. However, the 
most interesting and pivotal part of that study concerned the debate about the timing 
for PVR.  There are two factions, some clinical equips are more “conservative” 
awaiting until the pathology reaches an advanced stage, and others, with a more 
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“aggressive” approach, assert the importance to perform surgery as soon as possible 
to avoid cardiac remodeling and impairment through years.  
One of the used parameters in the ESC guidelines to time the PVR is the MRI 
RVEDV threshold at 165ml/m2. However, there are some studies showing that this 
value could be too high and the patient could be in a late stage of the pathology 
[86], but even this is a matter of debate. In this thesis, patients above and under this 
threshold were enrolled. What it has been noticed, comparing the most valuable 
Vi.Ki.E. clinical parameters (Energy and Force) with the RVEDV distribution, it 
was that patients under the 150ml/m2 had a very small recovery and parameters 
distribution. On the contrary, patients above 150ml/m2 showed a high intra-surgery 
recovery. However the overall recovery was far from the basal recovery, with 
values often twofold higher compared to those who underwent PVR under the 
threshold. To note, the data distribution was very high.  
Moreover, the conventional intervention (i.e. above 150ml/m2) denoted advantages 
in terms of patient’s recovery compared to those operated early.  However, the 
overall recovery is far from the baseline reached by the patients operated earlier. 
This could lead to the development of future cardiac pathologies or re-
hospitalization. On the contrary, the unconventional intervention (i.e. below 
150ml/m2) has a little impact on the cardiac functionality but could be performed, 
as a prevention, to avoid possible future cardiac pathologies. In particular the 
baseline parameters are drastically lower in those patients rather than in patients 
operated with the conventional surgery. The follow-up monitoring of those patients, 
in the next 5 to 10 years, as well as this study (and the further ones), could lead to 
a reduction of the actual threshold for the surgery and the amelioration of the 
patients’ outcomes.  
 
As it concerns the case study patient#1, with a physiopathology comparable with 
the Tetralogy of Fallot, all the parameters increased after the PVR suggesting a 
worsening in the patient’s conditions due to an augmented cardiac fatigue and 
energy consumption. The patient was in a critical state even before the surgery due 
to an elevated degree of valvulopathy. Unfortunately, this patient died some days 
after surgery in the intensive care unit.  
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4.3. Gender differences 
 
During the ToF study one patient, Patient #3, suffered from an intraoperative 
tachycardia at the ECC exit and all the Vi.Ki.E. parameters resulted higher after the 
PVR compared to those before the PVR. Starting from what happened in the Case 
Study Patient#1, the entire equip was worried about the Patient #3’s condition and 
she was monitored carefully. The patient was dismissed in the average time of the 
other patients with a good outcome. This fact raised a question about Vi.Ki.E. 
technology reproducibility. The only difference in Patient #3 compared to the others 
was the high sinus rhythm reaching a stable 155 beats per minute. It was 
hypothesized that the high frequency could impair or change the heart kinematic. 
Furthermore, it was performed a pacing protocol on rats (both males and females), 
driving the atrium at different basic cycle lengths (BCL), and finally the data were 
evaluated separately in both genders [30]. The results obtained showed that the 
female kinematic increased exponentially with the pacing increase, while the male 
one showed an increase until reaching a plateau followed by a decrease, with a 
changed pattern of contraction. The data confirmed the trend observed in Patient #3 
(a female), confirming the high accuracy of the Vi.Ki.E. technology. Moreover, the 
results confirmed what is already known in literature, asserting that female heart is 
stronger than male heart, probably due to estrogen production, which exerts 
protective properties on the cardiovascular system.  
This work, started as a collateral work, placed the basis for the normalization of the 
Vi.Ki.E parameters according to the cardiac frequency in those cases where the 
reproducibility of the same physiological conditions before and after the surgery is 
challenging.  
 
4.4. Hypoplastic Heart Syndromes 
 
The hypoplastic heart syndrome is a rare congenital disease with a very dangerous 
pathophysiology incompatible with life until two decades ago. Nowadays the 
surgical approach is the only way to survive, and it requires three or more surgeries 
in the first three years of life. In this thesis, 4 patients with hypoplastic left ventricle 
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and 2 patients with hypoplastic right ventricle were evaluated. Patients were taken 
in different surgical stages (GLENN and FONTAN) and no one was followed since 
the Norwood stage, thus it is difficult to assess the heart behavior. However, some 
interesting speculation can be made. In the HLHS, the GLENN surgery seems to 
have a low impact on the cardiac mechanics, probably due to the deviation of the 
Superior Vena Cava (SVC) flux into the pulmonary artery during the surgery. The 
SVC is responsible for about 20% of the venous flux returning to the right atrium. 
Nevertheless, the importance of this step is well known for its crucial effect on the 
pulmonary vasculature development able to manage the entire venous blood flow 
after the FONTAN step. As a matter of fact, in the FONTAN surgical step, the 
Inferior Vena Cava (IVC) is deviated into the Pulmonary Artery, finally separating 
the venous and the arterial fluxes. In this step the ventricle is unloaded because the 
IVC brings about 80% of the venous system to the Right Atrium. The Vi.Ki.E. 
parameters are in line with this physiological state showing a reduction in all the 
parameters. 
As it concerns the two patients with right hypoplastic ventricle, the data are similar 
to those with left hypoplasia. The main difference is that the GLENN surgery seems 
to have a stronger impact on the ventricle mechanic, while the FONTAN does not 
show any changes. With only one patient for each repair stage, it is very hard and 
inaccurate to assess some hypothesis, however, the difference could be related to 
the different ventricle roles. In the HLHS the RV becomes the systemic ventricle, 
but it does not have the histological properties to perform this task. The RV is, 
indeed, sensible to the load. In the HRHS, the LV is the systemic ventricle perfectly 
fitting its task. The LV is sensible to the pressure and less sensible to load compared 
to RV. The different histological and mechanical properties of LV and RV could 
lead to the different behaviors observed during surgical steps. However, these 
theories need more studies to be confirmed or retracted. 
 
4.5. LVAD 
 
The pathophysiology of patients in need of a ventricular assist device is simple: the 
heart failure. The heart failure is the most worldwide spread disease and its 
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incidence will keep increasing in the next decades, especially in the developing 
countries.  
The assist devices are small turbines sucking the blood from the LV apex and 
carrying it directly in the Aorta, therefore bypassing the LV. The VAD implantation 
could be a destination therapy or a palliative before the heart transplantation. One 
of the main issues during the surgery, apart from bleeding and often the risky 
patient’s conditions, is that, once the VAD is turned on, about 30 to 40% of patients 
develop an acute RV overload with a consequent failure that can lead to death [7]. 
The restoring of the arterial flux velocity to a more physiological condition, due to 
the VAD implant, in most cases unload the RV ventricle because the LV request of 
blood supply form the pulmonary circulation is restored, thus restarting the venous 
circulation. However, in some cases, although the patient does not show any 
pulmonary hypertension before surgery (that is a ESC guideline pre-request for 
surgery), the starting of the VAD can lead to an acute engulf in the pulmonary 
circulation with a consequent pulmonary hypertension and RV overload.  
During the video kinematic evaluation of the LVAD patients in this work both the 
situation mentioned above were encountered. 
Five out of Six patients enrolled in this study showed a mechanical RV unload and 
a consequent decrease in all the Vi.Ki.E. parameters after the Heart Mate implant 
with a good clinical outcome. The sixth patient was presented as Case Study 
Patient#2 in the Results section. The patient showed a consistent increase of all the 
mechanical parameters, with a consequent bad outcome that worsened during the 
following days, until the patient, unfortunately, passed away. The LVAD study is 
currently on, thanks to a recently founded European Project (LVAD-STRAT) 
aimed to understand how LVAD implant may impact on LV recovery. 
 
4.6. Heart Transplantation 
 
The final series of surgeries followed was the heart transplantations. The 
importance of the evaluation of a non-pathological heart will provide important 
physiological/pathological thresholds that could be extremely useful for clinicians 
in the operating room, as an outcome comparison to the basal parameters of a 
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healthy heart. Furthermore, the increasing request of hearts for transplantation, due 
to the aforementioned heart failure incidence increase, has led the researcher all 
over the world to work on recreating laboratory functional organs thanks to the 3D 
printing technique. The Vi.Ki.E. technology will play a pivotal role in this field of 
research since the 3D printed hearts will need to pass extremely restrictive 
requirements to be implanted in humans. Vi.Ki.E. could be the Gold Standard 
technique for the evaluation of the mechanical functioning and pressure/load 
managing of those hearts. 
In this preliminary study, only 2 patients were enrolled in two different stages. One 
of them was a patient with VAD implanted that obtained the HT. The other one was 
a patient with a failing heart due to post-ischemic dilatative cardiomyopathy. As 
well as Hypoplastic patients, the obtained data needs to be handled with care 
because there is no statistical potency. As expected, all the mechanical parameters 
increased in the implanted hearts compared with failing ones. However, the 
implanted hearts, in both cases, suffered from a 4-hour ischemia and hibernation. A 
deep myocardium hibernation requires a lot of time to recover, moreover, this 
procedure is fastened by the administration of inotropic drugs. All these conditions 
can impair the mechanical evaluation with misleading interpretations. Furthermore, 
although data seems in line with the expected physiology, it was set up a new 
protocol with the AOUI of Verona with the possibility to record the healthy heart 
just before the explant and finally after the implant in the new patient to compare 
both the condition and correct the errors that could have been introduced in the two 
patients evaluated. The new protocol is still under the evaluation of the ethic 
committee. Moreover, The Verona Hospital performs very few cases of “in house” 
transplant every year. Most of the hearts for HT derive from other Hospitals all 
around Italy where it is actually not possible to have access to. Therefore, a 
multicentric collaboration is crucial to continue this study. 
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5. LIMITATIONS 
The limitations of this study are both technical and theoretical.  
The main technical limitation is the recording of a 3D movement with a two-
dimensional approach. This limitation will be overcome with the novel set-up of a 
single 3D camera or multiples 2D cameras synchronized together to create a 3D 
photogrammetry stereovision. 
As it concerns the theoretical limitations, the main limitation consist in the small 
number of patients for each cohort, limiting the statistic potency. Furthermore, 
except in some isolated studies, the deep correlation between Vi.Ki.E. and Imaging 
Gold Standard techniques like Echocardiography and MRI is lacking.  
Ongoing studies are focusing on the correlation between the kinematics data and 
the PV loop obtained through cardiac catheterization in small (rats) and big (pigs) 
animals as well as the Working Heart/Langendorff approaches.  
Future studies will focus on the correlations with the Gold Standard techniques 
despite the presence of important technical gaps between technologies.  
 
6. CONCLUSIONS 
During my Ph.D. fellowship, I had the unique opportunity to join the Professor 
Giovanni Battista Luciani’s surgical equipe and learn the pathophysiological 
aspects behind each pathology. I also discovered how an operating room works, 
discussing with perfusionists and anesthetists, sharing the knowledge underneath 
our Video Kinematic technology. I also had the opportunity to grow up as an 
“expert” constantly discussing with Elite Scientists, always trying to push me 
towards improvement. 
The experimental environment forced me to be extremely precise and to create 
flawless models and protocols. It was essential in the “review phase” of our 
published articles. 
The Clinical and the Experimental fields led me to understand the translational 
aspects of the research activities, where the data of an ischemia/reperfusion rat 
protocol were compared to the data deriving from revascularized hearts through 
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aortocoronaric bypass, or when an uncommon heart mechanical behavior was noted 
in a female patient leading us to study the heart mechanical aspects in both genders. 
Finally, the development of the Vi.Ki.E. technology and the data obtained from the 
clinical field in a multitude of different procedures led us to consider our technology 
safe and not invasive, with promising possible clinical applications. 
 
The ease in the evaluation and the algorithm-based approach makes Video 
Kinematic Evaluation a widespread technique from the cellular level to Human 
cases, covering the entire experimental field with in-vivo evaluation and possibly 
Langendorff/Working Heart approaches. 
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